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Cytosolic molecular chaperones reactivate misfolded or aggregated proteins by their polypeptide unfoldase activity. Protein 
synthesized de novo follow a native folding pathway under optimal conditions to acquire a terminal tertiary functional structure or may 
assemble to form a functional quaternary oligomer (upper pathway). Under stress or non-native conditions, protein may misfold (2) and 
enter an aggregation pathway (lower pathway), leading to the formation of aggregates and fibrils that can be cytotoxic. Chapter (2) 
presents an innovative method of preparation and biophysical characterization of stable misfolded monomers that were paradigmatic of 
the earliest species in the aggregation process and were unique chaperone amenable substrates that I used in most of the subsequent 
chapters of my thesis. In chapter (3), I addressed the disaggregation mechanism of stable protein aggregates by human Hsp70 and 
Hsp110 that acted as equal partners and synergistically combined their individual ATP-consuming polypeptide-unfoldase activity to 
reactivate stable protein aggregates. In chapter (4), my collaborators and I, showed that Hsp60 could act as a polypeptide unfoldase at 
reactivating stable misfolded proteins without ATP and without necessarily encaging them. In chapter (5) we investigated the role of 
Hsp40 (J-protein) at targeting Hsp70 onto the misfolded substrates and the inhibitory effect of potentially toxic protein aggregates on J-
proteins that rendered Hsp70 unfolding activity less efficient, as in Parkinson’s diseases. In chapter (6) we performed an innovative 
type of meta-analysis of chaperone expressomic data under various stress conditions that revealed possible co-expressions between 
core chaperone machineries and their co-chaperone regulators. Encircled numbers in the figure represent chapters of the thesis.  
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  Abstract
 Under optimal non-physiological 
conditions of low concentrations and low 
temperatures, proteins may spontaneously fold to 
the native state, as all the information for folding 
lies in the amino acid sequence of the polypeptide. 
However, under conditions of stress or high 
protein crowding as inside cells, a polypeptide may 
misfold and enter an aggregation pathway resulting 
in the formation of misfolded conformers and 
fibrils, which can be toxic and lead to 
neurodegenerative illnesses, such as Alzheimer’s, 
Parkinson’s or Huntington’s diseases and aging in 
general. To avert and revert protein misfolding and 
aggregation, cells have evolved a set of proteins 
called molecular chaperones. Here, I focussed on 
the human cytosolic chaperones Hsp70 (DnaK) 
and Hsp110, and co-chaperone Hsp40 (DnaJ), and 
the chaperonin CCT (GroEL). The cytosolic 
molecular chaperones Hsp70s/Hsp110s and the 
chaperonins are highly upregulated in bacterial and 
human cells under different stresses and are 
involved both in the prevention and the reversion 
of protein misfolding and aggregation. Hsp70 
works in collaboration with Hsp40 to reactivate 
misfolded or aggregated proteins in a strict ATP 
dependent manner. Chaperonins (CCT and GroEL) 
also unfold and reactivate stably misfolded 
proteins but we found that it needed to use the 
energy of ATP hydrolysis in order to evict over-
sticky misfolded intermediates that inhibited the 
unfoldase catalytic sites. 
 In this study, we initially characterized a 
particular type of inactive misfolded monomeric 
luciferase and rhodanese species that were 
obtained by repeated cycles of freeze-thawing 
(FT). These stable misfolded monomeric 
conformers (FT-luciferase and FT-rhodanese) had 
exposed hydrophobic residues and were enriched 
with wrong β-sheet structures (Chapter 2). Using 
FT-luciferase as substrate, we found that the 
Hsp70 orthologs, called Hsp110 (Sse in yeast), 
acted similarly to Hsp70 as were bona fide ATP-
fuelled polypeptide unfoldases and was much more 
than a mere nucleotide exchange factor, as 
generally thought. Moreover, we found that 
Hsp110 collaborated with Hsp70 in the 
disaggregation of stable protein aggregates in 
which Hsp70 and Hsp110 acted as equal partners 
that synergistically combined their individual 
ATP-consuming polypeptide unfoldase activities 
to reactivate the misfolded/aggregated proteins 
(Chapter 3). Using FT-rhodanese as substrate, we 
found that chaperonins (GroEL and CCT) could 
catalytically reactivate misfolded rhodanese 
monomers in the absence of ATP. Also, our results 
suggested that encaging of an unfolding 
polypeptide inside the GroEL cavity under a 
GroES cap was not an obligatory step as generally 
thought (Chapter 4). Further, we investigated the 
role of Hsp40, a J-protein co-chaperone of Hsp70, 
in targeting misfolded polypeptides substrates onto 
Hsp70 for unfolding. We found that even a large 
excess of monomeric unfolded α-synuclein did not 
inhibit DnaJ, whereas, in contrast, stable misfolded 
α-synuclein oligomers strongly inhibited the 
DnaK-mediated chaperone reaction by way of 
sequestering the DnaJ co-chaperone. This work 
revealed that DnaJ could specifically distinguish, 
and bind potentially toxic stably aggregated 
species, such as soluble α-synuclein oligomers 
involved in Parkinson’s disease, and with the help 
of DnaK and ATP convert them into from 
harmless natively unfolded α-synuclein monomers 
(chapter 5). Finally, our meta-analysis of 
microarray data of plant and animal tissues treated 
with various chemicals and abiotic stresses, 
revealed possible co-expressions between core 
chaperone machineries and their co-chaperone 
regulators. It clearly showed that protein 
misfolding in the cytosol elicits a different 
response, consisting of upregulating the synthesis 
mainly of cytosolic chaperones, from protein 
misfolding in the endoplasmic reticulum (ER) that 
elicited a typical unfolded protein response (UPR), 
consisting of upregulating the synthesis mainly of 
ER chaperones. We proposed that drugs that best 
mimicked heat or UPR stress at increasing the 
chaperone load in the cytoplasm or ER 
respectively, may prove effective at combating 
protein misfolding diseases and aging (Chapter 6). 
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     Résumé 
 Dans les conditions optimales de basse 
concentration et de basse température, les 
protéines vont spontanément adopter un repliement 
natif car toutes les informations nécessaires se 
trouvent dans la séquence des acides aminés du 
polypeptide. En revanche, dans des conditions de 
stress ou de forte concentration des protéines 
comme à l’intérieur d’une cellule, un polypeptide 
peu mal se replier et entrer dans un processus 
d’agrégation conduisant à la formation de 
conformères et de fibrilles qui peuvent être 
toxiques et causer des maladies 
neurodégénératives comme la maladie 
d’Alzheimer, la maladie de Parkinson ou la chorée 
de Huntington. Afin d’empêcher ou de rectifier le 
mauvais repliement des protéines, les cellules ont 
développé des protéines appelées chaperonnes. 
Dans ce travail, je me suis intéressé aux 
chaperonnes cytosoliques  Hsp70 (DnaK) et 
Hsp110, la co-chaperones Hsp40 (DnaJ), 
le complexe CCT/TRiC et GroEL. Chez les 
bactéries et les humains, les chaperonnes 
cytosoliques Hsp70s/Hsp110s et les 
« chaperonines» sont fortement activées  par 
différentes conditions de stress et sont  toutes 
impliquées dans la prévention et la correction du 
mauvais repliement des protéines et de leur 
agrégation. Hsp70 collabore avec Hsp40 pour 
réactiver les protéines agrégées ou mal repliées et 
leur action nécessite de l'ATP. Les chaperonines 
(GroEL) déplient et réactivent aussi les protéines 
mal repliées de façon stable mais nous avons 
trouvé qu’elles utilisent l’ATP pour libérer les 
intermédiaires collant  et mal repliés du site 
catalytique de dépliage. 
 Nous avons initialement caractérisé un 
type particulier de formes stables de luciférase et 
de rhodanese monomériques mal repliées obtenues 
après plusieurs cycles de 
congélation/décongélation répétés (FT). Ces 
monomères exposaient des résidus 
hydrophobiques et étaient plus riches en feuillets β 
anormaux. Ils pouvaient cependant être réactivés 
par les chaperonnes Hsp70+Hsp40 (DnaK+DnaJ) 
et de l’ATP, ou par Hsp60 (GroEL) sans ATP 
(Chapitre 2). En utilisant la FT-Luciferase comme 
substrat nous avons trouvé que Hsp110 (un 
orthologue de Hsp70) était une authentique 
dépliase, dépendante strictement de l’ATP. De 
plus, nous avons trouvé que Hsp110 collaborait 
avec Hsp70 dans la désagrégation d’agrégats 
stables de protéines en combinant leurs activités 
dépliase consommatrice d’ATP (Chapitre 3). En 
utilisant la FT-rhodanese, nous avons trouvé que 
les chaperonines (GroEL et CCT) pouvaient 
réactiver catalytiquement des monomères mal 
repliés en absence d’ATP. Nos résultats 
suggérèrent également que la capture d’un 
polypeptide en cours de dépliement dans la cavité 
de GroEL et sous un couvercle du complexe 
GroES ne serait pas une étape obligatoire du 
mécanisme, comme il est communément accepté 
dans la littérature (Chapitre 4). De plus, nous 
avons étudié le rôle de Hsp40, une co-chaperones 
de Hsp70, dans l’adressage de substrats 
polypeptidiques mal repliés vers Hsp70. Ce travail 
a révélé que DnaJ pouvait différencier et lier des 
polypeptide mal repliés (toxiques), comme des 
oligomères d’α-synucléine dans la maladie de 
Parkinson, et clairement les différencier des 
monomères inoffensifs d’α-synucléine (Chapitre 
5). Finalement une méta-analyse de données de 
microarrays de tissus végétaux et animaux traités 
avec différents stress chimiques et abiotiques a 
révélé une possible co-expression de la machinerie 
des chaperonnes et des régulateurs de co-
chaperonne. Cette meta-analyse montre aussi 
clairement que le mauvais repliement des protéines 
dans le cytosol entraîne la synthèse de chaperonnes 
principalement cytosoliques alors que le mauvais 
repliement de protéines dans le réticulum 
endoplasmique (ER) entraine une réponse typique 
de dépliement (UPR) qui consiste principalement 
en la synthèse de chaperonnes localisées dans 
l’ER. Nous émettons l’hypothèse que les drogues 
qui reproduisent le mieux les stress de chaleur ou 
les stress UPR pourraient se montrer efficaces dans 
la lutte contre le mauvais repliement des protéines 
et le vieillissement (Chapitre 6). 
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        GENERAL OVERVIEW  
 Anfinsen demonstrated that under 
optimal conditions of low protein concentrations 
and low temperatures, the primary amino acid 
sequence of a polypeptide contains all the 
necessary instructions for its spontaneous 
acquisition of its functional three dimensional 
native conformation (Anfinsen, 1973). Yet, the 
refolding process is often inefficient because 
hydrophobic residues that become abnormally 
exposed to the aqueous phase in stress-unfolded 
or de novo-synthesized polypeptides, may 
spontaneously seek intra-molecular stability by 
forming wrong beta sheets and improper inter-
molecular ensembles generally called aggregates. 
The aggregates-entrapped polypeptides are 
precluded from dissociating and reaching their 
native state within a biologically relevant time-
scale (Dobson, 2003). Moreover, aggregates may 
be cytotoxic, especially to animal cells and cause 
degenerative disorders, such as Parkinson’s, 
Huntington’s and Alzheimer’s diseases (Hinault 
et al., 2006). In order to prevent and retard the 
onset of protein conformational diseases, 
prokaryotes and eukaryotes have evolved a 
complex network of molecular chaperones. The 
most abundant chaperones are classified into five 
canonical families on the basis of sequence 
homology and have been named (1) the small-
Hsps (IbpA/B), (2) the Hsp90s (HtpG), (3) the 
Hsp70s (DnaK), (4) the Hsp104s (ClpB), and (5) 
the chaperonins Hsp60 (GroEL) (E. coli orthologs 
shown in parentheses). Apart from sequence 
homology, molecular chaperones share high 
structural and functional homologies within their 
respective classes. Molecular chaperones are 
abundant and can be found in all the 
compartments of the cell. Thus, Hsp70 and 
Hsp90, which together may be 2 % of the protein 
mass of a human cell, are present in all the ATP-
containing compartments of the eukaryotic cell 
(Finka and Goloubinoff, 2013; Hemmingsen et 
al., 1988; Mattoo and Goloubinoff, 2014).  In 
addition to the canonical molecular chaperones, 
prokaryotic and eukaryotic cells harbour other 
protein molecules, such as foldases (peptidyl-
prolyl-isomerases and protein disulphide 
isomerases) and proteases (ClpAP, FtsH, DegP, 
Lon and 26S protease) and chemical chaperones 
that maintain protein homeostasis. Chaperones 
likely form the first line of the cellular defence 
against stress-induced protein aggregation by 
unfolding misfolded, aggregated or alternatively-
folded proteins, thereby favouring their refolding 
to the native state, foldases directly assist the 
native folding of polypeptides by alleviating 
blockages caused by wrongly oriented prolines or 
wrongly associate disulfide bounds, and proteases 
degradation unnecessary or damaged proteins (for 
further details on chemical chaperones, protein 
chaperones and foldases please see chapter 1). 
 Under physiological conditions, 
molecular chaperones and proteases control 
house-keeping processes of cellular proteostasis, 
such as assisting the proper de novo folding of 
polypeptides exiting the ribosome, or of 
cytoplasmic proteins exiting the import pores in 
the endoplasmic reticulum lumen or the 
mitochondrial matrix. Molecular chaperones also 
activate or inhibit various signalling pathways, 
such as the activation of the steroid hormone 
receptor or the inhibition of heat-shock 
transcription factor-1 (Picard, 2006; Voellmy and 
Boellmann, 2007; Weiss et al., 2007).  Molecular 
chaperones like Hsc70 (an Hsp70 member) 
control vesicle formation by de-oligomerizing 
clathrin cages (Sousa and Lafer, 2006). Hsp70s 
also serve as molecular motors that pull, unfold 
and translocate across membranes proteins that 
are synthesized on cytoplasmic ribosomes, into 
the ER lumen or the mitochondrial matrix. Other 
chaperones may also target short-lived or stress-
damaged proteins to proteasomal or lysosomal 
degradation and reorient mutant proteins prone to 
aggregation back on track of the native folding 
pathway (Hinault et al., 2006). Under stress 
conditions, such as heat-shock or oxidative 
stresses, molecular chaperones like Hsp70s and 
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Hsp60s can prevent actively avert protein 
misfolding and aggregation (Sharma et al., 2009).  
 The first in vitro chaperone assay showed 
that the GroEL chaperonin without ATP could 
effectively bind and prevent the aggregation of 
misfolding intermediates of urea- or acid-
unfolded RubisCO enzymes, with a 
RubisCO:GroEL stoichiometry of about 1:14 
(protomers) (Goloubinoff et al., 1989). Both ATP 
and the co-chaperone GroES were necessary to 
subsequently induce the release of the inactive 
GroEL-bound RubisCO species, into soluble, 
natively refolded RubisCO enzymes (Goloubinoff 
et al., 1989). Later, a similar situation was 
described with other types of chaperones and 
various model unfolded or misfolded substrates. 
For instance, GroEL/GroES and 
DnaK/DnaJ/GrpE chaperones with urea- or 
Guanidine-HCl-unfolded malate dehydrogenase 
(MDH) and rhodanese (Langer et al., 1992) and 
MDH that was pre-bound with GroEL during 
heat-denaturation without ATP and released from 
the chaperone after the heat-stress upon addition 
of ATP and GroES (Diamant et al., 1995). These 
experiments suggested that the primary role of 
chaperone binding is primarily to prevent the 
obligate aggregation of an unfolded polypeptide, 
a function also called holdase, and the role of 
ATP hydrolysis is generally thought to release the 
high-affinity chaperone-bound intermediates to 
allow them refold in solution. However, the 
precise state of the chaperone-bound polypeptides 
remained unclear.  
 A central question in the field, which is 
yet unresolved for lack of being asked by most 
chaperone specialists is, what is the nature of the 
polypeptide substrate when tightly bound to a 
chaperone such as GroEL or DnaK? Is it 
unfolded, alternatively folded, misfolded and/or 
partly aggregated?  
 It has long been assumed, albeit on the 
basis of scarce experimental evidence, that the 
bound polypeptides are nearly completely 
unfolded. This served the widely accepted model 
assuming that sequestration within the GroEL or 
CCT cavities is at the centre of the mechanism by 
which cage-like chaperonins mediate the native 
refolding of aggregation-prone polypeptides 
(Hayer-Hartl et al., 1996; Horovitz and Willison, 
2005; Weber et al., 1998). Hence, the 2011 
Lasker prize was awarded to A. Horwich and FU. 
Hartl “For discoveries concerning the cell's 
protein-folding machinery, exemplified by cage-
like structures that convert newly made proteins 
into their biologically active forms.” 
(http://www.laskerfoundation.org/awards/2011ba
sic.htm).  
 Although other chaperones like Hsp90, 
Hsp70, Hsp40 and the small-Hsps do not 
necessarily form anti-aggregation cages, it is still 
generally maintained that in their case too the 
high-affinity bound polypeptide substrate are 
unfolded. It was assumed that these chaperones 
act primarily as passive devices that prevent 
aggregation (Horwich et al., 2009), rather than as 
active unfolding motors that extend and unwind 
misfolded and aggregated species to convert them 
into natively-refoldable species (Mattoo et al., 
2013; Sharma et al., 2010).  
 A first indication that some molecular 
chaperones may also interact with already stably 
misfolded polypeptides, and not exclusively with 
completely unfolded species, already came from 
the very first in vitro chaperone refolding assay 
25 years ago (Goloubinoff et al., 1989). The assay 
showed that inactive acid-denatured RubisCO, 
which contained many misfolded β-sheets, as 
revealed by circular dichroism, was nearly as an 
amenable substrate for subsequent GroEL-
GroES + ATP dependent refolding, as completely 
urea-pre-unfolded RubisCO. This suggested that 
the chaperonin can apply an unfolding force on 
stable pre-formed misfolded substrate species 
during initial binding (Stan et al., 2003). 
Subsequent ATP hydrolysis and GroES binding, 
would allow the thus unfolded substrate 
polypeptide to spontaneously refold to the native 
state upon release. A similar ability of chaperones 
to act upon stably misfolded polypeptide species, 
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formed beforehand in the absence of chaperones, 
was confirmed in vitro with the bacterial Hsp70 
chaperone system (DnaK/DnaJ/GrpE) using 
preformed heat-denatured (Diamant et al., 2000). 
The mechanism involved first unfolding of the 
stable aggregates in a strict ATP-dependent 
manner, then their refolding to the native state 
upon release. Similarly, DnaK/DnaJ/GrpE, 
assisted by the bacterial co-chaperone ClpB, 
could solubilise stable pre-formed MDH 
aggregates (Goloubinoff et al., 1999) and yeast 
SSA and Hsp104 (ClpB like) could reactivate 
stable preformed luciferase aggregates in a strict 
ATP-dependent manner (Glover and Lindquist, 
1998). Metazoans lack ClpB-like proteins but 
have Hsp110 chaperones, members of Hsp70 
family described as mere nucleotide exchange 
factors that upon collaboration with Hsp70 
functionally resemble ClpB-Hsp70 system. 
Hsp110 was found to collaborate with Hsp70 at 
disaggregating large stable protein aggregates, 
such as luciferase aggregates, α-synuclein fibrils 
and aggregated polyglutamine repeats 
(Duennwald et al., 2012; Mattoo et al., 2013; 
Rampelt et al., 2012; Shorter, 2011). All these 
findings used molecular chaperones in molar 
excess over the substrate, rendering the process of 
reversing the protein aggregation process 
energetically expensive. Moreover, the substrates 
that were used for chaperone-mediated refolding 
were generally prepared in presence of 
chaperones, which limited the estimation of the 
real effect of chaperones on already stable 
misfolded or aggregated proteins. This raised the 
need to develop and characterize obligate stable 
chaperone substrates that were pre-formed in the 
absence of chaperones and moreover that were 
neither obligatorily prone to aggregation nor 
tended to spontaneously refold to the native state 
in the absence of chaperones.  
 To this aim, the Goloubinoff laboratory 
has used in the last decade several new forms of 
chaperone substrates that were prepared in the 
absence of chaperones, such as heat-inactivated 
G6PDH and MDH, and, which were then refolded 
upon addition of chaperones (and ATP). The use 
of these substrates conducted to seminal 
discoveries. For instance, Hsp100 (ClpB) was 
found to cooperate with Hsp70 (DnaK) and use 
ATP to solubilise and reactivate stable inactive 
protein aggregates. Moreover, it was discovered 
that the size of the stable pre-aggregated 
chaperone substrates determined the efficiency 
and the degree of cooperation between chaperone 
systems. It was found that without ClpB, DnaK 
can efficiently solubilize and reactivate small 
aggregates and that the efficiency of the reaction 
decreased as the size of the aggregates increased. 
The refolding efficiency was restored by adding 
either an excess DnaK, or substoichiometric 
amounts of ClpB (Diamant et al., 2000; 
Goloubinoff et al., 1999). Recently, the 
Goloubinoff laboratory generated inactive 
misfolded luciferase monomers that neither 
tended to aggregate nor to spontaneously refold 
without the assistance of chaperones. The 
substrates were generated by repeated freeze thaw 
(FT) cycles and were optimally refolded by the 
bacterial Hsp70 system (DnaK/DnaJ/GrpE). 
These results provided a first proof that molecular 
chaperones, even in sub-stoichiometric amount 
compared to the misfolded substrate, can use the 
energy of ATP-hydrolysis to efficiently unfold 
and reactivate its misfolded inactive polypeptide 
substrate. In this study by Sharma et al., 2010, the 
misfolded (FT-luciferase) substrate was shown to 
bind bacterial Hsp40 and Hsp70 where, as a result 
of ATP hydrolysis it became completely 
unfolded. The unfolded substrate was then 
released from the Hsp70 in a nucleotide exchange 
factor (GrpE)-accelerated manner. The released 
unfolded substrate finally spontaneously refolded 
to the native state, much like in the original 
experiments of Anfinsen, i.e. free in solution 
apparently solely directed by the primary amino 
acid sequence (for details please see chapters 1 
and 7). These results showed that theHsp70 
chaperone acts as ATP-fuelled polypeptide 
unfoldase and not as a foldase per se (Sharma et 
al., 2010). This study suggested that unfolding of 
a misfolded monomeric luciferase substrate by a 
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single DnaK molecule can result from a forceful, 
ATP-fuelled, local “clamping” effect by DnaK on 
a bulky misfolded segment in a polypeptide 
substrate. However, in case the polypeptides were 
severely damaged, the clamping of a single DnaK 
molecule was apparently insufficient to cause 
productive unfolding (Diamant et al., 2000). In 
this case, several DnaKs needed to become 
concomitantly clamped onto the same misfolded 
polypeptide, in order to exert a fruitful 
cooperative unfolding force on the misfolded 
segments that were located in-between the 
chaperone-clamped binding sites. This 
mechanism involving several Hsp70s cooperating 
at pulling on an individual misfolded polypeptide 
entangled within an aggregate was called 
“entropic pulling”. Entropic pulling also applied 
to the mechanism by which an organellar Hsp70 
can cooperate with an import membrane pore, to 
pull upon and unfold an imported cytoplasmic 
polypeptide into the lumen of the endoplasmic 
reticulum or the matrix of mitochondria and 
chloroplasts (De Los Rios et al., 2006). Moreover, 
the study by Sharma et al., 2010 reported the most 
efficient in vitro chaperone mediated refolding 
assay to date. Only 5 ATPs were needed to be 
hydrolysed in order to recover one native 
luciferase from a stable misfolded state. Apart 
from mechanistic insights and energy costs of 
Hsp70 folding cycle, this study provided a 
method of generating new chaperone-amenable 
substrates that can act as novel tool to study the 
mechanisms of other chaperones. 
 At this juncture, I joined Goloubinoff 
laboratory in 2009 and took forward the ongoing 
challenges and obtained several results, which I 
am presenting here in the form of a thesis. The 
thesis is divided into seven chapters. A short 
description of all the interlinked chapters is given 
below: 
 The first chapter is an introduction on 
the different classes of molecular chaperones and 
their mechanisms of action with special emphasis 
on bacterial chaperones that are involved in the 
prevention and reversion of protein aggregation.  
 The second chapter presents the 
biochemical and biophysical characterization of 
two freeze thaw (FT)-generated misfolded 
monomeric species (luciferase and rhodanese) 
that were further used in most experiments 
presented in the subsequent chapters. These 
misfolded species neither tend to spontaneously 
refold to the native state nor to aggregate. We 
found that FT-luciferase and FT-rhodanese were 
differently processed by the Hsp70 chaperone 
machinery and their conformational properties 
were investigated by biophysical techniques: 
Fourier transform infrared spectroscopy (FTIR), 
Circular dichroism (CD) spectroscopy and 
Fluorescence spectroscopy. In spite of their 
monomeric nature, they displayed more non-
native β-sheets, and tertiary structures with 
surface-accessible hydrophobic patches, but 
differed in their conformational stability and 
aggregation propensity. Interestingly, minor 
structural differences between the two misfolded 
species could account for their markedly different 
behaviour in chaperone-mediated 
unfolding/refolding assays. Indeed, only a single 
DnaK molecule was sufficient to unfold by direct 
ATP-fuelled “clamping” a misfolded luciferase 
monomer. In contrast, several DnaK molecules 
proved to be necessary to unfold the more 
resistant misfolded rhodanese monomer by a 
combination of direct clamping and cooperative 
entropic pulling.  
 The third chapter addressed the role of 
human cytoplasmic Hsp70 and Hsp110 in protein 
homeostasis. In this chapter, I showed that human 
cytosolic Hsp110, a member of Hsp70 family, 
acted as bona fide ATP-dependent polypeptide 
unfoldase like Hsp70 and not as a mere 
nucleotide exchange factor as generally thought. 
Moreover, Hsp70 and Hsp110 acted as equal 
partners in the disaggregation of soluble protein 
aggregates where they combine their individual 
polypeptide unfolding activity and synergistically 
reactivate inactive protein aggregates in an ATP 
dependent manner.  
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 The fourth chapter addressed the 
mechanism by which cytosolic chaperonins, 
Hsp60s (GroEL and CCTs), can efficiently 
process to the native state, the stable FT-
rhodanese misfolded substrate that we 
characterized in chapter 2, even without co-
chaperones (GroES) and ATP. We showed that 
both GroEL and the eukaryotic chaperonin can 
unfold the stable misfolded polypeptide 
conformers and readily release them from the 
access ways to the cage. Reconciling earlier 
disparate experimental observations to ours, we 
presented a comprehensive model whereby 
following unfolding on the upper cavity, in-cage 
confinement was not needed and even counter-
productive for the released intermediates to 
slowly reach their native state while being free in 
solution. As over-sticky intermediates 
occasionally stalled the catalytic unfoldase sites, 
GroES mobile loops and ATP were found to be 
necessary to dissociate the inhibitory species and 
regenerate the unfolding activity of GroEL. Thus, 
chaperonin rings were found to be non-obligate 
confining anti-aggregation cages. They were 
rather revealed to be polypeptide unfoldases that 
could iteratively convert stable off-pathway 
conformers into functional proteins but needed an 
ancillary ATP-fuelled removal mechanism to 
evict over-sticky intermediates acting at time as 
competitive inhibitors to the intrinsic catalytic 
polypeptide unfoldase reaction of GroEL and 
CCT. 
 The fifth chapter addressed the role of 
Hsp40 in the Hsp70 folding cycle and the 
consequences of potentially toxic protein 
aggregates (α-synuclein oligomers) on bacterial 
Hsp40 that cause the inhibition of Hsp70 folding 
cycle. We developed a protocol for preparing a 
homogeneous population of highly stable β-sheet 
enriched α-synuclein oligomers with a diameter 
typical of toxic pore-forming oligomers. These 
oligomers were partially resistant to in vitro 
unfolding by the bacterial Hsp70 chaperone 
system (DnaK, DnaJ, GrpE) and ATP. Moreover, 
both bacterial and human Hsp70/Hsp40 
unfolding/refolding activities of model chaperone 
substrates were found to be strongly inhibited by 
the oligomers but, remarkably, not by the 
unstructured α-synuclein monomers, even in large 
20 fold excess. The oligomers acted as a specific 
competitive inhibitor of the J-domain co-
chaperones, indicating that J-domain co-
chaperones may preferably bind to exposed bulky 
misfolded structures in misfolded proteins and, 
thus, complement Hsp70s that lock onto extended 
segments. Together, our findings suggested that 
Inhibition of the Hsp70/Hsp40 chaperone system 
by α-synuclein oligomers may contribute to the 
disruption of protein homeostasis in dopaminergic 
neurons, leading to apoptosis and tissue loss in 
Parkinson disease and related neurodegenerative 
diseases. 
 The sixth chapter presented a meta-
analysis of up-regulated chaperone networks 
under different stress conditions in mammalian 
and plant cells and brought new avenues of 
research for chaperone inducing drugs. We 
performed a meta-analysis of published 
microarray data and compared expression profiles 
of HSP genes from mammalian and plant cells in 
response to heat or isothermal treatments with 
various drugs. The differences and overlaps 
between HSP and chaperone genes were 
analysed, and expression patterns were clustered 
and organized in a network. HSPs and chaperones 
only partly overlapped. Heat-shock induced a 
subset of chaperones, which organized into a 
network with a central core of Hsp90s, Hsp70s 
and sHsps, primarily targeted to the cytoplasm 
and organelles but not to the endoplasmic 
reticulum. Heat was best mimicked by isothermal 
treatments with Hsp90 inhibitors, whereas less 
toxic drugs, some of which non-steroidal anti-
inflammatory drugs, weakly expressed different 
subsets of Hsp chaperones. This type of analysis 
may uncover new HSP-inducing drugs to improve 
protein homeostasis in misfolding and aging 
diseases. 
 The seventh chapter is a review that 
summarized and integrated the major themes of 
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my thesis about the mechanisms of molecular 
chaperones that act mainly as polypeptide 
unfolding enzymes. 
 All the chapters of the thesis have been 
published in peer-reviewed international journals 
and are available online. My contribution in the 
published chapters is explained in detail on a page 
appended before the start of each chapter. 
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RECRUITING UNFOLDING 
CHAPERONES TO SOLUBILIZE 
MISFOLDED RECOMBINANT 
PROTEINS
Rayees U.H. Mattoo and Pierre Goloubinoff
2.1 INTRODUCTION
Anfinsen demonstrated that under optimal conditions, artificially unfolded 
proteins can spontaneously refold into their native conformation without 
requiring external assistance from other molecules. This seminal finding 
implied that the amino acid sequence of a polypeptide suffices to determine 
its native biologically active conformation (Anfinsen, 1973). Yet Anfinsen 
also observed that following artificial unfolding by urea, the yield of recovered 
native proteins decreased significantly as the temperature and protein 
concentration increased, suggesting that alternative nonproductive misfolding 
and aggregation pathways can compete with the physiological native refolding 
pathway of proteins. Destabilizing mutations, high temperatures, and 
prolonged stresses in general can cause more frequent transient unfolding 
events in proteins, which can be followed by misfolding and aggregation 
events. Moreover, early misfolded and aggregated species can be toxic to 
animal cells, neurons in particular. Thus, compact fibrils and amyloids are a 
hallmark of degenerative pathologies such as Parkinson’s and Alzheimer’s 
diseases (Hinault et al., 2006; Uversky, 2008).
2
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As observed while cooking an egg, the higher and longer the exposure to 
denaturing temperatures, the higher will be the oligomeric state, stability, 
compactness, SDS resistance, β-sheet content, and hydrophobic exposure of 
the resulting protein aggregates (Bagriantsev et al., 2006; Khare and 
Dokholyan, 2007; Uversky, 2008; Vendruscolo et al., 2011). With the advent 
of recombinant DNA technology, gene overexpression in bacteria became a 
central tool in biomedical and fundamental research as well as for industry 
(Ventura and Villaverde, 2006). Yet overexpression of recombinant 
polypeptides in bacteria produce inactive polypeptide species tightly 
compacted within insoluble inclusion bodies (IBs). Whereas IB formation 
can be a simple way to isolate large amounts of relatively pure recombinant 
polypeptides, subsequent steps to convert them into soluble functional 
proteins are often limiting. Thus, the effectiveness of iterative rounds of IB 
solubilization and unfolding by urea, guanidinium-HCl, and/or mild 
detergents, followed by refolding to the native state, typically by slow dialysis 
in the presence of osmolytes at low temperatures, determines whether initial 
IB formation is a favorable or a counterproductive prerequisite for the 
effective massive production of a given recombinant protein (Hagel et al., 
1971; Vallejo and Rinas, 2004).
To obtain higher cellular amounts of recombinant proteins in their sol-
uble, natively folded functional state, several parameters can be modified, 
which, however, generally correlate with a reduction in polypeptide 
 production rates by bacteria. Thus, to reduce IB formation, the promoter 
strength can be decreased, the culture media impoverished, and the 
codon usage rarefied. The growth temperature can also be decreased and 
salts and osmolytes can be added to the medium to increase viscosity of 
the folding environment (Diamant et al., 2001; de Marco et al., 2007; 
Bandyopadhyay et al., 2012). Additionally, increasing the number of members 
of the chaperone network can improve the native folding of aggregation-
prone recombinant proteins, either by plasmid-encoded chaperone genes, or 
by increasing the fluidity of the plasma membrane by chemical fluidizers, 
or naturally by heat shock, increasing the bacterial production of endogenous 
chaperones. Yet chaperone overexpression can reduce yields of the 
recombinant protein of interest, artificial fluidizers can be poisonous and 
impair protein synthesis, and heat shock can increase the propensity of a 
labile protein to misfold and aggregate rather than reach its native 
state  (Worrall and Goss, 1989; Strandberg and Enfors, 1991; de Marco 
et al., 2005).
In the next section we discuss the various mechanisms by which chemical 
chaperones, foldases, and unfolding molecular chaperones can prevent 
IB formation in bacteria and convert in vivo, stable misfolded recombinant 
polypeptides into soluble active proteins.
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2.2 CHEMICAL CHAPERONES
Osmolytes are naturally occurring small organic molecules, such as trehalose, 
glycerol, free proline, glycine betaine, trimethylamineN-oxide (TMAO) and 
trimethylglycine, which can be specifically absorbed by cells from the 
surroundings against a gradient of concentrations, or synthetized by cells in 
response to salt dehydration and/or osmotic stress (Diamant et al., 2001, 
2003; Bandyopadhyay et al., 2012; De Los Rios and Goloubinoff, 2012). 
Osmolytes have been shown to inhibit in vitro protein aggregation during 
refolding of unfolded/misfolded proteins and can be considered as chemical 
chaperones standing first in line of the cellular defenses against stress-induced 
protein aggregation. Thus, the accumulation of osmolytes, such as free amino 
acids (proline in particular) and sugars in the cytoplasm, or their presence in 
molar amounts in the in vitro refolding buffer during dialysis, generally 
results in higher refolding yields of various recombinant proteins from urea-
unfolded IBs (Yancey et al., 1982; de Marco et al., 2005). Arginine, glutamic 
acid, and proline are among the most commonly used folding aids to recover 
soluble proteins from IBs (Tsumoto et al., 2010; Wu et al., 2011). The present 
understanding of the mechanism of action of many osmolytes can be attributed 
to their presumed ability to destabilize unstructured segments in polypeptides, 
thereby shifting the free-energy balance in favor of protein conformers with 
a higher content of secondary structures (Cho et al., 2011). Moreover, 
depending on the amino acid composition of polypeptides, various osmolytes 
may be preferentially attracted to, or repulsed from, different unstructured 
segments of the polypeptide. Thus, TMAO may interact more strongly with 
α-helices than with β-structures (Cho et al., 2011). As misfolded proteins 
generally accumulate more misfolded β-structures at the expense of native 
α-helices, the presence of TMAO could favor the refolding of unfolded 
polypeptides into stable native structures and disfavor misfolded structures 
(De Los Rios and Goloubinoff, 2012). Osmolytes alone can act as buffers of 
protein evolution by stabilizing mutants with new functions that have not yet 
reached an optimal folding pathway to the native state (Bandyopadhyay 
et al., 2012). Osmolytes such as glycine betaine, glycerol, proline, alone or at 
best in combination with molecular chaperones (e.g., GroEL, DnaK, and 
ClpB), can assist the de novo folding of polypeptides and stabilization of the 
native end products of the folding reaction (Diamant et al., 2001; Tokuriki 
and Tawfik, 2009). Thus, whereas under nonstressed conditions, polypeptides 
emerging from the ribosome, especially short single-domain polypeptides, 
may not need particular assistance and readily follow the folding path dictated 
by their primary amino acid sequence and reach the native state. Yet when 
mutated or subject to external stress, they may, instead, misfold and aggregate 
(Figure 2.1, cycle I).
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2.3 PPIs AND PDIs ARE FOLDING ENZYMES
The native folding of some polypeptides may be limited by unfavorable dis-
tribution between cis- and trans-prolines and by the formation of the wrong 
disulfide bonds, requiring assistance of folding enzymes of peptidyl prolyl 
isomerases (PPIs) and protein disulfide isomerases (PDIs), respectively.
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FIGURE 2.1 Schematic representation of the E. coli unfolding chaperone network 
promoting the native folding of aggregation-prone recombinant proteins. As nascent 
polypeptides (purple) emerge from the ribosome, the trigger factor, which is a PDI 
associated with the ribosome, assists in the sequential shaping of small native-like 
domains. Once released from the rhibosome and trigger factor, the partially folded 
proteins may reach the native state spontaneously, possibly assisted by chemical 
chaperones (cycle I). Yet, under stress or when mutated, they may instead misfold 
and become unfolded by the DnaK (KJE) system (cycle II), or by the GroEL/GroES 
chaperonin system (cycle III). In case the misfolded monomers escape unfolding by 
KJE or GroELS, they may form stable aggregates and IBs, but the KJE system can 
collaborate with ClpB to use the energy of ATP hydrolysis to unfold and solubilize 
individual polypeptides from the stable aggregates (cycle IV), thereby allowing 
them to reach their native state spontaneously. (See insert for color representation of 
the figure.)
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Native proteins have a strong bias in favor of cis-prolines, which may be 
lost in the unfolded state. Reacquisition of biased cis-prolines can be rate 
limiting for native folding and lead to aggregation (Brandts et al., 1977). 
Several classes of PPIases, such as cyclophilins, FK-506 binding proteins 
(FKBPs), and parvulins, can accelerate the cis-trans isomerization of prolines 
in refolding proteins and thus overcome rate-limiting steps in the folding 
pathway. Hence, the Escherichia coli trigger factor (TF), which is the first 
protein to interact with nascent chains exiting the ribosome (Deuerling and 
Bukau, 2004) (Figure 2.1), can catalyze prolyl-cis-trans isomerization of the 
nascent polypeptide while assisting in the sequential shaping of small protein 
domains (Stoller et al., 1995).
In the oxidative environment of the endoplasmic reticulum lumen, the 
cysteines of secreted proteins can wrongly associate with one another and 
lead to protein misfolding and aggregation. Thus, in his experiment with 
ribonuclease A, Anfinsen found that removing β-mercaptoethanol before 
removing the urea led to a dramatic decrease in the recovery of activity. This 
was attributed to the formation of random disulfide bridges between the eight 
cysteines present in the protein. Protein disulfide isomerases (PDIs) are 
folding enzymes, which, by virtue of their ability to disallow nonnative disul-
fide bonds can accelerate the formation of properly aligned disulfide bonds in 
native structures. However, because the bacterial cytoplasm is reduced and 
correspondingly less favorable to disulfide bonds than the endoplasmic 
reticulum lumen, the role of PDIs in the production of soluble recombinant 
proteins in the cytoplasm of bacteria is less relevant than for eukaryotes, 
where secreted proteins such as immunoglobins and pro-insulin need to be 
stabilized by properly aligned disulfide bonds.
2.4 MOLECULAR CHAPERONES
Behind the chemical chaperones and alongside the PPIs and PDIs foldases, 
the molecular chaperones form another line of active cellular defenses 
against stress- and mutation-induced protein misfolding and aggregation. 
Noticeably, although generally referred to misleadingly as being heat-shock 
proteins (Hsps), many molecular chaperones but not all are stress-inducible 
proteins. For example, of about 120 identified molecular chaperones, 
co-chaperones, and foldases that form the human genome, only a third are 
heat-induced (Finka et al., 2011). All molecular chaperones control cellular 
proteostasis by sharing the ability to screen the surfaces of potential 
misfolded or alternatively folded protein substrates, for nonnative structural 
elements, such as abnormal β-sheets associated with hydrophobic patches 
exposed to the aqueous phase (Hinault et al., 2006). They may act as passive 
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“holding” chaperones upon mere binding to misfolding polypeptide inter-
mediates, thus preventing further aggregations, and/or as active polypeptide 
unfoldases, which upon hydrolyzing ATP can pull apart stable aggregates 
and open stable misfolded structures in misfolded polypeptides, thereby 
promoting spontaneous folding to the native state (Nollen et al., 1999; 
Sharma et al., 2009). In addition to their role under stress, heat shock in 
particular, molecular chaperones may also carry housekeeping cellular 
functions, such as controlling the assembly and activity of native protein 
complexes (Morgan et al., 2001; Weiss et al., 2007); targeting and importing 
proteins into organelles; and blocking or activating various receptors, 
signaling proteins, and transcription factors. Importantly, chaperones are 
also involved in the selection of proteins to be targeted for degradation 
(Muchowski and Wacker, 2005).
Most molecular chaperones can be classified within five canonical  families 
on the basis of sequence homologies and have been named according to their 
approximate molecular mass on SDS gels (in kilodaltons): (1) the small Hsps 
(IbpA/B), (2) the HSP90s (HtpG), (3) the HSP70s (DnaK), (4) the HSP104s 
(ClpB), and (5) the chaperonins HSP60 (GroEL) (E. coli orthologs shown in 
parentheses).
2.5 THE SMALL Hsps
The small Hsps (sHsps) are a family of ubiquitous chaperones found in 
bacteria and most cellular compartments of plants, fungi, and animal cells. 
They share a conserved 80- to 100-amino acid α-crystallin domain. The 
small Hsps do not hydrolyze ATP. They include mammalian Hsp27 and 
α-crystallins; organellar Hsp23, Hsp17, and Hsp16; and bacterial IbpA/B 
(E. coli) and Hsp17 (Synechocystis). IbpA and IbpB were originally isolated 
from inclusion bodies formed during the overproduction of recombinant 
proteins in E. coli cells and accordingly named inclusion body binding 
protein A/B. IbpA/B can also coaggregate with endogenous E. coli proteins 
and stress-misfolded proteins (Laskowska et al., 1996, 2003). Deletion of the 
ibpA/B operon resulted in a twofold increase in aggregated proteins and a 
10-fold decrease in cell viability under stress conditions (Kuczynska-Wisnik 
et al., 2002). Indicating a possible overlap with other chaperone functions, 
overexpression of IbpB can alleviate thermo-sensitive point mutations of 
GroEL (Veinger et  al., 1998). The oligomeric state and chaperone-like 
activity of IbpB is temperature responsive: Heat shock decreases IbpB’s 
oligomeric size while increasing its chaperone-like activity (Jiao et al., 2005). 
By virtue of their association with misfolded proteins in IBs, the two E. coli 
sHsps (IbpA/B) are pivotal to the possible solubilization of IBs, as they 
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can  optimally present bound misfolded polypeptides to other unfolding 
chaperone systems, such as DnaK/DnaJ/GrpE and GroEL/GroES (Veinger 
et  al., 1998) or to the disaggregating machinery ClpB-DnaK/DnaJ/GrpE 
(Mogk et al., 2003; Lethanh et al., 2005). In addition to preventing aggregation 
by passive binding, sHsps may also mediate the refolding of unfolded species 
to the native state (Lee and Vierling, 2000; Basha et al., 2004).
2.6 Hsp90
Hsp90s, named HtpG in bacteria and tumor necrosis factor receptor-associated 
protein (TRAP) in animal mitochondria, are among the most abundant 
proteins in human cells. They form dimers that can interact with a broad 
spectrum of misfolded, translocating, and native “client” proteins, particularly 
with polypeptides involved in signal transduction (Pearl and Prodromou, 
2006). Structurally and mechanistically, it is not clear precisely where and 
how the various clients bind the Hsp90 dimers. The ATPase cycle is intimately 
coupled to the opening and closing of the dimer, which could act as a molecular 
clamp (Chadli et al., 2000; Prodromou et al., 2000), suggesting that Hsp90 
may unfold its various misfolded or alternatively folded “clients,” similar to 
other ATPase chaperones, (Walerych et al., 2010). Whereas eukaryotes require 
a functional cytoplasmic Hsp90 for viability (Borkovich et al., 1989; Versteeg 
et al., 1999), the E. coli HtpG knockout has no apparent phenotype. Thus, 
although HtpG is a highly conserved heat-inducible molecular chaperone, 
it  is not a primary E. coli chaperone to improve the transitions between 
aggregated and native state in recombinant proteins.
2.7 Hsp70/Hsp40
The Hsp70 system, which in eubacteria is composed principally of DnaK and 
of its two co-chaperones DnaJ and GrpE, forms the central hub of the E. coli 
chaperone network (Hesterkamp and Bukau, 1998). Without ATP, DnaK and 
its co-chaperone DnaJ can prevent protein aggregation by mere passive 
“holding” of the labile proteins. Yet in the presence of DnaJ and ATP, 
prevention of aggregation by DnaK can be improved dramatically, suggesting 
an active process (Sharma et al., 2011). Moreover, the bacterial DnaK–
DnaJ–GrpE (KJE) system can act as powerful polypeptide unfolding 
machinery that can catalytically unfold misfolded polypeptide monomers 
(Figure  2.1, cycle II) and disaggregate small soluble complexes of heat-
denatured proteins (Diamant et al., 2000; Sharma et al., 2010). The mechanism 
by which the bacterial Hsp70 (KJE) system may facilitate substrate native 
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folding comprises five main steps: (1) DnaJ and low-affinity ATP-DnaK bind 
a high-affinity misfolded polypeptide substrate. This triggers ATP hydrolysis 
in DnaK and the dissociation of the J-domain of DnaJ; (2) the ADP-DnaK 
“locks” onto the misfolded substrate and, by doing so, unfolds the substrate; 
(3) Unfolding of the polypeptide causes DnaJ dissociation from it (Hinault, 
2010); (4) GrpE drives the release of ADP from DnaK and the release of the 
unfolded intermediate from DnaK; (5) the released intermediate spontaneously 
refolds in solution into a low-affinity native product, or misfolds again and 
re-enters the chaperone cycle as a high affinity substrate (Sharma et al., 2010) 
(Figure 2.1, cycle II). When, despite the unfolding activity of KJE, misfolded 
polypeptide became entangled and packed within IBs, the bacterial KJE 
system can recruit the  disaggregating co-chaperone ClpB (Diamant et al., 
2000) (Figure 2.1, cycle IV), which is a member of the AAA + superfamily 
(ATPases associated with a variety of cellular activities). The KJE system can 
activate and recruit the ClpB hexameric rings to the polypeptide aggregates 
(Oguchi et al., 2012). Individual polypeptides become disentangled upon 
being partially threaded in an ATP-dependent manner through the central 
channel of the ClpB hexameric ring (Haslberger et al., 2008) This may lead 
to dissociation of individual misfolded polypeptides from the aggregates, 
whose final refolding to the native state may, further, need partial unfolding 
by the KJE system (Goloubinoff et al., 1999) (Figure 2.1, cycle IV).
By virtue of its strong ATP-fueled unfolding and disaggregating activities, 
the KJE system is the most important chaperone machinery to maintain 
overexpressed recombinant proteins in a soluble form in E. coli cells and in 
vitro. It may also act in concert with other chaperones, such as GroEL, either 
upstream, by conditioning misfolded monomers to be fed to the GroEL cavity 
(Langer et al., 1992; Veinger et al., 1998), or downstream, by processing 
GroEL-released inactive species into natively refoldable species (Buchberger 
et al., 1996) (Figure 2.1, cycle III).
2.8 GroEL CHAPERONINS
GroEL is a complex of 14 identical 57-kDa subunits arranged as two back-to-
back heptameric rings with two noncommunicating open cavities. The distal 
surfaces of the GroEL cavities exposed hydrophobic residues that nonnative 
polypeptide substrates can access from the external solution (Braig et al., 
1994). GroES is a seven-membered ring of 10-kDa subunits that can cap one 
or both open ends of the GroEL cavities. The cage-like structure of GroEL is 
thought to mediate its chaperone activity (Horwich, 2011). Upon transiently 
sequestering stress-denatured or newly synthesized polypeptides in the cavity 
under GroES caps, GroEL is thought to prevent deleterious misfolding and 
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aggregation events during the folding process (Figure 2.1, cycle III). Increased 
expression of both GroEL and GroES on a high-copy-number plasmid 
has  been shown to increase the solubility and activity of recombinant 
cyanobacterial RubisCO (Goloubinoff et al., 1989). Moreover, co-expression 
on the same plasmid of up to four different complementing chaperone 
systems—IbpA/B, DnaK/DnaJ/GrpE, ClpB, and GroEL/GroES—can 
produce very high yields of soluble, natively folded recombinant proteins (de 
Marco et al., 2007).
2.9 CONCLUSIONS
A detailed understanding of the mechanisms by which chemical chaperones, 
folding enzymes, and various molecular chaperones can collaborate to pre-
vent and actively revert misfolding and aggregation events in the cell is 
necessary for the successful massive production of soluble native recombinant 
proteins in bacteria. This can be achieved by reducing the synthesis rate, and 
thus the burden on the protein quality-control network, as well as by increasing 
the concentrations of chemical and protein chaperones in the cytoplasm. In 
addition to the advantages for biotechnology, finding new ways to increase 
the cellular levels of various molecular chaperones, particularly in animal 
cells, holds biomedical promises to find cures to protein-conformational 
diseases.
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Edited by J. BuchnerAbstractMisfolded polypeptide monomers may be regarded as the initial species of many protein aggregation
pathways, which could accordingly serve as primary targets for molecular chaperones. It is therefore of
paramount importance to study the cellular mechanisms that can prevent misfolded monomers from entering
the toxic aggregation pathway and moreover rehabilitate them into active proteins. Here, we produced two
stable misfolded monomers of luciferase and rhodanese, which we found to be differently processed by the
Hsp70 chaperone machinery and whose conformational properties were investigated by biophysical
approaches. In spite of their monomeric nature, they displayed enhanced thioflavin T fluorescence, non-native
β-sheets, and tertiary structures with surface-accessible hydrophobic patches, but differed in their
conformational stability and aggregation propensity. Interestingly, minor structural differences between the
two misfolded species could account for their markedly different behavior in chaperone-mediated unfolding/
refolding assays. Indeed, only a single DnaK molecule was sufficient to unfold by direct clamping a misfolded
luciferase monomer, while, by contrast, several DnaK molecules were necessary to unfold the more resistant
misfolded rhodanese monomer by a combination of direct clamping and cooperative entropic pulling.
© 2013 Elsevier Ltd. All rights reserved.Introduction
Anfinsen demonstrated that the sole primary
sequence of a polypeptide can dictate the three-
dimensional structure of its native state.1 However,
under non-physiological and stressful conditions,
mutant and labile proteins can misfold and assemble
into oligomers and higher-molecular-weight aggre-
gates, with various degrees of toxicity to cells,
leading to degenerative tissue loss. Protein misfold-
ing is the central cause for a number of pathological
conditions, generally referred to as protein confor-
mational diseases, associated with the formation of
highly organized protein aggregates, as in the case
of diabetes type 2, amyotrophic lateral sclerosis,
cystic fibrosis, and a rising number of neurodegen-
erative diseases, such as Alzheimer, prion, and0022-2836/$ - see front matter © 2013 Elsevier Ltd. All rights reserveParkinson diseases.2–5 There is increasing evi-
dence that cytotoxicity correlates with the more
soluble misfolded protein conformers with a high
surface-to-volume ratio. Presenting abnormally ex-
posed hydrophobic surfaces, the misfolded con-
formers likely cause toxicity by partaking in aberrant
interactions with the hydrophobic components of the
cell, primarily cellular membranes and other hydro-
phobically exposed misfolded proteins that can co-
aggregate and seed other amyloidogenic species
into fibrils, tangles, amyloids, and even infectious
prions.6–10 In contrast, the later species in the
misfolding pathway, such as large amyloid fibrils,
tangles, and other insoluble aggregates, although
still associated to a certain degree of toxicity,11 are
generally considered less harmful than the more
soluble species. The active compaction in cells ofd. J. Mol. Biol. (2013) 425, 1158–1171
1159Stable Misfolded Monomers as Chaperone Substratesthe soluble misfolded protein species by the aggre-
some thus appears to be a costly, yet effective
mechanism to detoxify protein aggregates.12–14
Whereas oligomers and end products of the
aggregation pathway have been widely character-
ized by various biochemical and biophysical
means,2,7,10,15 little is known about the structural
properties of full-length misfolded monomeric
polypeptides16 at the state where they waver
between reverting to the native state or further
proceeding into the aggregation pathway. This
knowledge is of great importance to the understand-
ing of how proteotoxic species develop in protein
conformational diseases and more efforts are
required to identify the initial events that lead to the
formation of early species, misfolded monomers in
particular.
Molecular chaperones are key components of the
cell that can counteract and actively revert poten-
tially toxic misfolded polypeptides into non-toxic
active species and reorient them from the aggrega-
tion pathway onto the native refolding pathway.4,17
Recently, a stable misfolded full-length 63 kDa
monomeric luciferase species [freezing-thawing
luciferase (FT-Luc)] has been isolated, which tends
to neither spontaneously refold to the native state
nor aggregate within the experimental time frame.18
Thus, although monomeric, FT-Luc is a stringent
chaperone substrate,19 whose unique ability to stay
un-aggregated was used to demonstrate that chap-
erones do not need to act as mere anti-aggregation
devices but also use ATP to catalytically unfold
stable misfolded polypeptide substrates into natively
refoldable products. Hence, in the presence of
substoichiometric amounts of DnaK, and of its co-
chaperones DnaJ and GrpE (KJE), the misfolded
FT-Luc can become transiently unfolded in a strict
ATP-dependent manner. Subsequent to GrpE-ac-
celerated ADP and luciferase release, the unfolded
luciferase polypeptide spontaneously refolds into the
native state with a very high efficiency.18 Therefore,
DnaK acts as a catalytic ATP-dependent polypep-
tide unfoldase enzyme, capable, together with DnaJ,
to recognize and iteratively bind misfolded luciferase
monomers, unfold, and subsequently release them
in a sufficiently unfolded state, allowing them to
thereafter spontaneously refold to the native state.
When polypeptides are more severely damaged, as
in the case of the small soluble aggregates of heat-
denatured glucose-6-phosphate dehydrogenase
(G6PDH),20 the clamping of a single DnaK molecule
is not sufficient to cause productive unfolding. In this
case, several DnaKs need to become concomitantly
clamped onto the same misfolded polypeptide, to
exert a fruitful cooperative unfolding force on in-
between misfolded segments, in a mechanism
called entropic pulling.21
The unfoldase activity of the Hsp70 chaperones
thus provides cells with a unique mechanism toactively counteract protein aggregation by neutral-
izing early species such as misfolded monomers
and small oligomers on the misfolding pathway,
before they can reach critical concentrations to
aggregate into more toxic species. The energy cost
to unfold early misfolded monomers was estimated
to be a thousand fold less than for heavily
aggregated species to be first degraded by ATP-
consuming proteases and then resynthesized into
new functional polypeptides.18
Because it is essential to understand the mecha-
nisms by which the cellular machinery can prevent
misfolded monomeric species from entering the
aggregation pathway, we investigated here the
conformational properties of two stable full-length
misfolded monomeric polypeptides generated by
iterative cycle of freeze–thawing, a misfolded 63-
kDa luciferase monomer (FT-Luc)18 and a stable
misfolded 33-kDa rhodanese monomer [freezing-
thawing rhodanese (FT-Rho)]. We characterize here
FT-Rho for the first time and show it to be a stringent
amenable substrate to the Hsp70 chaperone ma-
chinery. In particular, we examined through various
complementary biophysical approaches the structur-
al differences between the two misfolded monomeric
species. Compared with their native conformers, the
FT-Rho and FT-Luc displayed a similar gel-filtration
profile typical of globular monomers with, however,
appreciably increased exposure of hydrophobic
patches. Although both misfolded monomeric spe-
cies contained a similar amount of non-native
intramolecular β-sheets and tertiary structures, they
markedly differed in terms of their intrinsic stability in
urea and aggregation propensity under heat stress.
Interestingly, in correlation with the markedly higher
stability in urea of FT-Rho, compared to FT-Luc, we
found that FT-Rho was also more resistant to
chaperone-mediated unfolding than FT-Luc. Unlike
FT-Luc, FT-Rho could be refolded only by a large
molar excess of DnaK necessary to unfold very
resistant misfolded species by cooperative entropic
pulling, highlighting that minor structural differences
can be relevant to the chaperone specificity and
unfolding/refolding efficacy.Results
Production of the misfolded monomers
We have reported earlier that consecutive cycles
of rapid freezing-thawing can generate, in phosphate
buffer, a high proportion of stable misfolded mono-
mers of diluted solutions (less than 3 μM) of
Photinus pyralis luciferase (Luc) variant.18 This
misfolded monomer (FT-Luc) was found to bind 1.8
times more thioflavin T (ThT) than the native
luciferase (Nat-Luc). As it did not significantly refold
1160 Stable Misfolded Monomers as Chaperone Substratesto the native state without chaperones and ATP, FT-
Luc was a stringent substrate of the bacterial
chaperone unfoldase system KJE.18 We developed
here a similar protocol to generate and purify a
seemingly uniform population of metastable mis-
folded monomeric rhodanese (FT-Rho) species that,
similarly to FT-Luc, was inclined to neither sponta-
neously aggregate nor significantly convert into the
native state within the experimental time frame of our
in vitro chaperone assays and biophysical measure-
ments. Figure 1a shows that following 10 successive
cycles of freezing at −160 °C and slow (45 min)
thawing to 4 °C, the native rhodanese (Nat-Rho)
became stably inactive up to 93%. After centrifuga-
tion (12,000g, 10 min) that removed about 40–45%
of the protein in the form of insoluble aggregates, gel
filtration showed that most of the remaining soluble
FT-Rho eluted as inactive monomers (Fig. 1b).
Although non-globular misshaped elongated pro-
teins may elute sooner on gel filtration and be
mistaken for larger proteins, it is not known that
oligomeric proteins abnormally elute later, precisely
where monomers do. Similar to native, but unlikeFig. 1. Nat-Rho can be inactivated by freeze–thawing and
activity before and after successive rounds of rapid freezing-th
enzymatic activity and ThT binding of Nat-Rho (upper) and FT
void volume, of the 800-kDa GroEL14 oligomers, and of the 3
(empty bars) and levels of ThT binding (gray bars) and of lightheat-denatured rhodanese (HD-Rho), FT-Rho did
not scatter light (Fig. 1c). Limited cross-linking
confirmed its monomeric nature (Fig. S1). Indeed,
whereas treatment with 0.012% glutaraldehyde (GA)
fully cross-linked HD-Rho aggregates, as evidenced
by their inability to enter and migrate in the SDS gel,
GA-treated Nat-Rho and FT-Rho entered the gel and
resolved as SDS-soluble monomers (Fig. S1). Thus,
as previously demonstrated by analytical ultracen-
trifugation in the case of FT-Luc,18 both FT-Rho and
FT-Luc are inactive metastable species that are
mostly monomeric.
Fluorescence spectroscopy showed that FT-Rho
bound 3.5 times more ThT than the native protein
(Fig. 1c), as already found in the case of FT-Luc that
displayed a 1.8-fold increase in ThT fluorescence,
compared to Nat-Luc.18 Lengthy incubations of FT-
Rho in buffer (i.e., without chaperones) at 22 °C
showed a very low rate of spontaneous refolding of
about 3% in the first hour (Fig. 2b), reaching ~12%
after 18 h (data not shown). Therefore, we generated
here a second example of a metastable inactive
misfolded monomeric species, whose chaperoneisolated as stable misfolded monomers. (a) Rhodanese
awing for 45 min at 4 °C. (b) Gel-filtration elution profile of
-Rho (lower panel). Arrows show the elution volume of the
3-kDa Nat-Rho monomers. (c) Relative enzymatic activity
scattering (black bars) of Nat-Rho, FT-Rho, and HD-Rho.
Fig. 2. Stable misfolded FT-Luc and FT-Rho monomers are refolded to the native state by the bacterial DnaKJE
chaperone system in a strict ATP-dependent manner. (a and b) Time-dependent refolding to the native state of 1 μM FT-
Luc (a) and 1 μM FT-Rho (b) in the presence of increasing DnaK concentrations (from 0 up to 6.4 μM, as indicated) and of
a constant concentration of 0.5 μM DnaJ, 0.7 μM GrpE, and 5 mM ATP. Refolding at 22 °C was evaluated from the
recovered enzymatic activity. (c and d) Initial rates (c) and yields of refolding after 60 min (d), evaluated from the data
reported in (a) and (b), are shown as a function of the DnaK concentration. Broken lines indicate the equimolar
concentration of DnaK and substrate.
1161Stable Misfolded Monomers as Chaperone Substratesamenabilities and biophysical properties could be
further analyzed.
Both stable misfolded luciferase and rhodanese
monomers are chaperone substrates
FT-Luc has been previously shown to be a stable
misfolded monomeric species that behaved as a
stringent substrate of the KJE chaperone unfoldase
system, where ATP hydrolysis fueled substrate
unfolding, whereas subsequent native refolding
occurred spontaneously.18 We therefore next tested
the ability of FT-Rho to be converted into Nat-Rho by
the ATP-fueled KJE chaperone system, as com-
pared to FT-Luc (Fig. 2a and b). FT-Rho was found
to behave as a specific, stringent ATP-dependent
KJE substrate (Fig. 2b), albeit it refolded to the native
state at lower rates than FT-Luc. Thus, in the
presence of 1.6 μM DnaK, FT-Rho was refoldedthree times more slowly than FT-Luc and the yields
were 3.5 lower, a difference that dramatically
increased when DnaK was equimolar or substoichio-
metric to the substrate (Fig. 2c and d). As expected,
the ATP cost of the unfolding/refolding reaction was
also different. The addition of 1 μM FT-Rho doubled
the rates of ATP hydrolysis by 6.4 μM DnaK (0.5 μM
DnaJ, 0.7 μM GrpE), while Nat-Rho had no signif-
icant effect (Table S1), confirming that FT-Rho is a
substrate that strongly interacts with DnaK and that
Nat-Rho is a low-affinity product of the chaperone
reaction. Yet, as expected from the slow rate of FT-
Rho refolding, the apparent ATP cost of the
unfolding/refolding reaction by DnaK was high.
Indeed, a 6.4-fold molar excess of DnaK over the
FT-Rho substrate reactivated a single Rho polypep-
tide, at the approximate net cost of 850 ATPs (Table
S1). Similarly high ATP costs have been observed
with urea heat-denatured G6PDH,20 in contrast with
1162 Stable Misfolded Monomers as Chaperone Substratesthe low net cost of 5 ATPs for substoichiometric
amounts of DnaK to refold FT-Luc molecule.18
Although slow and energy consuming, 6.4 μM
DnaK specifically accelerated the rate of spontane-
ous FT-Rho refolding by 100-fold, qualifying FT-Rho
as a stringent chaperone substrate. Moreover, the
chaperone reaction was not inhibited by the pres-
ence of up to a 16-fold molar excess of native malate
dehydrogenase, or native G6PDH (Fig. S2), both of
which are typical native products of KJE-mediatedFig. 3. FT-Rho is more stable than FT-Luc. Stable
inactive FT-Rho (continuous line) and FT-Luc (dotted
line) were incubated for 1 h at 25 °C in the presence of
increasing concentrations of urea and of 60 μM ThT. (a)
ThT fluorescence was measured and normalized to the
signal without urea, with (100% intensity) and without
(0% intensity) proteins. (b) The samples from (a) were
then diluted in refolding buffer, and after 3 h at 25 °C,
the recovered rhodanese or luciferase activities were
measured. The reported FT-Rho results are representa-
tive of three independent experiments. The FT-Luc data
were taken from a previous work18 and shown here for
comparison.refolding reactions.20,22 Thus, FT-Rho is a bona fide
chaperone substrate because it does not significantly
refold to the native state without chaperones and
because DnaK can identify it as a high-affinity
substrate, in contrast to low-affinity native products
of the chaperone reaction.
FT-Rho is more stable than FT-Luc
To address the reasons for the difference of
chaperone amenability between the two species,
we next measured their steady-state ThT fluores-
cence in the presence of increasing urea concen-
trations. Remarkably, FT-Luc lost half of its
misfolded ThT-binding structures in the presence
of as little as 0.7 M urea, as compared to 3.3 M urea
in the case of FT-Rho (Fig. 3a). Similarly, following
dilution of the urea-treated samples, half-maximal
yields of spontaneously refolded species were
obtained with FT-Luc pretreated with 3.6 M urea,
as compared to 4.3 M in the case of FT-Rho
(Fig. 3b). Together, this shows that FT-Rho is a
much more stable misfolded species than FT-Luc.
Indeed, FT-Rho needed higher concentrations of
urea, or of unfolding chaperones, to become
sufficiently unfolded to thereafter regain its ability to
spontaneously refold to the native state.
We next used various complementary biophysical
techniques to characterize the two stable misfolded
monomers, in an attempt to find the structural
differences accounting for their different degrees of
chaperone amenabilities.
Misfolded monomers contain non-native β-sheet
structures
The secondary structures of native and FT
luciferase and rhodanese were first analyzed by
Fourier transform infrared (FTIR) spectroscopy and
CD. In Fig. 4a and b, the infrared (IR) absorption
spectra of native proteins were reported in the amide
I region, where the stretching vibrations of the CO
peptide bonds occur. This band is particularly
sensitive to the protein secondary structures and to
the presence of intermolecular β-sheets, diagnostic
of protein aggregation. To extract this structural
information from the IR absorption spectrum, its
second derivative can be performed, since the
minima in this derivative spectrum corresponds to
the maxima of the band absorption, becoming in this
way more resolved.23–25
The second-derivative spectrum of Nat-Luc
(Fig. 4c) displayed well-resolved components,
which could be assigned to the protein secondary
structures. The ~1639 cm− 1 component and the
shoulder at ~1688 cm− 1 could be assigned to
intramolecular β-sheets; the ~1657 cm− 1, to α-
helices and random coil; and the ~1681 cm− 1, to
β-turns. Also, the second-derivative spectrum of Nat-
Fig. 4. Luciferase and rhodanese
secondary structures. (a–d) The
FTIR absorption (a and b) and
second-derivative (c and d) spectra
of luciferase and rhodanese, in the
native (Nat) and misfolded (FT)
forms, are reported in the amide I
region, where peak positions of the
main components are indicated. The
spectra of heat-denatured aggre-
gates (HD) are also presented. (e
and f) Far-UV CD spectra of lucifer-
ase (e) and rhodanese (f) in the
native and FT forms, both collected
at 20 °C and 90 °C. The reported
data are representative of more than
four independent experiments.
1163Stable Misfolded Monomers as Chaperone SubstratesRho (Fig. 4d) was characterized by components at
~1639 and ~1690 cm− 1 due to intramolecular β-
sheets, and ~1655 cm− 1, which could be assigned
to α-helices and random-coil secondary structures.23
The second-derivative spectra of the misfolded
monomers (Fig. 4c and d) displayed only small
differences, compared to that of the native proteins.
In the case of luciferase, the intramolecular β-sheetcomponent was upshifted from 1639.1±0.2 cm− 1 in
the Nat-Luc to 1640.0±0.2 cm− 1 in the FT-Luc,
suggesting the presence of slightly loosely packed
and/or distorted β-sheet structures in the misfolded
monomer, as compared to the native state.23,24,26,27
A similar shift of the β-sheet component was
reported for monomeric β-galactosidase after
freeze–thaw in 100 mM sodium phosphate buffer.28
1164 Stable Misfolded Monomers as Chaperone SubstratesIn the case of rhodanese second-derivative spectra,
the IR response of intramolecular β-sheets of FT-
Rho occurred at the same wavenumber as in the
native protein but displayed a higher intensity and a
narrower bandwidth. It should be noted that the
absorption spectra of the two forms (Fig. 4b) were
almost superimposable, indicating that the differ-
ences in the second-derivative spectra mainly
reflected a structural rearrangement of the native
β-sheets. As also suggested by the CD data
reported below, these FTIR results indicate that the
misfolded monomers retained their intramolecular β-
sheet structures to a similar extent compared to the
native proteins, but in a different conformation, which
could also account for their increased ThT binding,
1.8 times higher in the case of FT-Luc18 and 3.5
times higher in the case of FT-Rho (Fig. 1c).
One should note that the IR marker bands of
protein aggregation (i.e., the intermolecular β-sheet
bands)23–25,27,29 were absent in the spectra of the
two native species and also were remarkably absent
in the spectra of the two FT variants, confirming their
monomeric, non-aggregated state, in agreement with
the gel-filtration and light-scattering data for both FT-
Luc18 and FT-Rho, and with the results of GA cross-
linking (Fig. 1; Fig. S1). In contrast, the IR spectra of
the thermally denatured proteins (Fig. 4a–d) dis-
played a clear reduction of the native secondary-
structure components and the appearance of two
new bands, due to the formation of intermolecular β-sheet structures in protein aggregates,24,25,27,29
respectively, at ~1626 cm− 1 and at ~1693 cm− 1
for heat-denatured luciferase and at ~1621 cm− 1
and at ~1695 cm− 1 for HD-Rho,whichwe showhere
for the first time not to occur in the misfolded species.
The secondary structures of the two FT species
were also investigated by CD. Nat-Luc and FT-Luc
displayed almost superimposable CD spectra at
20 °C (Fig. 4e), characteristic of an α/β protein.30
However, a minor unfolding of the protein secondary
structures seemed to have occurred after FT
treatment, as indicated by the decreased CD signal
around 200 nm in the FT-Luc spectrum (Fig. 4e). In
the case of rhodanese, again, the CD spectra of
native and FT conformers at 20 °C were almost
superimposable (Fig. 4f), displaying a spectral
shape in agreement with an α/β protein.30
Misfolded monomers display an increased
exposure of hydrophobic patches
To highlight possible tertiary-structure changes
induced by FT treatment, we next investigated the
intrinsic fluorescence of the protein aromatic amino
acids. Upon excitation at 280 nm, both FT-Luc and
FT-Rho displayed a strongly reduced fluorescence
emission, compared to that of their native con-
formers (Fig. 5a and b). These results suggest that
FT treatment caused in both proteins a higher
solvent accessibility of the aromatic residues. InFig. 5. Tertiary structures of na-
tive and FT luciferase and rhoda-
nese. (a and b) Intrinsic fluorescence
emission spectra are reported for
luciferase (a) and rhodanese (b) in
the native and FT forms, with
excitation at 280 nm. (c) Fluores-
cence emission spectra of ANS at
30 μM concentration are pre-
sented in the absence (broken
line) and in the presence of 1 μM
Nat-Luc (continuous line) or of
1 μM FT-Luc (dotted line). (d)
Fluorescence emission spectra of
ANS at 30 μM concentration are
presented in the absence (broken
line) and in the presence of 4 μM
Nat-Rho (continuous line) or of
4 μM FT-Rho (dotted line). ANS
fluorescence was exci ted at
350 nm. The reported data are
representative of more than three
independent experiments.
1165Stable Misfolded Monomers as Chaperone Substratesaddition, the structural properties of luciferase and
rhodanese were further investigated using the
fluorescent dye 8-naphthalene-1-anilino-sulfonate
(ANS). When ANS binds to the protein's exposed
hydrophobic patches, its fluorescence quantum yield
is strongly enhanced and its emission maximum is
shifted to lower wavelengths. Interestingly, both in the
case of Nat-Luc and FT-Luc, the ANS fluorescence
emission was increased and shifted. Similar results
of ANS interactions were recently reported for the
native luciferase.31 However, a much higher fluores-
cence was observed for FT-Luc, indicating more
exposure of hydrophobic patches on its surface,
compared to the native protein (Fig. 5c). This
structural difference, that is, the increased exposure
of hydrophobic patches after FT treatment, was more
pronounced in the case of FT-Rho (Fig. 5d).
FT-Rho and FT-Luc have different degrees of
thermal stability and aggregation propensity
We next investigated the thermal stability of FT-
Rho and FT-Luc by CD, monitoring the ellipticity
changes at 222 nm, while gradually heating the
samples from 20 °C to 90 °C (Fig. 6a and b). The
Nat-Luc was found to be stable up to ~40 °C. Above
40 °C, the protein rapidly lost its CD signal with a
midpoint at ~43 °C (Fig. 6a). Noticeably, FT-Luc
displayed a reduction of about 4 °C of thermal
stability. During the thermal treatment, luciferase
aggregation occurred, as indicated by the high
tension voltage (HT[V]) changes (Fig. 6c), whichFig. 6. Luciferase and rhodanese thermal stability and ag
222 nm for luciferase (a) and rhodanese (b) conformers durin
percentage of variation. (c and d) The HT[V] changes monitored
during thermal treatment, from 20 °C to 90 °C, are reported
representative of more than four independent experiments.allow to monitor the variation of the solution's
turbidity, induced by the formation of protein
aggregates.32,33 In particular, the HT[V] signal at
222 nm firstly increased, as the ellipticity at the same
wavelength, and then decreased, as a consequence
of protein precipitation. Again, the HT[V] plots
indicated a reduced stability of the FT-Luc. After
heating up to 90 °C, the direct inspection of the CD
spectra (Fig. 4e) for both native and FT-Luc
indicated that the aggregated protein still in solution
displayed the spectral response of β-sheet struc-
tures, as expected from the FTIR results.
When Nat-Rho was heated, the ellipticity at
222 nm changed (Fig. 6b) with a similar trend as
for native luciferase, but with a midpoint temperature
at ~50 °C, indicating higher stability of Nat-Rho, as
compared to both Nat-Luc and FT-Luc. Also in the
case of Nat-Rho, the increase of HT[V] indicated that
the thermal treatment induced protein aggregation,
leading to a higher turbidity of the solution. Above
~55 °C, the HT[V] decreased due to protein precip-
itation (Fig. 6d).
A markedly different behavior was observed with
FT-Rho, where a gradual ellipticity variation at
222 nm was observed, with no evident transition
(Fig. 6b). Moreover, for FT-Rho, the 50% change of
ellipticity occurred at a higher temperature, as
compared to Nat-Rho. The HT[V] signal (Fig. 6d) of
FT-Rho decreased very slowly in the ~30–57 °C
temperature range, while it dropped abruptly at
higher temperature. This behavior suggests the
formation of small soluble aggregates that did notgregation. (a and b) The ellipticity changes monitored at
g thermal treatment, from 20 °C to 90 °C, are reported as
at 222 nm for luciferase (c) and rhodanese (d) conformers
as absolute voltage variations. The displayed data are
1166 Stable Misfolded Monomers as Chaperone Substratescontribute to the solution turbidity, but interacted as
“sticky” protein intermediates, leading to insoluble
aggregates that simultaneously precipitated at a
critical temperature. The different thermal behavior
of FT-Rho andNat-Rhowas also evident by the direct
inspection of their CD spectra collected at 90 °C
(Fig. 4f). In the case of FT-Rho, the fraction of protein
still in solution at this temperature in the CD spectrum
displayed a more evident minimum around 203 nm,
indicative of less ordered secondary structures.Discussion
In this work, we focused on the structural charac-
terization of two stable misfolded monomers of
luciferase and rhodanese, obtained by iterative
cycles of freezing–thawing. They were both stringent
DnaK chaperone-amenable substrates, yet, interest-
ingly, they displayed very different behaviors in in
vitro chaperone refolding assays. Whereas FT-Rho
was slowly refolded only by a molar excess of the
chaperone, FT-Luc was rapidly and efficiently
refolded already by substoichiometric amounts of
DnaK. To better understand the mechanism of
chaperone-mediated unfolding/refolding, it was thus
important to investigate the biophysical properties of
these two unique stablemonomeric species and gain
insights on the structural characteristics favoring
specific chaperone interactions with misfolded sub-
strates and disfavoring interactions with the unfolded
and natively refolded products of the chaperone
reaction.
Alongside chaperone amenability, there is an
increasing interest in studying protein species at
the very early stage of their aggregation in view of
understanding their role in the early onset of protein
conformational diseases. It is a major concern for
medicine, pharmacology, and biotechnology to
reach a better understanding of the natural mecha-
nisms by which young cells may succeed to rescue
themselves from pathological protein misfolding
conditions, while the natural defense mechanisms
in aging cells and diseased tissues apparently fail at
protecting themselves from proteotoxic damages.
The two newly characterized, stable misfolded
monomeric species might serve as new tools to
study the ways cells counteract toxic protein mis-
folding events at very early stages of the aggregation
pathway, before they become irreversibly damaged.
Indeed, the partial unfolding of globular proteins, or
partial folding of intrinsically disordered proteins, is
often considered to be the first event in protein
fibrillogenesis.2,16,34,35 Whereas oligomers and ma-
ture aggregates are extensively studied to highlight
their structure and toxic properties,2,7,10,15 little is
known about the initial misfolded monomers that
enter the aggregation pathway. Due to their unstable
structure under native-like conditions, a thoroughdescription of their conformational properties and
possibly of their toxic properties has been only rarely
reported. Nevertheless, they might represent a very
important therapeutic target of protein conformation-
al diseases.36 The full relevance of the misfolded
monomeric species is apparent when considering
that during their lifetime, cells are continuously
challenged by external stresses, such as cold stress
and heat shock, and they need molecular defenses
to counteract and rescue potentially toxic misfolded
species that may sporadically form, even under
physiological conditions.
Here, we performed a detailed biophysical charac-
terization of the two stable inactive misfolded mono-
mers of luciferase and rhodanese, investigating their
secondary and tertiary structures, conformational
stability in urea and under heat stress, and their
aggregation propensity. In particular, we found that
the secondary structures of the native proteins and of
their misfolded monomers displayed minor but
significant differences, mainly involving the quality of
their β-sheet structures that displayed, after the FT
treatment, a different structural rearrangement, as
indicated by FTIR and CD spectroscopy.
Interestingly, the aromatic amino acids in the
misfolded monomers were also found to be more
accessible to the solvent, as observed by intrinsic
fluorescence measurements. Furthermore, the mis-
folded monomers were found to expose more
hydrophobic patches than the native proteins, as
detected by ANS fluorescence studies. These prop-
erties could account for the expected higher affinity of
chaperone for the misfolded FT-Luc and FT-Rho
substrates, compared to their native conformers.37,38
Moreover, ThT fluorescence gave new insights on
the conformational changes that were induced by
the iterative FT treatments of native luciferase and
rhodanese. Although ThT fluorescence is the most
used method for staining amyloid material, both in
vivo and in vitro, the ThT interactions with fibrils and
misfolded species at the molecular level still need to
be better understood (see, for reviews, Refs. 39 and
40). Among different proposals, the “channel” model
suggests that ThT binds to grooves formed by the
amino acid side chains of the fibril β-sheets, with ThT
aligned to the fibril axis, perpendicularly to the β-
strands. The side chains are required to produce a
surface channel-like structure on flat β-sheets,
involving at least four to five β-strands. Moreover,
they should contain aromatic and hydrophobic
amino acids, avoiding charged side chains in order
to reduce repulsive electrostatic interactions. The
central role of hydrophobic cavities of proper size in
the ThT–fibril interaction has been underlined in the
literature.39,40 These studies highlight that structural
constraints are required for ThT binding, justifying
why most native proteins, even rich in β-sheets,
interact relatively poorly with the dye. Indeed, native
β-sheets are typically highly twisted, that is, not flat
1167Stable Misfolded Monomers as Chaperone Substratesenough and do not always expose side chains to
support efficient ThT binding. Both luciferase and
especially rhodanese misfolded monomers displayed
a markedly higher ThT fluorescence compared to
their native conformer, a result that might help to
understand ThT interactions with non-aggregated
protein species. This can be explained by the
structural changes detected in this work, namely, (i)
the structural rearrangement of the intramolecular β-
sheets, (ii) the increased surface exposure of
hydrophobic patches, and (iii) the increased acces-
sibility of aromatic amino acids to the solvent.
Therefore, the FT-Luc and FT-Rho could be taken
as novel model species for a detailed study on ThT
interactions with non-aggregated misfolded species.
Interestingly, we found that up to 60 μM, ThT did not
inhibit or activate the enzymatic activities of native
chaperone products Nat-Luc, Nat-Rho (data not
shown), and G6PDH.41 Moreover, 60 μM ThT did
not affect the ATPase activities of KJE, the rates and
yields of spontaneous refolding, the aggregation
propensity of misfolded species, or the stability of
already aggregated species (data not shown). Thus,
ThT can be used as a specific molecular probe to
monitor online structural changes into non-native β-
sheet structures of misfolded and aggregated
conformers during chemical and physical treat-
ments, as well as during ATP-fueled chaperone-
mediated unfolding and refolding assays, as
reported here and earlier.18,42
Steady-state ThT fluorescence in the presence of
increasing concentrations of urea clearly demon-
strated that FT-Luc is much less stable than FT-Rho
(Fig. 3a), in agreement with their different levels of
intrinsic ThT binding (1.8 and 3.5, respectively) and
their various degrees of chaperone amenability.
Concerning the thermal stability, the two misfolded
monomers displayed a very different behavior. In the
case of luciferase, while at the temperature used in
the chaperone assay, the native and misfolded
monomers were both stable; above ~35 °C, the
FT-Luc displayed a reduced thermal stability
(Fig. 6a) and underwent a fast aggregation process
(Fig. 6c). This behavior was in agreement with the
increased presence of hydrophobic patches in FT-
treated species (Fig. 5c). It confirmed that hydro-
phobic exposure is the main intrinsic physicochem-
ical property determining the propensity of a
misfolded species to aggregate or bind a molecular
chaperone. In particular, it has been found that the
protein regions involved in the first stage of
aggregation are those with higher hydrophobicity
and propensity to form β-sheets.43
In the case of rhodanese, it has been previously
reported that above ~40 °C, the protein first forms
small active oligomers in a concentration-dependent
manner, which thereafter aggregate in large assem-
blies at higher temperature.44 It has been suggested
that the small oligomers protect the protein fromthermal inactivation45 and are the starting material
for larger aggregates.44 In light of these studies, a
possible explanation of the peculiar thermal profiles
reported here for FT-Rho is that the increased
exposure of hydrophobic patches during FT treat-
ment (Fig. 5d) might increase the propensity to form
small oligomers at high temperature, leading to a
temperature-dependent ellipticity change smoother
for FT-Rho than for Nat-Rho (Fig. 6b). However,
above a critical temperature, these oligomers might
undergo aggregation into large insoluble assem-
blies, resulting in a drop of the solution turbidity
observed in the HT[V] plot (Fig. 6d).
As conclusive remarks, our biophysical character-
ization disclosedminor structural differences between
the native and the two misfolded FT monomers (i.e.,
increased hydrophobic patches and misfolded β-
sheets) that could account for the expected difference
of chaperone affinity. Moreover, our results provide
an explanation for the different behavior of the two
stable misfolded monomers as chaperone sub-
strates: whereas a substoichiometric amount of
DnaK (Fig. 2c, left of the broken line) can efficiently
unfold/refold FT-Luc by the unfolding action of a
single DnaK molecule per luciferase substrate at a
time—likely by a direct clamping mechanism18,46—
only a stoichiometric excess of DnaK could efficiently
unfold FT-Rho (Fig. 2c, right of the broken line). This
suggests that in the case of the more stable and
therefore more chaperone-resistant FT-Rho species,
the unfolding action likely involves the concomitant
binding of several DnaK molecules at different
positions of the same misfolded rhodanese polypep-
tide. This concomitant binding enables them to apply
an unfolding force resulting from the combined effect
of chaperone clamping and cooperative entropic
pulling. Such a cooperative mode of DnaK action
has been previously reported in the case of stable
soluble heat-denatured G6PDH aggregates.21,41
Accordingly, the FT-Rho structure was found to be
significantly more stable than that of FT-Luc (Figs. 3
and 6a and b), accounting for the need of an additional
unfolding mechanism, both clamping and cooperative
entropic pulling, in the case of FT-Rho. In contrast, FT-
Luc required only the unfolding by a direct chaperone
clamping. Moreover, the propensity of rhodanese to
form non-productive and aggregation-prone interme-
diates during its refolding process47 could further
contribute to the reduced refolding yields of chaper-
one, as compared to FT-Luc (Fig. 2d).Materials and Methods
Materials
DnaK of Escherichia coli was expressed and purified as
described previously.48 DnaJ and GrpE of E. coli49 were a
gift from H. J. Schönfeld, F. Hoffmann-La Roche, Basel,
1168 Stable Misfolded Monomers as Chaperone SubstratesSwitzerland. The plasmid pT7lucC-His, carrying the
luciferase gene of P. pyralis with the additional His6-
coding sequence50 was a gift from A. S. Spirin, Institute of
Protein Research, Russian Academy of Sciences, Push-
chino, Moscow Region, Russia. His-tagged luciferase was
purified as described previously18 and stored only once in
15% glycerol at −80 °C. Bovine rhodanese was purchased
from Sigma.Activity assay
Luciferase activity was measured using a Victor Light
1420 Luminescence Counter from Perkin–Elmer as
described previously.18 Rhodanese activity was measured
by a colorimetric method (monitored at 460 nm) based on
the formation of the complex between ferric ions and one of
the reaction products, thiocyanate.51,52 Rates of ATP
hydrolysis during the first 4 min of the chaperone re-
actions, reported in Fig. 2b, were measured as previously
described.18Purification of stable misfolded monomeric
rhodanese and luciferase
The misfolded monomeric rhodanese was prepared
by repeated cycles of freezing-thawing (rapid freezing at
−160 °C and slow thawing at 4 °C) of Nat-Rho (not more
than 5 μM) in the presence of 20 mM sodium phosphate,
pH 7.5, 20 mM DTT, and 50 mM Na2S2O3. Once stably
inactivated to 95%, the protein was centrifuged at
12,000g for 10 min and the supernatant was injected
on a gel-filtration column (Superose 6HR10/30). The
fractions corresponding to inactive and monomeric
rhodanese were collected and further concentrated, on
Amicon ultra-10 concentrator with a 10-kDa cutoff, to
about 5 μM and stored in 10% glycerol at −80 °C. The
purification of stable misfolded monomeric luciferase
species was as previously described.18Preparation of HD-Rho
Rhodanese was incubated for 10 min at 62 °C in 50 mM
Tris–HCl, pH 7.5, 150 mM potassium chloride, and 20 mM
magnesium chloride. The residual activity after heat
exposure was b2% of the initial value.Thioflavin T fluorescence and light-scattering
measurements
Rhodanese (1 μM) was incubated in the presence of
60 μM ThT (from Sigma), which we found to have no
detectable effects on the activity of the chaperones and
Nat-Rho enzyme, as previously reported to be the case for
G6PDH41 and luciferase18 as well. ThT fluorescence was
measured with a Perkin–Elmer LS55 luminescence
spectrometer at 25 °C. Fluorescence was recorded online
for 30 min (excitation 450 nm, bandwidth 15 nm; emission
485 nm, bandwidth 2.5 nm). Light scattering was mea-
sured online at 550 nm (excitation wavelength 550 nm) at
25 °C with a Perkin–Elmer LS55 luminescence
spectrometer.Chaperone activity assay
Refolding assays were performed in refolding buffer
(50 mM Tris–acetate, pH 7.8, 50 mM KCl, and 10 mM
MgCl2) in the presence of 5 mM ATP. The concentrations
of chaperones, except DnaK, were kept constant for DnaJ
(0.5 μM) and GrpE (0.7 μM). Rates of luciferase and
rhodanese refolding were derived from the initial linear
phase of the time curves of recovered enzymatic activity.Urea unfolding experiments
The urea unfolding of FT-Rho was performed as
previously reported for FT-Luc.18 Briefly, 1 μM FT-Rho or
FT-Luc was incubated for 1 h at 25 °C in the presence of
60 μM ThT and different concentrations of urea, as
indicated in Fig. 3. The ThT fluorescence was then
measured as described in the previous paragraph and
expressed as the percentage of the maximal ThT
fluorescence measured after pretreatment with 0 M urea.FTIR spectroscopy
FTIR spectroscopy measurements in attenuated total
reflection were performed on protein hydrated film follow-
ing an already standardized approach,29,53,54 which allows
to obtain spectra with high signal-to-noise ratio also for
proteins at low concentrations. In particular, luciferase has
been analyzed at 5 μM in 20 mM phosphate buffer and
100 mM NaCl, pH 7.5, whereas rhodanese has been
measured at 5–12 μM concentration in 20 mM phosphate
buffer, pH 7.5. Sample aliquots of 3 μl were deposed on
the diamond plate of the nine-reflection attenuated total
reflection device (DuraSamplIRII, Smith Detection) and
dried at room temperature in order to obtain a protein
hydrated film. Spectra were collected by the Varian 670-IR
spectrometer (Varian Australia Pty Ltd., Mulgrave, VIC,
Australia) equipped with a nitrogen-cooled mercury cad-
mium telluride detector under accurate dry air purging. The
following conditions were employed: 2 cm− 1 spectral
resolution, 25 kHz scan speed, 1000 scan co-addition,
and triangular apodization. The buffer spectrum, collected
under identical conditions, has been then subtracted to
that of the protein. All the measured spectra were reported
after normalization to the amide I band area, to compen-
sate for possible differences in protein content. The
second derivatives were obtained by the Savitsky–Golay
method (third-grade polynomial, 5 smoothing points) after
a binomial smoothing (11 points) of the absorption spectra
using the GRAMS/32 software (Galactic Industries Cor-
poration, Salem, NH, USA).Circular dichroism
CD spectra were recorded on the same samples
employed for FTIR measurements using the Jasco J-
815 (Jasco Corp., Tokyo, Japan) spectropolarimeter. For
both luciferase (at 2.5 μM) and rhodanese (at 8 μM), far-
UV spectra were collected in a 0.1-cm path-length quartz
cell, in the 260–190 nm spectral range, and averaged
over four scans. The bandwidth and time-response
parameters were respectively set to 1 nm and 1 s for
1169Stable Misfolded Monomers as Chaperone Substratesluciferase and 2 nm and 2 s for rhodanese. CD spectra
are presented after buffer subtraction and binomial
smoothing. For thermal stability experiments, the sample
temperature was varied from 20 to 90 °C at 1 °C/min and
the ellipticity and the HT[V] signals were monitored at
222 nm every 0.2 °C.
Intrinsic fluorescence and ANS binding
measurements
Fluorescence measurements were performed using
Cary Eclipse (Varian, Palo Alto, CA, USA) and the LS55
Perkin–Elmer luminescence spectrometers (Waltham,
MA, USA). Intrinsic fluorescence of the aromatic protein
amino acid was recorded, exciting the sample at
280 nm. Luciferase conformers have been measured at
2.5 μM (in 20 mM phosphate buffer and 100 mM NaCl,
pH 7.5) and rhodanese conformers have been mea-
sured at 1 μM (in 20 mM phosphate buffer, pH 7.5). For
ANS binding studies, the fluorescence emission of the
dye excited at 350 nm was recorded for luciferase at
1 μM protein and at 30 μM ANS concentrations (20 mM
phosphate buffer and 100 mM NaCl, pH 7.5). For
rhodanese, ANS fluorescence was collected at 4 μM
protein and at 30 μM ANS concentrations (in 20 mM
phosphate buffer, pH 7.5). Quartz cuvette of 1 cm path
length was employed.Acknowledgements
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SUPPLEMENTARY MATERIALS 
 
FIGURE S1: Cross-linking shows that FT-Rho is not aggregated and similar to monomeric 
Nat-Rho.  
2µM of native or heat-denatured (HD) Rhodanese, both from the stock solution, and of gel-filtered 
purified freeze thaw (FT) Rhodanese, were incubated in phosphate buffer for 1 hour at 25 °C with 
increasing concentrations of glutaraldehyde (GA), as indicated. The reaction was stopped with SDS 
sample buffer and, following boiling for 30 seconds, samples were resolved by SDS-PAGE and 
coomassie blue stained. 
 
 
 
  
FIGURE S2: The FT-Rho refolding is not affected by the presence of native chaperone 
products. 
FT-Rho (0.5µM) was incubated with DnaK (2.5µM), DnaJ (1.25µM), and GrpE (1.75µM) with and 
without 5 mM ATP (-ATP), and with different concentrations of native MDH and G6PDH, as 
indicated. After 60 minutes at 22°C, Rhodanese activity was measured. Basal FT-Rho activity 
without chaperones is shown (labeled as “Nothing”). Error bars represent s.e.m. of three 
independent measurements.  
Up to a 16 fold molar excess of typical natively folded chaperone products (MDH or G6PDH), as 
compared to the FT-Rho substrate, does not inhibit the KJE- and ATP-dependent refolding reaction. 
These results indicate that the FT-Rho substrate have a much higher affinity to the chaperone 
system than the natively refolded products. 
 
 
  
SUPPLEMENTARY TABLE 1 
Rates of ATP hydrolysis during chaperone-mediated refolding of FT-Rho at 22°C, as in Fig. 2B. 
ATP was incubated during 4 minutes without or with 6.4 µM DnaK, 0.5 µM DnaJ, 0.7 µM GrpE 
(KJE), without or with 1 µM FT-Rho, or 1 µM Nat-Rho, as indicated. 
 
 
            
 
 
 
 
 
Sample nM 
ATP/min 
ATP DnaK-1 min-1 Net ATP/refolded Rho 
FT-Rho 200 - - 
Nat-Rho 260 - - 
KJE 9700 1.52 - 
KJE + FT-Rho 19500 3.02 857 
KJE +  
Nat-Rho 
10700 1.63 - 
 
 
 
 
 
 
 
CHAPTER 3 
 
Hsp110 is a bona fide chaperone using ATP to unfold stable 
misfolded polypeptides and reciprocally collaborate with 
Hsp70 to solubilize protein aggregates 
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Hsp110 Is a Bona Fide Chaperone Using ATP to Unfold Stable
Misfolded Polypeptides and Reciprocally Collaborate with
Hsp70 to Solubilize Protein Aggregates*
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Background: Hsp110s are considered as mere nucleotide exchange factors of the Hsp70s.
Results: Human cytosolic Hsp110s can use ATP to unfold misfolded polypeptides and act as equal partner with Hsp70 to
solubilize stable protein aggregates.
Conclusion: Hsp110s are Hsp70-like polypeptide unfolding chaperones.
Significance:Hsp110s are powerful disaggregating chaperones that can collaboratewithHsp70s to detoxifymisfolding proteins
in degenerative diseases.
Structurally and sequence-wise, the Hsp110s belong to a sub-
family of the Hsp70 chaperones. Like the classical Hsp70s,
members of theHsp110 subfamily can bindmisfolding polypep-
tides and hydrolyze ATP. However, they apparently act as a
mere subordinate nucleotide exchange factors, regulating the
ability of Hsp70 to hydrolyze ATP and convert stable protein
aggregates into native proteins. Using stably misfolded and
aggregated polypeptides as substrates in optimized in vitro
chaperone assays, we show that the human cytosolic Hsp110s
(HSPH1andHSPH2) arebona fide chaperones on their own that
collaborate with Hsp40 (DNAJA1 and DNAJB1) to hydrolyze
ATP and unfold and thus convert stablemisfolded polypeptides
into natively refolded proteins. Moreover, equimolar Hsp70
(HSPA1A) and Hsp110 (HSPH1) formed a powerful molecular
machinery that optimally reactivated stable luciferase aggre-
gates in an ATP- and DNAJA1-dependent manner, in a disag-
gregation mechanism whereby the two paralogous chaperones
alternatively activate the release of bound unfolded polypeptide
substrates fromone another, leading to native protein refolding.
Under optimal in vitro conditions, such as low protein con-
centrations and low temperature, the primary amino acid
sequences may contain all the necessary information for small
unfolded polypeptide chains to spontaneously reach their
native three-dimensional structure (1). However, the cyto-
plasm of human cells may contain as much as 200 mg/ml pro-
teins (2, 3), a highly crowded environment that may interfere
with the productive native folding pathway of de novo synthe-
sized or translocated multidomain polypeptides and with the
proper refolding of stress-unfolded polypeptides (4–6). When
a new polypeptide chain exits the ribosome or an organellar
import pore orwhen a labile native protein becomes transiently
heat- or cold-denatured, it may transiently unfold and expose
hydrophobic segments to the aqueous environment (7, 8). It
may then seek higher stability either by refolding to the native
state or by generating non-native intramolecular misfolded
structures, predominantly short-strandswith exposed hydro-
phobic residues (8). Depending on the intensity and duration of
a stress and the degree of hydrophobic exposure, the misfolded
monomers may then further proceed into the misfolding path-
way by seeking intermolecular hydrophobic associations, lead-
ing to the formation of various insoluble disordered complexes,
generally termed aggregates, thatmay further condense in vitro
into compact protofilaments and insoluble fibrils, or in vivo,
into tangles, protofibrils, and extracellular amyloids (7, 9–11).
Stable misfolded monomers, such as freeze-thaw-inactivated
luciferase (FTluc)2 (12) or freeze-thaw-inactivated rhodanese
(8, 13), may thus serve as the start points of an alternative pro-
tein misfolding and aggregation pathway, which, at variance
with the native folding pathway, may be toxic to animal cells,
neurons in particular (10, 14, 15). Because of their high surface-
to-volume ratio, intermediate misfolded proteins, such as sta-
ble soluble aggregates (16) and protofibrils, may be among the
most toxic species (17), causing mammalian cell leakage,
inflammation-induced oxidative stress, apoptosis, and tissue
loss in neurodegenerative diseases such asAlzheimer,Hunting-
ton, and Parkinson diseases, amyotrophic lateral sclerosis, and
aging in general (10, 17, 18).
Opportunely, both prokaryotes and eukaryotes have evolved
a complex network of chemical and protein chaperones (19,
20), which can prevent the conversion of stress-labile native
proteins into toxic aggregates. Moreover, proteotoxic species
that already formed can be actively converted by disaggregating
and unfolding chaperones into harmless natively refoldable
proteins or be degraded by chaperone-gated proteases into
reusable amino acids (14). Therefore, stress-induced or crowd-
* This work was supported in part by the Faculty of Biology and Medicine of
Lausanne University of Lausanne and by Grant 31003A-140512/1 from the
Swiss National Fund.
1 To whom correspondence should be addressed. E-mail: Pierre.Goloubinoff@
unil.ch.
2 The abbreviations used are: FTluc, freeze-thaw inactivated luciferase; PDB,
Protein Data Bank; SBD, substrate-binding domain; ThT, thioflavin T; Luc,
luciferase; NEF, nucleotide exchange factor; NBD, nucleotide-binding
domain.
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ing-induced protein misfolding and aggregation can be effi-
ciently counteracted by a network of so-called “holding” chap-
erones that upon binding to exposed hydrophobic residues on
the surface of the misfolded polypeptides can prevent the for-
mation of large aggregates (21–24). However, with the excep-
tion of the small Hsps, the other canonical families ofmolecular
chaperones are ATPases with demonstrated abilities to act as
polypeptide unfolding enzymes. Thus, even without ATP,
apoGroEL and apoCCT chaperonins can act as effective
enzymes, unfolding metastable misfolded monomeric species
and thus averting further proceeding into the misfolding path-
way and instead promoting native refolding (10, 12, 13, 24).
Other molecular chaperones, such as Hsp104 and Hsp70, are
strict ATP-dependent polypeptide unfoldases that can disen-
tangle stable protein aggregates and unfold stable misfolded
monomeric polypeptides species. Thus, Hsp70 (DnaK; the
names of the Escherichia coli proteins are shown in parenthe-
ses), co-chaperoned by Hsp40 (DnaJ), regulated by nucleotide
exchange factors (GrpE), and the disaggregating co-chaperone
Hsp104 (ClpB) can use the energy of ATP hydrolysis to scav-
enge stable insoluble aggregates and unfold stably misfolded
polypeptides by binding, clamping, and pulling apart entangled
misfolded structures and whole polypeptides (12, 25–27).
Whereas in bacteria, chloroplasts, mitochondria, and the
cytosol of plants and yeast, Hsp104/ClpB type chaperones can
use their hexameric ring structure to pull apart stably entangled
polypeptides in aggregates and collaborate with Hsp70 to
recover native proteins, animal cells lack obvious Hsp104
orthologs. However, animal cells are not devoid of disaggregat-
ing chaperones, because recent in vivo and in vitro data showed
that the mammalian Hsp110 (HSPH2, Apg-2) can act in syn-
ergywithHsp70 (HSPA8,Hsc70) andHsp40 (Ydj1,DNAJB1) to
catalyze the ATP-dependent disentanglement, solubilization,
and native refolding of various stable protein aggregates (28,
29).
The human cytosol contains three distinct Hsp110s: HSPH2
(Apg-2), HSPH1 (Hsp105), and HSPH3, present in 800, 510,
and 130 copies per cubic micron of HeLa cell, respectively (28).
Amounts and stoichiometries indicate that 15% of the cyto-
solic Hsp70 pool may be involved in the formation of Hsp70-
Hsp110-dependent disaggregating machineries (3). Here, we
tested with stringent in vitro refolding assays the chaperone
activity of purified recombinant humanHSPH1 in various com-
binations withHSPA1A andDNAJA, which are abundant cyto-
solicmembers of theHsp70/110/40 chaperone family in human
cells (3). This allowed us to assess the precise mechanistic con-
tribution of Hsp110, individually as an independent molecular
chaperone and as a possible chaperone that reciprocally collab-
orate with Hsp70 in the in vitro unfolding and reactivation of
stable misfolded species and the disaggregation of extensively
damaged protein substrates preformed in the absence of chap-
erones (12, 28, 29).We found thatHsp110 is by itself a bona fide
ATP-dependent unfolding chaperone that can catalyze the
unfolding of stable misfolded polypeptides and thus favor the
conversion of stable, high affinity misfolded substrates in to
stable low affinity native products of the chaperone reaction.
Interestingly, even without ATP, Hsp110 could activate the
release of a prebound luciferase substrate from Hsp70, and
reciprocally Hsp70 could activate the release of a prebound
luciferase substrate from Hsp110. Titration of the ATP- and
HSP40-dependent luciferase refolding activity in the presence
of various relative amounts of Hsp110 and Hsp70 showed opti-
mal disaggregation activity at a 1:1 ratio. Confirming earlier in
vivo and in vitro evidence with human HSPH2, yeast YDJ1, or
the other major cytosolic human DNAJB1 (28, 29), our in vitro
results mainly with HSPH1 (Hsp105) and DNAJA1 show that
the cytosol and likewise the endoplasmic reticulum of mam-
malian cells contain powerful Hsp110/Hsp70 bichaperone
machineries that can unfold and solubilize stablymisfolded and
aggregated protein species to combat the onset of protein con-
formational diseases.
EXPERIMENTAL PROCEDURES
Cloning—HSPA1A (HSP70, HsCD00002890) and DNAJA1
(HSP40, HsCD00002610) were amplified from cDNA, using
following set of primers: HSPA1A forward, 5-ATGATGGGC-
TCTTCTCATCATCATCATCATCATTCTTCTGGCCTG-
GTTCCGCGTGGCTCTCATATGGCCAAAGCCGCGGCG-
ATCGGCATCG-3; HSPA1A reverse, 5-CGTGGCCACTA-
GTCTAATCCACCTCCTCAATGG-3; DNAJA1 forward, 5-
ATGATGGGCTCTTCTCATCATCATCATCATCATTCT-
TCTGGCCTGGTTCCGCGTGGCTCTCATATGGTGAAA-
GAAACAACTTACTACG-3; and DNAJA1 reverse, 5-CGT-
GGCCACTAGTTTAAGAGGTCTGACACTGAACACCAC-
CTC-3. The PCRproductwith theN-terminalHis6 tag and the
thrombin cleavage site was cloned in between restriction sites
NcoI and SpeI of the pSE420 expression vector (Invitrogen)
using BspHI and SpeI at the 5 and 3 ends of the amplified PCR
product.
Purification of His-taggedHSPA1A, DNAJA1, Luciferase, and
HSPH1—E. coli DH5 cells transformed with pSE420 vector
carrying HSPA1A and DNAJA1 were grown in LB medium
with 100 g/ml ampicillin at 37 °C. 0.6 mM isopropyl -D-thio-
galactopyranoside (Sigma-Aldrich) was added at OD 0.6, and
12 h later, the cells were harvested by centrifugation at 6000
rpm. Cell pellet was resuspended and sonicated in Buffer A (20
mM sodium phosphate buffer, pH 7.5, and 500 mM NaCl, sup-
plemented with phenylmethanesulfonyl fluoride (Sigma-Al-
drich). The lysate was centrifuged at 16,000 rpm (JA 25.50
rotor, Beckman J2-21 centrifuge) for 30 min, and supernatant
was filtered though a 0.2-m membrane and loaded onto a
nickel affinity column (HisPrep FF 16/10; GE Healthcare) with
buffer A. After loading, columnwas extensively washed (30–40
column volumes). The bound protein was eluted with linear
gradient of 10–500 mM imidazol in buffer A. The purity of the
fractions was confirmed on SDS-PAGE. Proteins were concen-
trated and stored in 20 mM Tris-HCl, pH 7.5, 10% glycerol, and
200 mM NaCl at80 °C.
Cells harboring pET28a-HSP110 (Hsp105) plasmid (a gift
from Dr. E. Lafer Department of Biochemistry, The University
of Texas Health Science Center) were preincubated overnight
at 37 °C on LB kanamycin (50 g/ml) and chloramphenicol (34
g/ml) plates. Cells from the plate were transferred to autoin-
duction media (for 1 liter: 10 g of tryptone, 5 g of yeast extract,
5 g of glycerol, 0.5 g of glucose, 2 g of lactose, 26.8ml of 0.1 g/ml
NH4Cl, 2 ml of 1 M MgSO4), then 100 ml of sterilized 10 salt
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solution (stock: 35.49 g ofNa2HPO4, 34.02 g of KH2PO4, 7.1 g of
Na2SO4) and kanamycin (50g/ml) were added, and cells were
grown at 30 °C for 24 h. Afterward, the cells were harvested and
sonicated in 20mM sodiumphosphate buffer, pH8, and 300mM
NaCl, 0.2%TritonX-100, PMSF, and centrifuged at 16,000 rpm;
supernatant was filtered and loaded onto previously equili-
brated nickel affinity column. After loading, the column was
extensively washed (30–40 column volumes) with wash buffer
(20 mM sodium phosphate buffer at pH 8.0, 20 mM imidazole,
and 500 mM NaCl), and the pure protein was eluted using elu-
tion buffer (20 mM sodium phosphate buffer at pH 8, 100 mM
imidazole, and 500mMNaCl). After confirming on SDS-PAGE,
pure fractions were pooled, buffer was exchanged into storage
buffer (20mMTris-HCl at pH 8, 100mMNaCl, 5% glycerol, and
3 mM DTT), concentrated, and stored at 80 °C. DnaK and
Luciferase was purified as in Ref. 12. DnaJ and GrpE of E. coli
were a gift from Dr. H. J. Schönfeld (Pharmaceutical Research,
F. Hoffman-La Roche Ltd., Basel, Switzerland).
Luciferase Assays—Luciferase activity was measured as
described previously (12) using a Victor Light 1420 Lumines-
cence Counter from PerkinElmer Life Sciences.
Immunoblotting—FTluc samples were incubated with chap-
erones in the presence of ATP; aliquots were taken at different
time intervals and treated with trypsin for 2 min and immedi-
ately mixed with loading dye; and samples were incubated at
95 °C for 2min, run on SDS-PAGE, and electrotransferred onto
a 0.2-m nitrocellulose membrane (Bio-Rad). Following seven
5-min rinses in TTBS, themembrane was incubated in primary
goat luciferase antibody in TTBS (1:20,000; Sigma-Aldrich) for
overnight, followed by secondary donkey HRP-goat antibody.
The membrane was washed and then developed using the
chemiluminescent ImmunstarTM kit (Bio-Rad) according to
the manufacturer’s instructions.
Measurement of ATP Consumption—The ATP content
([2,5,8-3H]ATP from Amersham Biosciences) of the refolding
solution supplementedwith 0.5MHsp70, 0.5MHsp110, 0.25
M Hsp40, 100 M ATP, and 0.5 M luciferase (FTLuc) was
determined as a function of time at 25 °C. At 50–60-s intervals
over a time period of 7 min, 5-l aliquots were taken and pro-
cessed as explained elsewhere (12).
Thioflavin T Binding—Thioflavin T (ThT) binding of lucif-
erase was measured in the presence of 60 M ThT as in Ref. 12
(excitation, 435 nm; and emission, 465 nm) using a PerkinElmer
Life Sciences LS55 fluorescence spectrometer.
Protein Structural Analysis—Protein structures of Hsc70-
Sse1 (Protein Data Bank (PDB) code 3C7N) complex and
DnaK/Hsp70 (PDB code 4B9Q, 2KHO) were taken from PDB
and by using PyMOL molecular graphics system, Hsc70 NBD
was structurally aligned with the structure of ADP-bound
DnaK (PDB code 2KHO) or ATP-bound DnaK/Hsp70 (PDB
code 4B9Q). Based on the analogy of DnaK structure, the sub-
strate-binding domain (SBD) of Sse1 was superimposed to
match the SBD structure of ADP-bound DnaK/Hsp70.
RESULTS
Human Hsp110 Cooperates with Hsp40 to Prevent Protein
Aggregation in an ATP-dependent Manner—We tested the
ability of purified recombinant Hsp110 (HSPH1) to prevent the
aggregation of native firefly luciferase, which is mildly thermo-
labile. When native luciferase was incubated at 34 °C without
chaperones and ATP or with equimolar Hsp40 or Hsp110, it
lost activity at similar rates of 2.4 0.2% per minute. The pres-
ence of bothHsp40 andHsp110 slightly slowed down luciferase
denaturation, as expected from a mild nonspecific protective
effect caused by the presence of native proteins (Fig. 1,A andB).
Whereas ATP alone did not stabilize the heat-denaturing
native luciferase, in the presence of ATP andHsp40 (DNAJA1),
Hsp110 drove the transient net reactivation of up to 120%of the
initial luciferase activity during the first 10 min, indicating that
the original native luciferase stock contained at least 20% of
misfolded inactive chaperone-amenable luciferase species (13).
Thereafter, the luciferase activity flattened and steadily
decreased at the same rate, yet at a constant higher level by 35%,
compared with without chaperones and ATP (Fig. 1D). Online
light scattering measurements showed that without ATP, the
presence of Hsp110, or of Hsp40 was mildly yet significantly
effective at passively preventing the aggregation of the denatur-
ing luciferase species. Together, their effect was additive (Fig.
1A), confirming that like Hsp70, the protein-binding domain of
Hsp110 can also bind aggregating polypeptides. In the presence
of ATP, Hsp110 or Hsp40 individually remained mildly effec-
tive at preventing the luciferase aggregation as without ATP.
Remarkably, in the presence of ATP, Hsp110 together with
Hsp40 became strongly synergic at preventing luciferase aggre-
gation (Fig. 1C). A similar synergic ATP-dependent prevention
of aggregation has been previously shown in the case of bacte-
rial DnaK and DnaJ (24) and was also confirmed here with
humanHsp70 (HSPA1A) andHsp40 (Fig. 1G). Thus, Hsp110 is
functionally indistinguishable from its structurally related
Hsp70 and DnaK paralogs. This is also strong evidence that the
Hsp40 co-chaperone undergoes an ATP-driven specific inter-
action with Hsp110, as it does with Hsp70.
The transient luciferase reactivation that we observed during
the first 10 min of the reaction with the particular Hsp110 
Hsp40 ATP combination (Fig. 1D) suggested that Hsp110 is
a bona fide Hsp40- and ATP-dependent chaperone that can
drive the transient renaturation of a misfolding protein against
the general tendency of the substrate at 34 °C to remain inactive
and become increasingly aggregated. Hsp70, Hsp40, and ATP
presented the same ability to transiently protect and reactivate
the heat-denaturing luciferase (Fig. 1F), implying that under the
conditions of the in vitro assay, the Hsp110 was an Hsp40-de-
pendent, ATP-fueled antiaggregation reactivating chaperone,
functionally indistinguishable from its structurally related
Hsp70 paralog.
HumanHsp110 Is a Bona Fide PolypeptideUnfolding/Refold-
ing Chaperone—We next addressed the ability of Hsp110
(HSPH1) to act upon stable inactivemisfolded luciferasemono-
mers (FTluc), which were prepared beforehand without chap-
erones by iterative cycles of freeze-thawing (12) and convert
them at 22 °C into native luciferase. Whereas ATP and/or
Hsp40 (DNAJA1) alone did not cause a significant net native
refolding of FTluc (Fig. 2A), the presence of equimolar Hsp110
with ATP regenerated a net 12% (120 nM) of native luciferase in
60 min. Remarkably, in the presence of Hsp40 (0.5 M) and
ATP, Hsp110 (1 M) produced a net 44% (440 nM) of native
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FIGURE 1. Hsp110 (HSPH1) and Hsp40 (DNAJA1) are synergic at preventing aggregation and transiently reactivating thermo-labile luciferase. A–D,
native luciferase (1 M) was incubated at 34 °C without or with Hsp110 (1 M) and/or Hsp40 (0. 5 M), without (A and B) or with (C and D) 5 mM ATP. Light
scattering at 550 nm (A and C) and luciferase activity (B andD) weremeasured online during exposure to 34 °C. E–H, similarly, Hsp70 andHsp40 are synergic at
preventing aggregation and transiently reactivating thermolabile luciferase at 34 °C.
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luciferase, demonstrating that alone but preferably when
assisted byHsp40,Hsp110 canuse the energy ofATPhydrolysis
to convert stable preformedmisfolded polypeptide species into
their stable native state. Similar specific assisted refolding
results were obtained when we used urea predenatured malate
dehydrogenase or stable pre-heat-denatured G6PDH aggre-
gates (Fig. 3, A and B). Thus, the chaperone activity of Hsp110
(Hsp105, HSPH1) is not limited to the special case of stable
inactive FTlucmonomers.Noticeably, using FTluc as substrate,
Apg-2 (HSPH2) and DNAJB1, which are respectively the other
most abundant human cytosolic Hsp110 and Hsp40, were
found to be as effective refolding chaperones as HSPH1 and
DNAJA1 (Fig. 3C). This was not unexpected, given that the
human Apg-2 (HSPH2), together with DNAJB1 or yeast YDJ1
have recently been shown in vivo and in vitro to act in synergy
with Hsc70 (HSPA8) at disaggregating preformed protein
aggregates (28, 29). Thus, we show here that Apg-2 is as a bona
fide ATP-fueled chaperone on its own, as HSPH1. Without
Hsc70, Apg-2 may also use ATP to drive the conversion of sta-
ble misfolded polypeptide substrates into natively refolded
products.
ThT is a fluorescent dye that specifically binds cross- struc-
tures, both in native proteins, butmore strongly and specifically
in misfolded polypeptides entangled within dense protein
aggregates, fibrils, and amyloids (30, 31). Because ThT does not
interfere with chaperone activity (12, 24), this allows online
measurements of the net time-dependent changes in the mis-
folded -structures of the substrates during the chaperone
reaction. When the Hsp110-mediated Hsp40-dependent
refolding reaction as in Fig. 2A was carried in the presence of
excess ThT, online fluorescence showed that addition of ATP
at T  0 min caused a sharp decrease in the net amount of
ThT-binding sites in the misfolded FTluc, indicating that the
chaperone caused a massive ATP-dependent loss of misfolded
structures and the unfolding, at least in part of the FTluc (Fig.
2B). After 5 min, during which 130 nM luciferase became
natively refolded, the decrease of ThT fluorescence leveled, and
a net regain of ThT-binding structures was observed, alongside
a parallel regain of up to 440 nM of native luciferase. The reac-
tivation profiles confirmed that Hsp110 alone with ATP (but
not Hsp40 alone with ATP) had a significant unfolding activity,
whose maximal yield at 5 min was4.5 times lower than when
FIGURE 2.Hsp110 (HSPH1) is an Hsp40- and ATP-dependent polypeptide unfolding/refolding chaperone similar to Hsp70. A and B, the activity (A) and
the net ThT fluorescence (B) of stable misfolded FT luciferase (1 M) were measured online at 22 °C in the presence of ThT (60 M) at various time points as
indicated, in theabsence (black) or presenceofATP (5mM)withHsp110alone (1M,purple), Hsp40 (DNAJA1) alone (0.5M,blue), or bothHsp110Hsp40 (red).
C and D, the activity (C) and the net ThT fluorescence (D) of stable misfolded FT luciferase (1 M) measured online without (black) or with ATP as in A and B, in
the presence of Hsp70 alone (1 M, purple), Hsp40 alone (0.5 M, blue), or both Hsp70 and Hsp40 (red).
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Hsp40 was also present. When in the same chaperone assay
Hsp110was replaced byHsp70, slightly faster reactivation rates
but overall similar refolding yields (Fig. 2C) and time-depen-
dent ThT changes in the luciferase substrate were observed
(Fig. 2D). Thus, as already shownwith bacterial DnaK (12), both
human cytoplasmic Hsp70 and Hsp110 can independently act
as efficient polypeptide unfolding enzymes that use ATP
hydrolysis to convert stable misfolded polypeptide substrates
into stable natively refolded protein products.
Partial trypsin digestions for 2 min at various time points of
the reaction and Western blots of SDS gels (Fig. 4) confirmed
that Hsp110 is an ATP-dependent polypeptide-unfolding
chaperone. Whereas at T  0 min, FTluc was 75.2% trypsin-
resistant, following addition of Hsp110Hsp40 ATP, tryp-
sin resistance dropped at T  5 min to 40.6% and thereafter
recovered to 85.6% within 30 min. Thus, confirming the chap-
erone-mediated transient loss of ThT binding misfolded
-sheets in the FTLuc substrate, partial trypsin digestions
showed a transient loss of the FTLuc compactness under the
FIGURE 3.VariousHsp110s andHsp40s can collaborate to reactivate var-
ious misfolded protein substrates. A, time-dependent refolding of ther-
mally predenatured G6PDH following 30 min of incubation at 30 °C without
orwith ATP, 6MHsp70 or Hsp110 (HSPH1), without orwith 3MDNAJA1, as
indicated. B, refolding yields of urea-preunfolded MDH (600 nM final concen-
tration) at 34 °C. 60 M MDH was incubated 30 min at 34 °C in 8 M urea and
diluted 100-fold in refolding buffer also containing 5% glycerol, without or
with 4 M Hsp70, or Hsp110 (Hsp105) and 2 M DNAJA1, as indicated. C,
time-dependent refolding of 1 M FTluc without or with ATP, 1 M Apg-2 or
Hsp105, and 0.5 M DNAJA1 or DNAJB1. The protein combinations are
indicated.
FIGURE4.Trypsin treatmentofmisfoldedmonomeric luciferase revealed
unfolding by Hsp110/Hsp40. Upper panel, Western blots of trypsin-treated
luciferase. At the indicated timepoints of theHsp110Hsp40ATP-depen-
dent refolding reaction as in Fig. 2A, the samples were treated for 3 min with
0.04 mg/ml trypsin, separated on SDS gel, and detected on Western blots
with luciferase antibodies. Lower panel, the relative semiquantitative lucifer-
ase signal at 60 kDa from the Western blot (plain circles). The relative net ThT
fluorescence signal of FTluc under the same conditions from Fig. 2B is shown
for comparison (red dotted line).
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combined ATP-fueled action of Hsp110, Hsp40, despite the
additional chaperones that were also competing for the limiting
amounts of trypsin. The subsequent regain of luciferase trypsin
resistance, which paralleled that of ThT rebinding and regained
luciferase activity (Fig. 2B), confirmed that the natively refolded
chaperone product was, as expected, more compact than the
chaperone-unfolded intermediate.
Equimolar Hsp110 and Hsp70 Form an Optimal Bi-chaper-
oneDisaggregatingMachine—Aslow significant disaggregating
activity has been demonstrated formammalianHsp110 (Apg-2,
HSPH2) and Hsc70 (HSPA8), which dissolved large disordered
aggregates but failed to act on -synuclein fibrils (29). We thus
next addressed the ATP-dependent chaperone activity of both
human cytoplasmic Hsp110 (HSPH1) and Hsp70 (HSPA1A) in
the presence of Hsp40 (DNAJA1), using two different sub-
strates: stable oligomeric FTluc aggregates, which eluted on gel
filtration with an apparent molecular weight of soluble 4–12-
mers (fraction I; Fig. 5A), or misfolded FTluc monomers that
eluted last (fraction II; Fig. 5A). At equal protomer concentra-
tions, light scattering and ThT fluorescence of the various gel
filtration fractions (data not shown) showed that, as initially
demonstrated by analytical ultracentrifugation, themonomeric
FTluc fraction was composed mostly of stable misfolded lucif-
erase monomers that bound 1.8 times more ThT than native
luciferase (12) but, similar to the native monomeric luciferase,
did not scatter light. In contrast, the oligomeric fraction,
although containing as many ThT binding misfolded struc-
tures, scattered light five times more than the monomeric
species (data not shown). When 2 h after their first elution
the 10-fold diluted oligomers were reinjected on the same
column, at least 95% eluted at the same positions as the orig-
inal oligomers, and the remaining 5% eluted at the same
position as monomer (Fig. 5A, peak I), confirming that
although soluble, the luciferase aggregates were stable and
mostly dilution-resistant.
When the monomeric misfolded luciferase species (fraction
II) were incubated with Hsp70 (HSPA1A), Hsp40 (DNAJA1),
and ATP, a net minor amount of 50 nM native Luc was pro-
ducedwithin 20min, and similarly, Hsp110 (HSPH1) with ATP
and Hsp40 produced 40 nM native Luc (Fig. 5B). In contrast, an
equimolar mixture of half as concentrated Hsp70 and Hsp110
with Hsp40 and ATP produced 75 nM luciferase, i.e., nearly
twice more than the average yield of 45 nM expected if the two
chaperones were acting independently from one another.
Hsp70, Hsp40, and ATP produced only 5 nM of net native lucif-
erase from stable aggregated species, as expected from less
amenable aggregated substrates. Hsp110, Hsp40, andATP pro-
duced twice more native protein than Hsp70, suggesting that
Hsp110, by itself, may be slightly more competent a chaperone
FIGURE 5.Hsp110 (HSPH1) collaborates with Hsp70 (HSPA1A) to convert
stable luciferase aggregates into native species. A, purification and con-
firmation of freeze-thawed luciferase aggregates (fraction I) and monomers
(fraction II). B and C, soluble monomeric misfolded FTluc (0.5 M) from frac-
tion II (B) or soluble oligomeric aggregates of FTlucmonomers from fraction II
(C) was incubated at 22 °C as in the presence of 5mM ATP, 125 nM Hsp40, and
either 250 nM Hsp70 alone (f) or 250 nM Hsp110 alone () or 125 nM Hsp70
together with 125 nM Hsp110 (), as indicated. D, the rates of reactivation of
monomeric FTluc (Œ) or oligomeric FTluc (●) in the presence of 5mMATP, 0.5
M Hsp40, and increasing concentrations of Hsp70 (0–1 M) supplemented
by corresponding decreasing concentrations of Hsp110maintaining the sum
of Hsp70 and Hsp110 molecules at 1 M. Luc., luciferase; Mono., monomer;
Agg., aggregate.
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to process large oligomeric misfolded polypeptides than Hsp70
(Fig. 5C). Remarkably, an equimolar mixture of half as concen-
trated Hsp70 and Hsp110 molecules produced 70 nM native
luciferase, which was nine times higher than the expected aver-
age yield of 7.5 nM if the two chaperones were acting independ-
ently from one another. This strongly suggests that Hsp110
forms a functional complex with Hsp70, combining their indi-
vidual chaperone unfolding abilities into a unique synergic
polypeptide disentangling andunfoldingmechanism to convert
stable protein aggregates in native proteins.
Further addressing the optimal stoichiometry in the 1:1
Hsp110:Hsp70 disaggregatingmachinery, wemeasured the ini-
tial rates of luciferase reactivation, either with stable misfolded
FTluc monomers as substrates or with stable misfolded FTluc
oligomers, in the presence of increasing concentrations of
Hsp70 (0–1 M), supplemented with the corresponding
decreasing concentrations of Hsp110 (1–0 M) to keep a con-
stant chaperone concentration of 1 M. As initially observed in
Fig. 5A, the reactivation rates of misfolded FTlucmonomers by
individual Hsp70, or individual Hsp110 were nearly equally
high:9 nMmin1 with aminor optimal rate of 10.3 nMmin1
observed at equimolar Hsp70:Hsp110 (Fig. 5D, upper line).
Whereas the reactivation rates of misfolded Luc oligomers by
individual Hsp70 or Hsp110 was expectedly low in both cases
(1–1.5 nM min1), as the stoichiometry between Hsp70 and
Hsp110 approached 1:1, the reactivation rates increased 5-fold,
to reach up to 55% of the optimal rates obtained withmisfolded
FTluc monomers (Fig. 5D, lower line). Thus, corroborating the
crystal 1:1 heterocomplexes between bovine Hsc70 and yeast
Hsp110 (SSE, 32), the human Hsp110 (Hsp105) can form in
solution with Hsp70 a functional 1:1 bichaperone complex to
disaggregate proteins.
Hsp70 and Hsp110 Mutually Catalyze Substrate Release
from One Another—We next assessed the ability of Hsp110
(HSPH1) to act as a presumed nucleotide exchange factor
(NEF) of Hsp70 (33, 34). Because a NEF, by definition, should
catalyze the ATP-dependent release of ADP and of polypeptide
substrates from stable preformed (ADP-Hsp70-substrate)
complexes, we use a simplified protocol from Ref. 12 in which
FTluc was first incubated for 2 min with Hsp40, ATP, and
Hsp70 (Fig. 6A). Because of the high ATPase activity of Hsp70
with Hsp40 even in the absence of a NEF, Luc expectedly
started to refold at 15 nM min1. Addition at T  2 min of
apyrase sharply reduced by 10-fold the rate of luciferase refold-
ing to 0.2 nMmin1. Thus, the instantaneous destruction of the
ATPmolecules reduced as expected the release and refolding of
the unfolded luciferase substrate from the so-called “locking”
state of the ADP-bound Hsp70 chaperone (12). Whereas the
subsequent addition at T 30 min of an equimolar amount of
free Hsp70 did not change the slow ATP-independent rate of
luciferase release and refolding from the preformed ADP-
Hsp70-Luc complex, addition of equimolar Hsp110 caused a
dramatic release and spontaneous refolding of the Hsp70-
bound FTluc, at a rate thatwas three times faster than the initial
rate with ATP, although release and refolding at T  30 min
took place in the total absence of ATP (Fig. 6A). Thus, justifying
in part why it was initially described as a NEF of Hsp70, we
found that Hsp110 is not a true NEF, because ATP binding was
apparently not necessary for its action upon Hsp70 as a sub-
strate release factor. Surprisingly, swapping the roles between
Hsp70 and Hsp110 in this experiment produced the same
results. The addition at T  30 min of equimolar amounts of
free Hsp70 to apyrase-treated preformed Hsp110-Luc com-
plexes caused a strong release and native refolding of the
unfolded luciferase, whereas addition of substrate-free Hsp110
FIGURE 6. Hsp70 (HSPA1A) and Hsp110 (HSPH1) mutually activate sub-
strate release. Misfolded luciferase monomers (1 M) were supplemented
with 0.1 mM ATP and Hsp70 (1 M), Hsp40 (0.5 M) (A), or Hsp110 (1 M) and
Hsp40 (0.5 M) (B), and luciferase activity was followed in time. At T 2 min,
apyrase (2 M) was added, which readily destroyed the ATP. At T 30 min, 1
M of Hsp110 in A and of Hsp70 in B was added, and luciferase activity was
further measured up to T 65 min.
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did not significantly affect the slow rate of luciferase release
fromHsp110 (Fig. 6B). Thus, Hsp110 is symmetrically as much
a substrate release factor for the Hsp70 unfolding chaperone as
Hsp70 is a substrate release factor for the Hsp110 unfolding
chaperone.
ATPHydrolysis Assays Show Functional Interactions between
Hsp110, Hsp70, Hsp40, and the Substrate—In the absence of
substrate polypeptides, the highly conserved J-domain of
Hsp40 spontaneously associates with the nucleotide-binding
domain (NBD) of nucleotide-less or ATP-bound Hsp70 mole-
cules, near the hinge region that connects the NBD to the SBD
(35). Thus, evenwithout a substrate polypeptide, DnaJ can acti-
vate futileATPhydrolysis by bacterialHsp70 (12, 36).Measures
of steady state rates ofATPhydrolysis (Table 1) showed that the
presence of Hsp40 expectedly nearly doubled the rate of ATP
hydrolysis, both by Hsp70 alone and by Hsp110 alone. Thus,
as previously shown in the case of SSE1 and Ydj1 (37), with
regard to J-domain-induced ATPase activity, humanHsp110
is functionally indistinguishable from other bona fide Hsp70
chaperones.
Whereas, theoretically, half amounts of Hsp70 and Hsp110
(in the presence of constant Hsp40) should hydrolyze 1.1 ATP
min1, they effectively hydrolyzed 1.8 ATP min1 (Table 1).
This 1.6-fold activation was in agreement with the refolding
rates, suggesting that Hsp110 and Hsp70 form a functional 1:1
complex, andwith the crystal structure of SSE1withHsc70 that
showed that the two chaperones interact though their distal
lobes in their respective NBDs, far away from where the J-do-
main of Hsp40 can bind Hsp110 or Hsp70.
Hsp110 ATPase Is Activated by FTMisfolded and Aggregated
Luciferase Substrates—The ATPase activity of DnaK, with and
without DnaJ and GrpE, has been shown to become activated
severalfold upon binding of various short, mostly hydrophobic
peptides (22, 38) and of artificially unfolded polypeptide sub-
strates (39, 40), as well as of native polypeptide substrates, such
as the32 (41).Here,we found that theATPase rate ofHsp70 in
the presence of Hsp40 was activated 2.2- or 2.5-fold by stable
misfolded luciferase monomers or oligomers, respectively
(Table 1). Similarly, the ATPase rate of Hsp110 (HSPH1) in the
presence of Hsp40 (DNAJA1) was activated 3.2- and 3.7-fold by
stable misfolded luciferase monomers or oligomers, respec-
tively. Thus, with regard to substrate-induced ATPase activa-
tion, Hsp110 was functionally indistinguishable from a bona
fide Hsp70 chaperone.
Although the luciferase aggregates were less efficiently
refolded, they triggered the ATPase activity to a higher extent
than the misfolded luciferase monomers, suggesting that there
is more futile hydrolysis and that despite strong interactions
with the chaperone, themisfolded oligomers aremore resistant
to ATP-fueled Hsp70- or Hsp110-mediated unfolding than the
misfolded monomers. Theoretically, if equimolar Hsp70 and
Hsp110 molecules were not collaborating with one another,
568ATPs should be hydrolyzedwhile reactivating a single lucif-
erase polypeptide entangled within a stable luciferase aggre-
gate.We found that only 229 ATPs were hydrolyzed, indicating
that the two chaperones collaborate in a way that increases the
efficiency of ATP hydrolysis to unfold/refold stable protein
aggregates (Table 1). In contrast, comparedwith the theoretical
average of 123 ATPs, the equimolar mixture of Hsp110 and
Hsp70 consumed 21%moreATP (149ATPs) while reactivating
a misfolded monomer, suggesting that the ATP-fueled unfold-
ing/refolding of misfolded monomers does not require that the
two chaperones collaborate.
DISCUSSION
The chaperone mechanism of Hsp70 has been extensively
studied (42). Bacterial DnaK was shown to use ATP to apply an
unfolding force on stable misfolded polypeptides and small
aggregates by two complementary mechanisms likely involving
both direct “clamping” by individual DnaK molecules that may
unfold non-native -structures in stable misfolded polypep-
tides (12, 43) and indirect “entropic pulling” by several concom-
itantly clamped DnaK molecules on the same misfolded poly-
peptide, cooperating to unfold by thermal movements local
misfolded regions in between chaperone-bound segments (44).
NEFs can accelerate both effects by promoting the dissociation
of ADP and the consequent release of the unfolded polypep-
tides from the stable ADP-Hsp70-substrate clamped com-
plexes, allowing the unfolded products to spontaneously refold
to their native state (12). In eukaryotes, at least four classes of
Hsp70 NEFs have been identified, all acting on the same distal
NBD lobes (IB and IIB) of Hsp70s. Three conserved classes of
the GrpE-like, HspBP1-like, and BAG1–5-like NEFs cannot
bind misfolded polypeptides. Although they are also unable to
bind ATP, they are considered to be ATP-dependent ADP
release catalysts (20, 45–48). The Hsp110s have been catego-
rized as a fourth class of NEFs (32, 48–51), despite the fact that
sequence-wise and structure-wise, they are close orthologs of
TABLE 1
Rate of ATP hydrolysis and ATP cost by various combinations of Hsp110, Hsp70, and Hsp40, without or with equimolar aggregated (Agg.) or
misfoldedmonomeric (Mono.) luciferase (Luc.) substrates
Sample
ATP consumed by
500 nM chaperones only
ATP consumed by chaperones
in the presence of substrates ATP
Net ATP cost to
refold a luciferase
min1 min1 chaperone1 min1
Hsp70 312 0.62
Hsp110 252 0.50
Hsp70 Hsp40 624 1.25
Hsp110 Hsp40 516 1.03
Hsp70 Hsp110 Hsp40 924 1.85
Hsp70 Hsp40 Luc. Mono. 1392 2.78 77.45
Hsp110 Hsp40 Luc. Mono. 1644 3.29 168.6
Hsp70 Hsp110 Hsp40 Luc. Mono 2772 5.54 148.9
Hsp70 Hsp40 Luc. Agg. 1536 3.07 650.7
Hsp110 Hsp40 Luc. Agg. 1890 3.8 485.4
Hsp70 Hsp110 Hsp40 Luc. Agg. 2388 4.8 228.9
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their acknowledged Hsp70 co-chaperone partners in disaggre-
gation. The Hsp110s have a very similar NBD and C-terminal
SBD, in which the peptide binding -sandwich subdomain
(SBD) and the -helical lid subdomain (SBD) can be clearly
recognized (52). In vitro, purified human Hsp110 (HSPH1) can
drive the ATP-, Hsc70-, and DNAJC6-dependent disaggrega-
tion of clathrin baskets (32). Like Hsp70s, Hsp110 can hydro-
lyze ATP (33) and is activated by J-domain co-chaperones (34).
Hsp110 can also bind nascent polypeptide chains (33, 34, 53)
and small peptides with different specificities (54). By doing so,
Hsp110 may act as a “holding” chaperone that passively pre-
vents the aggregation of stress- or mutation-induced misfold-
ing and aggregating proteins (55). Moreover, yeast Hsp110
(Sse1) has been co-crystallized in 1:1 complex with the NBD of
bovine Hsp70 (Hsc70), showing a pseudosymmetrical dimer
with many tight interactions between the two NBDs, mostly in
the distal lobes (IB and IIB), precisely at the same locations
where the other NEFs also interact with Hsp70 and DnaK (32).
However, at variancewith theDnaK structure, the crystal struc-
ture of Sse1 showed the SBD lid in an extensively wide open
conformation. Although this initially questioned the ability of
Hsp110 to close on its base and consequently to act as unfold-
ing chaperones on its own (28), the same extensively wide open
conformationwas observedwith functional DnaKmutants that
crystallized as dimers associated through their NBDs as in the
case of the SSE1 and Hsp70 crystals (56).
Hsp70s are polypeptide-unfolding enzymes on their own
with a significant disaggregase and reactivation activities,
which need to be in a large stoichiometric excess to coopera-
tively solubilize misfolded polypeptides from small soluble
aggregates (12, 16). Generalizing the initial finding that
Hsp105, together with Hsc70, can efficiently disaggregate puri-
fied clathrin cages (32), less specific in vitro disaggregating
assays recently showed that mammalian cytosol prepared from
different sources possess a potent, ATP-dependent activity
requiring the apparent NEF activity of mammalian Hsp110
(Apg-2), the chaperone activity of Hsc70, and the co-chaperon-
ing of Hdj1, to slowly dissolve large disordered aggregates and
recover natively refolded proteins. A similar significant disag-
gregase activity was also observed in the case of yeast Sse1 act-
ing upon Ssa1 together with the Sis1 or Ydj1 J-domain proteins
(29). Likewise, Hsp110 (Apg-2) promotes the ATP- and Hdj1-
dependent disaggregation activity of Hsc70 on stable heat-de-
natured aggregates in vitro and in vivo (28). Thus, contrary to
other co-chaperones, Hsp110 is a unique NEF by being able to
turn Hsc70 into an effective disaggregating machinery that can
solubilize and reactivate large stable proteins aggregates (33),
thereby possibly reducing the need for a large molar excess of
Hsp70 to obtain some disaggregation by cooperative entropic
pulling (16, 25, 44).
Noticeably, prior in vitro chaperone assays have reported
that Hsp110 (Apg-2) lacks a chaperone unfolding/refolding
activity of its own (28). In contrast, using various sensitive mis-
folded substrates, we found here in vitro that HSPH1 (Hsp105)
or HSPH2 (Apg-2), assisted by DNAJA1 or DNAJB1, can act as
bona fide ATP-dependent unfolding/refolding chaperones,
even when Hsp70 is not present. This difference may be attrib-
uted to the use of slightly different substrates: predominantly
stable freeze-thawed misfolded luciferase monomers rather
than urea preaggregated luciferase.
Our finding that humanHsp110 alone can act as a chaperone
using ATP hydrolysis to drive the catalytic unfolding of stable
misfolded polypeptide substrates and to efficiently convert
them into natively refolded products suggests that in solution,
the substrate-binding domain of Hsp110 can effectively
“clamp” upon itsmisfolded substrate and apply a pressure lead-
ing to unfolding, as in the case of DnaK (43). We therefore
suggest amodel accounting for the polypeptide unfoldase activ-
ity of Hsp110, in which the -helical lid may depart from its
stable position alongside the nucleotide-binding domain
observed in the crystal structures and adopt during ATP
hydrolysis an extensively opened position capable of binding to
large bulky hydrophobicmisfolded domains of a substrate poly-
peptide and, upon ATP hydrolysis, operate a large clamping
movement toward the-sheet base subdomain, as in the case of
DnaK (57), that may in turn cause the unfolding of the clamped
misfolded polypeptide segment (43).
An allosteric communication between the NBD and the sub-
strate-binding domain of Hsp110 has been recently reported
(54). Our dose responses further showed that, as suggested
from the crystal structure of yeast Hsp110 with bovine Hcp70
NBD, equimolar Hsp70 andHsp110 can optimally refold stable
aggregated luciferase, likely by binding to orthologous topolog-
ical sites in their respective NBDs and by effective reciprocal
allosteric signals of similar quality and intensities between the
two orthologous SBDs (42). The presence of such symmetrical
allosteric signals was confirmed by the reciprocal release of the
unfolded luciferase that we observed in the presence of apyrase,
upon addition of Hsp110 to stable preformed ADP-Hsp70-Luc
complexes or symmetrically of Hsp70 to stable preformed
ADP-Hsp110-Luc complexes.
Despite their optimal 1:1 functional association, Hsp110 and
Hsp70 apparently form loose heterodimers, because gel filtra-
tion, dynamic light scattering, chemical cross-linking, and
electrophoresis on native gels thus far failed to reveal the unam-
biguous presence of stable Hsp110-Hsp70 heterodimers.
Noticeably, proteomic analysis showed that in the cytoplasm
and the endoplasmic reticulum of human cells, the Hsp70s are
respectively 7- and 14-fold more abundant than the Hsp110s
(3). Thus, despite their low affinity, most of the Hsp110 mole-
cules are expected to form loose but potent disaggregating het-
erocomplexes with Hsp70, leaving the remaining excess Hsp70
molecules free to carry Hsp70-specific functions, such as the
catalytic unfolding of amenable misfolded monomers (12) and
the pulling apart of native clathrin cages (32) or of active IB
complexes (58), the activation of steroid hormone receptors,
the inhibition of the heat shock transcription factor (59), or
mediating proteasomal and lysosomal degradation (60).
Analysis of the x-ray structures from various Hsp70s associ-
ated with NEFs (DnaK-GrpE, Hsp70-Bag1, and Hsp70-Bag2)
shows a common region of interaction (data not shown) in the
IB lobe of theHsp70NBD, which is structurally similar as in the
reciprocal binding of the SSE1 to bovine Hsc70 NBD. This may
justify initial description of Hsp110 acting as an apparent NEF
of Hsp70 (33, 61). However, our results with apyrase suggested
that Hsp110 does not need ATP to catalyze the release of a
Hsp110 Is an Unfolding Chaperone
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locked polypeptide clamped into an ADP-boundHsp70.More-
over, Hsp110 was found to be as much an ATP-independent
substrate release factor for Hsp70, as Hsp70 was a substrate
release factor for Hsp110.
A Possible Disaggregation Mechanism—The molecular
mechanism by which Hsp110-Hsp70 heterodimers may utilize
ATP to disentangle stable protein aggregates and fibrils is
unclear. The core mechanism should include basic unfolding
by individual Hsp70 and, as we found, also of Hsp110 mole-
cules, amplified by the heterodimeric complex into a coopera-
tive disaggregating machine. Inspired from the partial crystal
structure of the heterodimer showing SSE1 and bovine Hsc70
in different nucleotide binding states (32), one could propose
a “clamping and walking on the aggregate” mechanism, in
which both SBDs of the Hsp110-Hsp70 heterodimer would
side by side face the aggregate. The cycles of ATP hydrolysis
would alternate between the ADP-Hsp110 (clamped):ATP-
Hsp70 (open) state and the ATP-Hsp110 (open):ADP-Hsp70
(clamped) state (Fig. 7). Although one SBD would be firmly
anchored onto the aggregate surface by way of an ADP-bound
subunit clamping and unfolding a misfolded polypeptide seg-
ment, the flexible hinge between the SBD and the NBD would
allow for the other ATP-binding chaperone molecule with its
wide open SBD to scan the surrounding surfaces for new
exposed hydrophobic surfaces to clamp upon (Fig. 7). Trig-
gered by this “substrate-probing” chaperone subunit, ADP
release from the NBD of the first subunit would “unclamp” its
SBD and thus allow the heterodimer to “walk” on the aggregate
surface, thus leaving behind a trail of unfolded polypeptide
loops that would thereafter spontaneously seek more native-
like conformations and thus gradually dissociate and refold into
soluble native polypeptides.
In Vivo Relevance of Hsp110—The cytoplasm and endoplas-
mic reticulum of animal cells lack ClpB/Hsp104-like co-chap-
erones andmay use only Hsp110-Hsp70 to disaggregate poten-
tial proteotoxic conformers. Thus, Hsp110 was co-localized to
GFP-luciferase aggregates in human U2OS cells, and Hsp110
RNAi dramatically increased the number of heat-induced
aggregates of Luciferase-YFP in whole Caenorhabditis elegans
animals. Moreover, knockdown of Hsp110 decreased the nema-
tode lifespan, particularly upon heat shock (28). Thus, functional
Hsp70-Hsp110 complexes in the cytoplasm and the endoplasmic
reticulum of human cells likely form a powerful unfolding/disag-
gregating machinery to counteract age- and mutation-induced
toxic protein misfolding and aggregations, causing the onset of
degenerative protein conformational diseases.
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FIGURE 7.Model for Hsp110-Hsp70-mediated disaggregation. A, model of the two alternating functional HSPA8-SSE1 heterodimers, respectively, in the
ATP-ADP state (left panel) and the ADP-ATP state (right panel), reconstructed by structural alignments of the SBDs fromHSPA8 (blue tones) and SSE1 (magenta
tones), eitherwith the closedADP-bound formofDnaK (PDB code 2KHO) orwith the openedATP-bound formofDnaK (PDB code 4B9Q). The association of the
HSPA8 NBDwith the SSE1 NBDwas from PDB code 3C7N. The substrate binding sites of HSPA8 and SSE1 SBDs are shown as red circles. The connecting red line
shows the distances between binding sites in the heterodimer. B, model for the disaggregation mechanism. The crystal structure of the HSPA8-SSE1 het-
erodimer (32) suggests that when one chaperone is ADP-bound, its SBD can be locked on an unfolded substrate, whereas the other chaperone is in the
ATP-bound state with a widely opened SBD. During disaggregation, SSE1 and Hsp70may thus alternate between a closed locked state, anchoring the whole
chaperone heterodimer to the aggregate surface at a singlemisfolded loop (left panel), becoming unfolded by entropic pulling (44), and an opened state that
can scan far from the anchor for new misfolded structures to bind to. Then, upon ATP hydrolysis, the second chaperone may bind and apply an unfolding
pressure on the newly targetedmisfolded loops (right panel). When successful, lockingmay unfold themisfolded structure, while concomitantly, an allosteric
signal is sent from the NBD of the second locking chaperone to the NBD of the first chaperone to release ADP and thus unlock the SBD from a now newly
enlarged unfolded anchoring loop, which may then refold to the native state.
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Chaperonins are cage-like complexes in which nonnative polypep-
tides prone to aggregation are thought to reach their native state
optimally. However, they also may use ATP to unfold stably bound
misfolded polypeptides andmediate theout-of-cagenative refolding
of large proteins. Here, we show that even without ATP and GroES,
bothGroELandtheeukaryotic chaperonin containing t-complexpoly-
peptide 1 (CCT/TRiC) can unfold stable misfolded polypeptide con-
formers and readily release them from the access ways to the cage.
Reconciling earlier disparate experimental observations to ours, we
present a comprehensivemodel whereby following unfolding on the
upper cavity, in-cage conﬁnement is not needed for the released
intermediates to slowly reach their native state in solution. As over-
sticky intermediates occasionally stall the catalytic unfoldase sites,
GroESmobile loops andATP are necessary to dissociate the inhibitory
species and regenerate the unfolding activity. Thus, chaperonin rings
are not obligate conﬁning antiaggregation cages. They are polypep-
tide unfoldases that can iteratively convert stable off-pathway con-
formers into functional proteins.
molecular chaperones | protein aggregation | protein misfolding |
protein unfolding
Newly synthesized polypeptides, or stress-labile proteins de-stabilized bymutations, may fail to properly reach their native
state and instead formmisfolded species that may coalesce further
into stable toxic aggregates (1–3). Molecular chaperones, such as
the cage-like eukaryotic chaperonin containing t-complex poly-
peptide 1 (CCT/TRiC) and GroEL/GroES chaperonins and the
heat shock protein (Hsp)70/Hsp40s (4, 5), form a ﬁrst line of
cellular defenses against early misfolded species on the cytotoxic
protein aggregation pathway, leading to degenerative conforma-
tional diseases and aging (6). In vitro, chaperonins may prevent
the aggregation of artiﬁcially unfolded proteins and use ATP
hydrolysis to promote their native refolding but fail to act upon
misfolded species already entangled into large aggregates (7, 8).
Eukaryotic cytosolic CCTs, bacterial GroEL, andmitochondrial
Hsp60 are double-ring complexes with two central cavities. Their
key role in cellular proteostasis is generally thought to be theATP-
driven transient conﬁnement of aggregation-prone polypeptides
within the central cavities, allowing “in-cage” protein refolding to
the native state. The mechanistic steps ﬁrst involve spontaneous
binding of an unfolded or misfolded polypeptide to exposed hy-
drophobic residues on the apical domains facing the upper pas-
sageway of the chaperonin cavity (9). Next, the ATP-regulated
movements of the apical domains cause the dissociation of the
tightly bound polypeptide, either within the conﬁned space of the
cavity or directly into the external solution, especially in cases of
large polypeptides (10). The transient capping of the cavity by
a helical lid domain in CCT, or a GroES7 cover in the case of
GroEL14 (5, 11), is generally thought to be an obligatory step to
conﬁne the released polypeptide within the cage, where it pre-
sumably needs to reach its native state while being secluded from
other aggregating polypeptides. An allosteric signal from the
empty trans-ring then prompts the uncapping of the substrate-
containing cis-cavity (12, 13), causing the release of the natively
refolded protein. Thus, ATP is thought to drive the reaction cycle
of GroEL and CCT by timely alternating between an in-cage se-
questration phase, to promote by conﬁnement the spontaneous
refolding of an unfolded polypeptide, and a dissociation phase, to
release the natively refolded protein from the cage into the so-
lution. However, exceptions also have been reported of large
proteins being released directly from the GroEL cage without
encapsulation, upon GroES binding to the opposite ring, possibly
leading to out-of-cage refolding (14, 15).
Here, we revisit the obligate link between the mechanism by
which chaperonins can convert a stable misfolded polypeptide into
a native protein and the mechanism of encaging to avoid aggre-
gation of the substrate during the various steps to native refolding.
To this aim, we used as a unique type of stringent chaperone sub-
strates in the form of stable misfolded inactive polypeptides that
without chaperonins tended neither to aggregate nor to refold
spontaneously to the native state. We found that both apoGroEL
and apoCCT acted as efﬁcient polypeptide unfolding molecular
machines that could rapidly convert an excess of misfolded poly-
peptide substrates into unfolded intermediates that were released
from the chaperonin to slowly reach the native state in solution.
However, following several full turnovers of binding, unfolding,
release, and out-of-cage refolding, both GroEL and CCT activities
gradually became stalled by over-sticky intermediates, whose dis-
sociation required the action of an ancillary regeneration mecha-
nism that depended on ATP hydrolysis and, in the case of GroEL,
also on GroES mobile loops (16).
Results
Freeze–Thaw Denatured Rhodanese Is a Stringent Substrate That Is Not
Aggregation Prone. Unstable guanidinium HCl- or urea-unfolded
rhodanese has been used in classic in vitro chaperonin assays by
virtue of its high propensity to aggregate readily upon removal of
the denaturant and form resistant species, unless readily assisted by
a large molar excess of GroEL, GroES, and ATP (17). In contrast,
here we used freeze–thaw (FT) denatured rhodanese (FTrho) as
a unique type of substrate generated beforehand in the absence of
GroEL, by iterative FT cycles. Similar to FT-denatured luciferase
(FTluc) (18), inactive FTrho was found to be composed of stable,
soluble, and mostly monomeric species (Fig. S1A) (19). Indicative
of the presence of stable misfolded β-structures, FTrho bound 3.5
times more thioﬂavin T (Th-T) than native rhodanese (Nrho) (Fig.
S1B). Without chaperones, less than 3% spontaneously converted
into Nrho in 60min at 25 °C. Remarkably, no FTrho converted into
light-scattering aggregates in 18 h (Fig. S1C). The FTrho species
were more resistant than Nrho to urea unfolding (Fig. S2), and
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FTIR spectroscopy showed the presence of intramolecular mis-
folded β-sheets different from Nrho (19). Therefore, FTrho was
a stringent candidate substrate with a potential to differentiate
between the chaperonin’s ability tomediate protein refolding per se
and its ability to prevent aggregation.
ApoGroEL Can Catalytically Unfold FTrho Without ATP. Whereas
during 18 h, up to 13% of the FTrho was converted spontane-
ously to Nrho, addition of equimolar apoGroEL (1 μM proto-
mers, i.e., 71.4 nM of GroEL14) produced the same amount of
Nrho in 3 min, corresponding to a 360-fold acceleration of the
native refolding reaction. Whereas without ATP other molecular
chaperones and proteins in equimolar amounts [DnaK, DnaJ,
Caseinolytic peptidase B protein (ClpB), HtpG, GroES, BSA]
remained ineffective, up to a third of the substrate (330 nM)
was refolded rapidly by apoGroEL in 15 min (T50 = 4 min 30 s;
Fig. 1A) and similar high refolding yields were observed with
equimolar single-ring GroEL7-mutant SR1 mutants (20). On
average, each GroEL7 ring converted half the FTrho substrate
per minute, generating 2.3 native products in 30 min. FTrho thus
allowed chaperonins to work through multiple turnovers, over-
coming the single-turnover limitation observed in previous in vitro
refolding assays with aggregation-prone substrates (7, 17). Enzyme
activity, kinetics of deuterium exchange, NMR, and FRET spec-
troscopy previously showed that mere binding to apoGroEL may
cause the unfolding of metastable native or misfolding proteins,
such as pre–β-lactamase (21), heat-denatured cyclophilin (22),
barnase (23), or urea-denatured Ribulose 1,5-bisphosphate car-
boxylase/oxygenase (RubisCO) (24). However, here we show that
a single apoGroEL ring may carry several complete, consecutive
turnovers including substrate binding, unfolding, release, and
native refolding.
Fluorescence spectroscopy showed that apoGroEL caused a
rapid net loss of the high FTrho Th-T signal (T50 = 1 min), in-
dicating that upon GroEL binding, FTrho lost a signiﬁcant fraction
of its intramolecular misfolded β-structures (18, 19), a result com-
patible with some degree of unfolding. Within 2 min, the apparent
unfolding signal leveled and was followed by a slower net regain
of Th-T signal, corresponding to the formation of some native
β-structures (Fig. 1B), as suggested by a parallel regain of rhodanese
activity (Fig. 1A). Time-lapse transient trypsin digestions at various
time points of the reaction conﬁrmed that binding of apoGroEL
caused an initial decompaction and partial unfolding of the bound
FTrho substrate. FTrho thus was incubated before and afterGroEL
addition with 0.02 mg/mL trypsin and, 3 min later, with an excess
of the trypsin inhibitor N-α-tosyl-L-lysine chloromethyl ketone hy-
drochloride (TLCK). A prior short trypsin treatment of GroEL
alone had no effect on its subsequent unfolding/refolding activ-
ity, and a prior short trypsin treatment of FTrho or Nrho alone
followed by GroEL addition produced 82% and 91% Nrho, re-
spectively, in 60 min (compared with the apoGroEL-mediated
yield without trypsin pretreatment set to 100%; Fig. 1C). The
similar elevated levels of trypsin resistance of FTrho and Nrho
imply that they were comparably compact. Remarkably, when
transient trypsin digestion of FTrho was applied 2 min after
GroEL addition, only 18% of the refolding yield (mediated by
apoGroEL in 60min) was observed. Amarked transient increase of
sensitivity of FTrho to trypsin, despite a possible partial recruitment
of trypsin by the added GroEL and a possible partial sequestration
of the substrate in the cavity, is strong evidence that upon binding,
GroEL caused a decompaction and, therefore, the partial unfolding
of the compact misfolded FTrho species. When the trypsin diges-
tions were applied later in the GroEL reaction, they progressively
became less effective, and the GroEL-mediated refolding yields
recovered up to a maximal 87%, with a T50 = 17 min (Fig. 1C).
Thus, following an initial rapid drop of the compactness of the
substrate, its subsequent slow regain of trypsin resistance is evi-
dence of its slow conversion into new compact native species, as
attested by its regained enzymatic activity.
In this reaction, each GroEL heptameric ring thus acted as
an ATP-independent enzyme, which ﬁrst rapidly unfolded the
misfolded polypeptide substrate upon binding, then rapidly re-
leased it as a species highly sensitive to the trypsin molecules of the
external solution, where it slowly refolded to the more compact
protease-resistant native state. Other misfolded substrates in ex-
cess, by virtue of their low propensity to aggregate, could patiently
wait their turn to be unfolded and released by the chaperonin in
several successive turnovers. The same results were found with the
single-ring SR1 mutants, indicating that the release step did not
depend on an allosteric signal from the trans-ring.
A
B
C
Fig. 1. GroEL is anATP-independent catalytic polypeptide-unfolding enzyme.
(A) Time course of stringent chaperonin-mediated refolding (reactivation) of
FTrho (1 μM) at 22 °C without or with equimolar (expressed in protomers)
GroEL14, single GroEL7 ring SR1, GroES7, DnaK + DnaJ + GrpE (KJE), HtpG2, or
BSA. (B) Time-dependent net relative changes in FTrho Th-Tﬂuorescence in the
presence of equimolar GroEL14, SR17, KJE, or only buffer as inA. Nrho is 100%.
(C) Time-lapse trypsin sensitivity of FTrho. FTrho (1 μM) was incubated with
equimolar GroEL (1 μMprotomers) as inA. Threeminutes before the indicated
time points, 0.02 mg/mL trypsin was added, and at the indicated time points,
trypsin activity was stopped by adding 100 μM trypsin inhibitor (TLCK).
Refolding was allowed to continue until 60 min after GroEL addition, and the
refolding relative yields (from A, 330 nM = 100%) were plotted against the
time at which the (3-min) trypsin treatments were ended by TLCK addition.
TLCK was added without (black▼) or following (red ●) a prior 3-min trypsin
treatment. Trypsin and inhibitor pretreatment of GroEL before FTrho addition
at T = 0 min did not affect refolding yields (*). Lines in A and C are simple
guides for the eyes.
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Although exceptionally effective, the catalytic unfolding ac-
tion of apoGroEL gradually halted after processing two to
three misfolded polypeptides per ring. To address the reasons
for arrest, we titrated the unfolding/refolding activity of increas-
ing substoichiometric amounts of apoGroEL sequentially added
to the reaction every 30 min, to a constant excess FTrho (2 μM).
As little as 250 nM GroEL (i.e., 36 nM of GroEL7 active sites)
was found to refold up to 280 nM rhodanese in 25 min, corre-
sponding to seven to eight turnovers per GroEL7 ring; then,
it stopped (Fig. 2A). The subsequent addition of fresh GroEL
(36 nMGroEL7 sites) produced nearly the same amount of Nrho,
indicating that the ﬁrst refolding reaction was not arrested be-
cause all the substrate had been consumed or turned into GroEL-
resistant species, but rather that the initial GroEL molecules
became inhibited. Further additions of substoichiometric amounts
of fresh GroEL expectedly processed less and less FTrho, until
equimolar GroEL (286 nM of GroEL7 catalytic sites) was found
saturating, yielding up to 46% of stable Nrho (Fig. 2A). Gel
ﬁltration chromatography, activity, and Western blots of FTrho
preincubated with apoGroEL for 0 min or 60 min (Fig. 2B)
conﬁrmed that the catalytic unfoldase action of apoGroEL
became stalled by inactive over-sticky rhodanese species acting
as inhibitors of the unfoldase catalysis.
These observations were tested and conﬁrmed by a mathematical
model based on simple thermodynamic and kinetic considerations
(SI Text, section S1 and Fig. S3) capturing the basic experimental
observations (SI Text, section S1 and Fig. S4), which provided
quantitative estimates of the parameters governing the different
steps of the catalytic unfoldase cycle mediated by an apoGroEL
heptameric ring: binding, unfolding, release, and refolding (Table
S1). The model provided insight into the evolution of the various
intermediate species produced in the reaction (SI Text, section S1
and Fig. S5). It showed best ﬁts with the data when assuming rapid
unfolding on the upper rim of the cavity (T50 < 1 min), followed by
a slow out-of-cage refolding (T50 = 6 min 18 s) of the released
unfolded FTrho species in solution (Fig. S4). The model could
account for the slower refolding rates we observed in the presence
of excess (7 μM) compared with limiting (0.5–1 μM) apoGroEL
(Figs. S4 and S5), implying that the species released from the cage
were in a nonnative, on-pathway state that, at variance with the
lowest-afﬁnity Nrho state, could be recaptured transiently by the
excess of apoGroEL. Modifying the model to compel the protein
to undergo obligate in-cage refolding, with the released product
being native and averse to GroEL rebinding, produced much
worse ﬁts than when assuming out-of-cage refolding. Moreover,
it predicted that an excess of chaperonin would accelerate the re-
action, whereas the experiments showed a slowing down. The op-
timal out-of-cage refolding model thus predicted that binding,
unfolding, and release of a ﬁrst substrate should have been rapid
enough (T50 < 1 min) to allow the binding of the next substrate,
whereas the ﬁrst released product continues its slow (T50 = 6 min
18 s) native refolding in solution. This might best account for the
ability of each apoGroEL ring to undergo up to eight consecutive
turnovers in several minutes (as in Fig. 2A, step one) while ac-
commodating in their cavity, at most, a single 30-kDa substrate at
a time.
Role of ATP and GroES. Because cells contain several millimolars of
ATP and mitochondria contain equimolar GroEL and GroES
protomers (Table S2), chaperonins will unlikely stay long without
binding ATP and GroES. Therefore, next we addressed the effect
of ATP and GroES on stalled chaperonins. First, we incubated
apoGroEL, apoSR1, or apoCCT with FTrho for 30 min until com-
plete unfolding/refolding arrest was achieved; then, we added ATP,
GroES, or both (Figs. 3B and 4).
Remarkably, apoCCT, but not the other chaperones tested,
showed the same ability to drive the catalytic refolding of FTrho,
with a similar number of turnovers and yields as apoGroEL (Fig.
4A), suggesting that catalytic unfolding/refolding is a particular
functional feature of both classes of chaperonins. The presence of
ATP from the start (Fig. 4A) or the subsequent addition of ATP to
FTrho-stalled–apoCCT complexes caused the release and refold-
ing of about 102 nM Nrho (Fig. S6A). This conﬁrmed that ATP
sufﬁces to decrease the afﬁnity for over-sticky polypeptides that
may stall the catalytic unfoldase sites ofCCT chaperonins. Addition
of ATP alone to FTrho-stalled–apoGroEL complexes was less ef-
fective at releasing refoldable inhibitory species from GroEL or
SR1, suggesting that the ATP-fueled upward and sidewise twisting
of the GroEL apical domains (11) remained predominantly frus-
trated by the bound over-sticky species. GroES addition to FTrho-
stalled apoGroEL released a more important fraction of stalling
species. This showed that GroES can bind GroEL even without
ATP and stabilize the low-afﬁnity state for over-sticky substrates, as
previously shown to be the case in GroEL prebound with heat-
denatured malate dehydrogenase (MDH) (25). As expected, ad-
dition of both ATP and GroES caused an effective net release and
native refolding of about 210 nM Nrho (Fig. 3B), demonstrating
synergism between the two at dissociating high-afﬁnity species (25).
In the case of SR1 single rings, addition ofATP andGroES resulted
only in a minor FTrho release and refolding (40 nM Nrho) (Fig.
S6B). These species were previously shown to be in-cage refolded
under the sealed GroES cap of SR1 (20). Remarkably, GroES and
ATP-mediated refolding of apoGroEL-stalled species was six times
more effective because of the ability ofGroEL trans-ring tomediate
the timely dissociation of GroES. Thus, although possible, obligate
in-cage refolding appears to be considerably less effective than out-
of-cage refolding, as independently suggested from model-based
simulations of the data (Figs. S3–S5).
A
B
Fig. 2. The chaperonin unfoldase activity becomes stalled by over-sticky
FTrho species. (A) An excess of FTrho substrate (2 μM) was supplemented
stepwise every 30 min, ﬁrst with substoichiometric amounts, then up to
equimolar GroEL protomers (black lines), and rhodanese activity was mea-
sured as in Fig. 1A at the indicated time points. (B) GroEL complexes become
stalled by over-sticky inactive rhodanese species. FTrho incubated for 0 (Left)
or 60 min (Right) with equimolar GroEL as in Fig. 1A was separated by gel
ﬁltration chromatography. The eluted fractions were assayed for total
protein concentration (black line) and rhodanese activity (red △) and fur-
ther separated by SDS-gel electrophoresis to detect the presence of rhoda-
nese by Western blots. Lines are simple guides for the eyes.
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Whereas apoSR1 was as effective as apoGroEL in refolding
FTrho, preincubation of SR1 with GroES and ATP before FTrho
addition completely inhibited refolding (Fig. 3A). Thus, the
known irreversible binding of GroES to SR1, not only prevents
the timely early exit of refolding species to complete optimal out-
of-cage refolding, but also prevented new misfolded substrates
from accessing the binding sites. This suggests that helices H and
I, which are involved in substrate binding on the GroEL apical
domains (11), also serve as the catalytic sites for unfolding.
To address the role of GroES binding in GroEL regeneration
further, we used a minimal fragment of the GroES mobile loop,
NH2-ETKSAGGIVLTGS-COOH, that binds GroEL with high
speciﬁcity but with a lower afﬁnity than whole GroES7 com-
plexes (26). Remarkably, a ﬁvefold molar excess of mobile loop
peptides recovered GroEL-stalled FTrho nearly as effectively as
equimolar GroES (in protomers; Fig. 3 and Fig. S6D), especially
with ATP. Thus, mere binding of mobile loops to apoGroEL
sufﬁced to drive the productive dissociation of sticky inhibitory
species from the catalytic unfoldase sites of GroEL14, leading to
native refolding, an effect that was however poorly efﬁcient with the
SR1 mutants (Fig. S3C). Because individual mobile loops bind far
from the cavity’s entry (11, 26), encapsulation and in-cage refolding
under sealed GroES7 caps are not obligate steps of the basic cat-
alytic unfolding mechanism by which apoGroELmay convert stable
misfolded polypeptides into natively refoldable proteins.
In the case of CCT, ATP alone sufﬁced to dissociate and refold
106 nM of over-sticky intermediates in 60 min (T50 = 8 min) (Fig.
S6A). This difference from GroEL was not unexpected, given that
CCTs encode for small apical loops with putative GroES functions
(27). Thus, GroEL and CCT strongly resemble each other in terms
of ATP-independent catalytic unfoldase/refoldase activity. They
both converted unbound misfolded substrates into free out-of-cage
native proteins, and when they became stalled by sticky interme-
diates, they activated an ancillary regeneration mechanism with
ATP (and mobile loops) to evict chaperonin-bound intermediates
and convert them into free, natively refolded proteins.
FTrho Is Not an Unique Substrate. Because our results were ob-
tained with a new type of substrate, FTrho, we next questioned
whether other chaperonin substrates might be generated with
similar characteristics. Early observations suggested the presence
of FTrho-like chaperonin-amenable species in native protein
stocks, as addition of GroEL + GroES + ATP to presumably
A
B
Fig. 3. The sequential additive effects of ATP + GroES on GroEL-mediated
unfoldase/refoldase activity. (A) The effects of ATP and GroES or mobile loop
preincubation on the GroEL unfoldase/refoldase activity. One-micromolar
protomers of GroEL (red ■) or SR1 (blue ▿) ﬁrst were preincubated with
5 mM ATP and 1 μM GroES7 or 5 μM mobile loops (ML) (ETKSAGGIVLTGS;
green ○) and subsequently supplemented at T = 0 min with 1 μM FTrho, and
the time-dependent refolding rhodanese was measured. For comparison, the
refolding of FTrho alone (black●) or with GroEL (without ATP from Fig 1A; red
♢, dashed line) also is shown with illustrative schemes of the possible GroEL14-
GroES7, GroEL14(GroES7)2 (34–36), SR17GroES7, or GroEL14(ML7)2 complexes that
may form under the various conditions. (B) Net chaperonin-assisted rhodanese
refolding. FTrho (1 μM) ﬁrst was incubated for 10 min in buffer at 22 °C then
supplemented with equimolar GroEL protomers as in Fig 2A; then at T = 40
min it was supplemented with only ATP (5 mM), with only equimolar GroES,
or with both as indicated. Lines are simple guides for the eyes.
A
B
Fig. 4. CCT can mediate the ATP-independent refolding of both FTrho and
FTluc. Time course of stringent chaperonin-mediated refolding of FTrho
(1 μM) (A) or FTluc (B) at 22 °C in the presence of buffer (□) or 1 μM bovine
CCT hetero-oligomers (protomers) without (blue ○) or with 5 mM ATP (red ●).
Lines are simple guides for the eyes.
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“all-native” stocks of rhodanese and pre–β-lactamase recovered
165% and 200% of active enzymes, respectively (21, 28). Here,
we further tested whether such inactive species in native stocks
might be processed by apoGroEL alone. Addition of apoGroEL
+ GroES to native stocks of Nrho or MDH produced 5% and
7% more native species, respectively (Fig. S7 A and B). Thus,
native protein stocks in general may contain signiﬁcant amounts
of stable inactive misfolded species that can be refolded by
apoGroEL. Following dilution of urea-unfolded rhodanese and
completion of spontaneous refolding, which reached 30% Nrho
(Fig. S7C), addition of apoGroEL also produced a net 4.5%
increase of Nrho, and adding apoGroEL + GroES without ATP
produced some additional Nrho (Fig. S7C), suggesting that
a subpopulation of sticky urea-denatured species binds apoG-
roEL with an afﬁnity similar to that of the GroEL-stalling FTrho
species. Similarly, mild heat denaturation also generated some
stable misfolded rhodanese species amenable to apoGroEL (Fig.
S7D). Importantly, whereas apoGroEL remained ineffective at
refolding FTluc (18), apoCCT was found to efﬁciently form up to
15%, and in the presence of ATP up to 22%, native luciferase
(Fig. 4B). Thus, stable FTrho monomers are not exceptional sub-
strates. Other in vitro denaturing conditions and different proteins
may accumulate as apoGroEL-amenable stable inactive species. It
is tempting to speculate that in stressed cells too, early misfolded
species similar to FTrho, FTluc, and MDH may form and become
as readily unfolded by GroEL or CCT and thus rehabilitated into
nontoxic functional proteins at a very low ATP cost (6).
Discussion
We found that both classes of double-ring cage-like chaperonins
act as polypeptide-unfolding enzymes, converting stable high-
afﬁnity misfolded polypeptide substrates into unstable high-afﬁnity
unfolded intermediates that subsequently refold into low-afﬁnity
native products. The unfoldase mechanism did not necessitate
ATP or the in-cage conﬁnement of the substrate. This was evi-
denced by the kinetic model that best ﬁt the data and by comparing
the volume of Nrho to that of the cavity in apoGroEL (Fig. 5).
FTrho was a compact, structurally damaged inactive species that
needed the ATP-dependent action of a large molar excess of
DnaK chaperones to become unfolded enough to thereafter un-
dergo spontaneous refolding to the native state (19); yet, we found
here that it could become as sufﬁciently unfolded by equimolar
apoGroEL or apoCCT (protomers) without ATP. Our data with
FTrho also showed that without nucleotides, GroES7 could cause
the release and native refolding of GroEL-bound inactive species,
conﬁrming initial observations with GroEL–MDH complexes
(25). Although this observation is important for the understanding
of the chaperonin mechanism, it is likely irrelevant in cells that
contain millimolars of ATP.
When FTrho was compelled to conﬁnement in SR1 under
a sealed GroES7 cap, this was counterproductive compared with
wild-type GroEL14, indicating that for particular substrates, un-
restricted out-of-the-cage refolding may be more effective than
restricted in-cage refolding. The unfoldase activity was also found
to be prone to gradual inhibition by over-sticky intermediates, and
the regeneration of the catalytic activity necessitated ATP and the
binding of GroES mobile loops. This further indicates that fol-
lowing binding and unfolding, tight conﬁnement under apical loops
in CCT, or a whole GroES7 cap inGroEL, is not mandatory for the
release of the intermediate. Moreover, our data suggest that when
free in solution, folding intermediates may be more at liberty to
sample various partially extended conformations to reach the na-
tive state than when detrimentally conﬁned deep inside chaperonin
cages. Thus, in general, chaperonins do not need to use their cage-
like structures to carry their main activity as catalytic polypeptide
unfoldases and to avert the formation of early off-pathway mis-
folded species. This does not exclude that in particular cases the
cage-like structures may also act to prevent the aggregation of
unfoldase-resistant misfolded polypeptides into potentially more
toxic species, but such antiaggregation activity would expectedly
inhibit the catalytic unfolding activity.
Relevance of Chaperonins Acting as Unfoldases in the Cell. A par-
ticular class of substrates has been identiﬁed by immune pull-
down on the basis of their selective ability to remain tightly
associated either to GroES-less GroEL particles or exclusively
to GroES–GroEL–ADP complexes (29, 30), suggesting that
similar to our in vitro data, some polypeptide substrates in cells
also may require assistance from GroEL without GroES.
Noticeably, we showed here that once unfolded, yet another
class of FTrho-like substrates might readily dissociate from
GroEL and consequently fail to be identiﬁed by immune pull-
downs as GroEL substrates.
Given that chaperonins hydrolyzeATP very slowly (0.1–0.5min−1),
this raises the possibility that despite the presence in human
cells of millimolars of ATP and equimolar protomers of GroES
(Table S2), the misfolded polypeptides sporadically forming
during synthesis and under stress may become readily unfolded
and released in solution before ATP is signiﬁcantly hydrolyzed by
the chaperonins (Fig. 5). ATP hydrolysis would thus strictly be
necessary to fuel structural changes in the chaperonins to in-
crease, against a gradient of free energy, the time they stay in the
low-afﬁnity releasing state and thus to recover over-sticky inter-
mediates as native proteins. Together with FTluc and MDH,
FTrho might serve as an attractive paradigm for very early-
misfolded species on the proteotoxic aggregation pathway, to
study the role of chaperones in preventing and curing protein
conformational diseases.
Our observation that stable misfolded FTrho-like polypeptides,
similar to the 82-kDa aconitase (14), need not fully enter the
chamber and stay under a sealed GroES lid suggests that large
polypeptides with several misfolded domains might be catalyti-
cally unfolded domain by domain, as shown to be the case with
chimerical rhodanese fused to GFP or dihydrofolate reductase
(31). CCT also was suggested to assist multidomain protein
refolding in a domain-by-domain manner, thus mimicking opti-
mal cotranslational folding (32).
Chaperonins are 2% (wt/vol) of the total mass of intracellular
proteins in human (HeLa) cells (Table S2) (33). Further experiments
beyond the scope of this work are needed to assess the relative im-
portance of iterative catalytic unfolding/refolding and prevention of
aggregation by sequestration as complementarymechanisms to delay
the onset of protein misfolding diseases and aging (34).
Methods
Proteins. GroEL and GroES were puriﬁed according to standard laboratory
procedure (35). His-tagged luciferase was puriﬁed as described previously
(18) and stored in 15% (vol/vol) glycerol at −80 °C. Bovine rhodanese and pig
heart mitochondrial MDH (mtMDH) were purchased from Sigma–Aldrich.
Binding &
unfolding
Partial refolding
& release
Native 
refolding
Fig. 5. Scheme of apoGroEL acting as an unfolding catalyst. ApoGroEL
(Blue) mediates iterative cycles of binding to the upper cavity (yellow),
unfolding, release, and out-of-cage refolding, thereby converting high-af-
ﬁnity misfolded polypeptide substrates (Left) into partially unfolded inter-
mediates (Center) that fold spontaneously in solution into low-afﬁnity
native products (Right). Here, native rhodanese is more voluminous than the
collapsed upper cavity of apoGroEL.
Priya et al. PNAS | April 30, 2013 | vol. 110 | no. 18 | 7203
BI
O
CH
EM
IS
TR
Y
Mobile loop peptides were from GenScript. All protein concentrations were
estimated by the Bradford Assay and mentioned as protomer concentrations
unless otherwise mentioned.
Protein Activity Measurements. Rhodanese activity was measured by a color-
imetric method (monitored at 460 nm) based on the formation of the
complex between ferric ions and one of the reaction products, thiocyanate
(17). Luciferase activity was measured using a Victor Light 1420 Lumines-
cence Counter (Perkin–Elmer) as described previously (18). The activity of
MDH was measured by following the time-dependent oxidation of NADH by
mtMDH at 340 nm (25).
Chaperone Refolding Assays. Refolding assays were performed in refolding
buffer [50 mM Tris acetate (pH 7.8), 150 mM KCl, 20 mM MgCl2] in the
presence or in the absence of ATP (5 mM) with different chaperone con-
centrations, as mentioned in the ﬁgure legends. For rhodanese, the refolding
buffer also included 50 mM Na2S2O4, 10% (vol/vol) glycerol, 2 μM BSA, and 20
mM DTT. Rates of rhodanese, luciferase, and MDH refolding were derived
from the linear phase of the time curves of recovered enzymatic activity.
Trypsin Sensitivity of Rhodanese. For trypsin digestion, 1 μM FTrho was in-
cubated with trypsin (0.02 mg/mL) for 3 min and the digestion was stopped
by adding 100 μM of the trypsin inhibitor TLCK (Sigma–Aldrich). The trypsin
digestion during GroEL-assisted unfolding/refolding of FTrho at different
time points was followed by measuring yields 60 min after GroEL addition,
regardless of when the transient trypsin treatment was applied. Time 0: the
3′ trypsin treatment was applied to FTrho and stopped by TLCK addition
before GroEL addition at T = 0 min.
Th-T ﬂuorescence and light-scattering measurements were as described
earlier (19).
Denaturation of Rhodanese. The misfolded monomeric luciferase was pre-
pared by freeze–thawing as described in ref. 18. The misfolded monomeric
rhodanese was prepared in general according to Natalello et al. (19). In
short, 2 μM Nrho in 20 mM Na phosphate (pH 7.5), 12.5 mM Na thiosulfate,
and 20 mM DTT was denatured by ﬁve to eight consecutive cycles of rapid
freezing at −160 °C and slow thawing at 18 °C. When inactivated more than
90%, aggregates were removed by 5′ centrifugation at 20,000 × g and the
supernatant was concentrated to a ﬁnal concentration of 2–3 μM of mostly
inactive FTrho species. For heat denaturation, rhodanese (5 μM) was in-
cubated for 10 min at 62 °C in 50 mM Tris·HCl, 150 mM KCl, and 20 mM
MgCl2, pH 7.5. The residual activity after heat exposure was <2% of the
initial. For urea-unfolded rhodanese, rhodanese was incubated in different
concentrations of urea up to a maximum of 8 M for 1 h at 25 °C.
Size-Exclusion Chromatography. To isolate GroEL stalled with misfolded in-
hibitory rhodanese, mixtures of GroEL and rhodanese at time 0 and 60 min
were passed through size-exclusion chromatography in buffer (50 mM
Tris·HCl, 150 mM potassium chloride, and 20 mM magnesium chloride,
pH 7.5) using a Superose 6 HR10/30 gel ﬁltration column (Amersham Pharmacia
Biotech, GE Healthcare) at a ﬂow rate of 0.5 mL/min. The absorbance was
monitored at 280 nm. Apparent molecular weights were estimated by gel
ﬁltration of standard proteins (Bio-Rad).
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SI Text
S1. Mathematical Modeling and Discussion for Figs. S3–S5. Mathematical
model. We propose a scheme for the catalytic unfolding process
mediated by GroEL in which the free energy levels of the various
molecular states of GroEL and the protein are represented qual-
itatively (Fig. S3A). First, the misfolded substrate can bind to
GroEL, resulting in a decrease of the free energy. To catalyze
substrate unfolding so that the thermally driven conversion of
freeze–thaw denatured rhodanese (FTrho) to native rhodanese
(Nrho) may be accelerated, chaperonin binding must lower the
free energy of the transition state (T) more than that of the mis-
folded state (M) of the substrate (1), whereas the free energy of
bound T may be higher by a few kBT than bound M. In other
words, the unfolded transitory intermediate T must have the
highest afﬁnity for the chaperonin. Passing through the tran-
sition state, the substrate T must then spontaneously convert into
a lower free-energy intermediate that can either reacquire some
native-like structures in regions that are between the direct contact
points with the chaperonin and thus fold on-pathway (I) or fail to
partially refold and thus misfold off-pathway (J). Once released
from the chaperonin in solution, the on-pathway intermediate I
can either rebind or complete refolding to the lowest-afﬁnity na-
tive state. The off-pathway intermediate J fails to reduce its high
afﬁnity (because of its unsuccessful partial local refolding) and
remains stalled onto the chaperonin. The kinetics of the cycle
are represented pictorially in Fig. S3 A and B.
Because we did not observe aggregation during the time scale of
the reaction (Fig. S1A), no aggregated state is included in the
model.Moreover, simple geometrical considerations argue against
the occupation of a single apoGroEL7 ring by more than one 33-
kDa rhodanesemolecule (compare the size of nativeRhowith that
of the cavity in apoGroEL; see Fig. 5) and thus the model con-
sidered only 1:1 substrate–GroEL7 ring complexes. Each GroEL7
ring liberated by a substrate molecule is readily available to bind
another substrate, allowing multiple unfolding turnovers per
GroEL7 ring. Given that in Fig. 1A, two SR1 single-ring mutants
are as active as a single GroEL14, in our modeling of the GroES-
and ATP-independent cycle, the two rings bind and process the
substrate independently of each other, allowing us to represent
one GroEL14 molecule by two effective GroEL7 rings in the
mathematical equations below. The model depends on several
parameters that are kept to a minimum on the basis of several
considerations:
i) Binding/unbinding of FTrho to and from the chaperonin is
fast compared with the time scale of the unfolding and re-
folding reactions, determined by looking at Fig. 2B for un-
folding (T50 = 2.5 min) and at Fig. 2A for refolding (T50 = 5
min); as a consequence, we described the binding/unbinding
of FTrho as an equilibrium with a dissociation constant Km.
Any misfolded molecule is either bound to a GroEL7 ring or
not, and at equilibrium we can express the amount of bound
misfolded ([GM]) as a fraction of the total amount of mis-
folded protein.
ii) As the transition state T is not detected in our experiments,
we did not include it explicitly in the mathematical formulae
of the model. Rather, we accounted directly for the transi-
tions from bound M to the bound on-pathway intermediate I
and the bound off-pathway intermediate J, which proceed at
rates kI and kJ, respectively.
iii) The bound intermediate I can be released (with rate krel) or
be recaptured (with rate λi).
iv) In solution, the intermediate can irreversibly natively refold
(with rate kF).
v) In addition, we included an initial contribution of a minority
of native rhodanese species in the FTrho preparation at T = 0
(Nbg), which is independent of GroEL and remains ﬁxed in
min, and a ﬁttable total amount of refoldable substrate (M0).
The model thus is described by eight parameters, and the
governing equations are
½Mtotal = ½M+ ½GM;
½GM= ½G½G+Km Mtotal;
d½Mtotal
dt
= − ðkI + kJÞ

GM

;
d½GI
dt
= kI ½GM+ λi½G½I− krel½GI;
d½GJ
dt
= kJ ½GM;
d½I
dt
= krel½GI− λi½G½I− kF ½I:
We determined the best values of the parameters by ﬁtting
the model results to the folding curves for three different values
of [GroEL] (Fig. S4). The parameter values are reported in
Table S1.
The ﬁtted dissociation constant (Km) for themisfoldedM is very
low, suggesting thatM has a high afﬁnity for the chaperonin. The
formation of on-pathway I and off-pathway J intermediates pro-
ceeds at fairly high rates (time scale of seconds). This is reasonable,
considering the thioﬂavin T (Th-T) and trypsin data from Fig. 1 A
and B, showing that the bound M becomes unfolded within 2 min.
The two rates for intermediate release (krel) and binding (λi) are
the fastest of all the processes we have modeled, whereas native
folding proceeds at the slowest rate and hence determines the
overall T50 = 10 min. Thus, in our model, the release of I from the
chaperonin is fast, whereas the ﬁnal folding to the native state in
solution is a slower process.
The Th-T and time-lapse trypsin treatments are an independent
check that the rates of the upstream processes of M binding and
unfolding are at least ﬁve times faster than the subsequent process
of native refolding and, therefore, that the latter is rate limiting.
The best ﬁts we obtained produced a very fast rate of release and
much slower refolding. In fact, replacing the intermediate release
and binding by an equilibrium process by an effective dissociation
constant of krel=λi = 792 nM had a negligible effect on our ﬁts.
However, the value of using a kinetic description for this binding/
release process is to explore other ways in which the overall re-
folding time is shared by intermediate release and refolding. De-
spite its good ﬁt, we ruled out the model with slow intermediate
release and fast refolding on the grounds that the amount of free
intermediate remained very low (Fig. S3). This was incompatible
with the trypsin digestion data, which showed the released in-
termediate to be most susceptible to trypsin digestion compared
with the GroEL-bound intermediate assumed to be more protected
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from digestion, because of the plausible decreased accessibility of
the 23-kDa trypsin molecules to the bound species in the upper
cavity of GroEL.
In-cage folding. The model we have discussed so far involved only
out-of-cage refolding. However, we also considered the in-cage
folding hypothesis, wherein the native polypeptide is released with
a rate kN from the cage directly into the solution in addition to the
folding intermediate I. In contrast to the out-of-cage folding hy-
pothesis, the intermediate does not fold to native in solution.
In Fig. S4 (dashed lines), the ﬁts for in-cage folding clearly were
worse than the ﬁts for out-of-cage folding: the χ2 value was much
larger (184 vs. 46) and, more importantly, in-cage folding pre-
dicted that a GroEL excess would accelerate the reaction, whereas
experimentally it slowed the refolding reaction while reaching the
same yields.
We thus reintroduced out-of-cage, in which the released in-
termediate I could refold slowly free in the solution. In the resulting
model with both in-cage and out-of-cage folding, the extra pa-
rameter can only improve the ﬁt. However, the χ2 improved by less
than 1 with respect to the only out-of-cage model. The ﬁtted value
of the rate of in-cage folding kN was 0.02 per minute, whereas out-
of-cage folding kF was ﬁvefold higher at 0.11 per minute, implying
that the partitioning between in-cage and out-of-cage was shifted
greatly in favor of out-of-cage folding.
1. Fersht AR (1998) Structure and Mechanism in Protein Science: A Guide to Enzyme
Catalysis and Protein Folding (Freeman, New York).
Fig. S1. FTrho is a stable misfolded species. Activity (A), relative Th-T ﬂuorescence (B), and relative light scattering (C) of Nrho (red ○), FTrho (●), and heat-
denatured rhodanese (HDrho) (▼) during 18-h incubation in folding buffer at 22 °C.
Fig. S2. FTrho is more resistant than Nrho to urea unfolding. One micromolar of FTrho (black line) or Nrho (red line) was incubated for 60 min at 25 °C in the
presence of 60 μM Th-T and different increasing urea concentrations, as indicated. Steady-state Th-T ﬂuorescence was measured as in Natalello et al. (1) and
normalized to the signal of Nrho without urea (100%). The EC50 value for Nrho was at 2.6 M urea (black ↓) and for FTrho at 3.0 M urea (red ↓).
1. Natalello A, et al. (2013) Biophysical characterization of two different stable misfolded monomeric polypeptides that are chaperone-amenable substrates. J Mol Biol 425(7):1158–1171.
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Fig. S3. Model for the catalytic action of GroEL and CCT chaperonins. (A) The qualitative free energies (horizontal bars) of the various complexes and the
major reaction steps involved in the binding, unfolding, release, and refolding of the polypeptide substrate are shown. The misfolded substrate (FTrho)M, has
a high afﬁnity for the chaperonin, to which it binds readily; the bound M rapidly unfolds on the surface of the apical domains, passing through a very
highafﬁnity transient state T. A consequent spontaneous local refolding leads to a medium-afﬁnity intermediate I that may dissociate spontaneously in the
external solution, where it refolds slowly to the lowest-afﬁnity native state. Alternatively, T may fail to refold locally and stay stalled as a high-afﬁnity in-
termediate J. The thermal energy available for the spontaneous dissociation is shown in the lower left corner. (B) Chemical kinetic scheme with its parameters
used to produce the formula we used to simulate the reactivation curves shown in Fig. S4. The orange arrow represents in-cage folding, which results in the
direct release of a native product. This branch of the reaction has been turned on and off to explore the differences between in-cage and out-of-cage folding.
R
Fig. S4. Simulations of the out-of-cage and in-cage folding model that ﬁt experimental refolding rates and yields at three GroEL concentrations. Symbols are
the experimental data from the time-dependent refolding of FTrho (1 μM) supplemented at T = 0 min (without ATP) with 0.5 μM (red■), 1 μM (green▼), or 7
μM (blue●) GroEL (protomers). The simulated activity of 0.5 μMGroEL (red line), 1 μMGroEL (green line), or 7 μMGroEL (blue line) is according to the equation
described in SI Text, section S1. The best ﬁts are obtained with parameter values shown in Table S1. Solid lines indicate out-of-cage folding, whereas dotted
lines show in-cage folding.
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Fig. S5. Time evolution of the various species according to the model. For two different concentrations of chaperonin (Left, equimolar GroEL; Right, ex-
cessGroEL), the solid blue line indicates the amount of free refolding amenable FTrho, the solid green line free Nrho, the solid red line free on-pathway
intermediate,the dashed red line intermediate bound to GroEL rings, and the solid violet line stalled intermediate on GroEL rings; ▼ (Left) and ● (Right)
areexperimental Nrho data. (Left) Binding of FTrho and release of the unfolded on-pathway intermediate are fast, so only a minor fraction of the substrate
maybe found transiently bound to GroEL rings. Instead, the gradual accumulation of stalled species progressively inhibits the full GroEL population (with
a 1:1ratio, at about 170 nM; solid black line). Once all rings are inactivated, no free amenable FTrho can be processed. (Right) Free FTrho is consumed readily,
andthere is a substantial increase in the amount of transiently bound substrate. This is a consequence of GroEL rebinding of the released substrate. Only later,
when native refolding is slowly occurring, does the concentration of both bound and released intermediate decrease. Inhibition of GroEL rings, in this case,
isnot complete and is determined mostly by the partitioning between stalling and productive intermediate accumulation. A major difference between the
twocases is the number of turnovers per GroEL ring: whereas with equimolar GroEL protomers (substoichiometric GroEL rings), each ring processes, on average,
about two substrate molecules before being stalled, when GroEL protomers are in excess (equimolar GroEL rings), at most one substrate molecule per ring
canbe produced on average, but actually fewer because of inhibition.
BA
EC D
Fig. S6. Sequential chaperonin-assisted refolding by CCT, GroEL or SR1. (A) FTrho (1 μM) was ﬁrst incubated for 10 min in buffer at 22 °C, then supplemented
with equimolar CCT as in (Fig. 1A), then supplemented at T = 40 min with ATP and allowed to refold for 50 additional minutes. (B) FTrho (1 μM) was ﬁrst
incubated for 10 min then supplemented with equimolar SR1 (protomers) as in Fig. 2B, then at T = 40 min supplemented with only ATP (5 mM), or with only
equimolar GroES or with both, as indicated. Mobile loop peptides (N-ETKSAGGIVLTGS-C) can replace whole GroES7 complexes at decreasing the afﬁnity of
sticky FTrho inhibitory species for GroEL or SR1. FTrho (1 μM) was supplemented with GroEL (1 μM) without or with GroES (1 μM) or mobile loops (ML, 5μM),
without or with ATP (5 mM), as indicated. (C) GroES, and/or ML and/or ATP was added at T = 0 min. ATP and increasing concentrations of ML as indicated were
added at 60 min to GroEL (D), or to SR1 (E).
Priya et al. www.pnas.org/cgi/content/short/1219867110 4 of 6
Table S1. Parameter values obtained by numerically ﬁtting the
model to the data for three different concentrations in Fig. S4
Parameter Fitted value
Km 1 nM
kI 38:34=min
kJ 20:32=min
krel 59:46=min
λi 75=ðμM minÞ
kF 0:11=min
Nbg 53 nM
M0 584 nM
Quality of the ﬁt was deﬁned by the error, X2 = Σt,g[(Ng,t − ng,t)2/ng,t,
where ng,t are obtained from the model and ng,t are the experimentally
observed values for data points corresponding to time and GroEL values
indexed by t (time) and g (GroEL protomer concentration), respectively.
We found a value of X2 ∼ 46 for a total of 8 parameters and 36 data points.
Fig. S7. Protocols other than FT can generate GroEL-amenable species. Time-dependent reactivation of “native” Nrho (1 μM) (A) or native mitochondrial
malate dehydrogenase (mtMDH; 2 μM) (B) from the native stocks provided by the suppliers, or Nrho that ﬁrst was urea denatured (C) or heat denatured (D)
then incubated at 22 °C either in buffer (♦) or supplemented with equimolar GroEL and GroES without (red▼) or with 5 mM ATP (●). For C, 40 μM Nrho ﬁrst
was denatured in 8 M urea for 60 min then diluted 40-fold in folding buffer and allowed to refold spontaneously for 3 h at 22 °C, and then was supplemented
with 1 μM chaperonins. For D, 1 μM Nrho was denatured at 62 °C for 10 min until it lost 89% activity, then was supplemented with chaperonins.
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Table S2. Copy number of cytosolic and mitochondrial chaperonins in HeLa cells
Gene Protein amount
Protein name Name % (wt/wt) P value Copy number (106) P value
Chaperonin-containing TCP1, subunit 1 (alpha) CCT1 0.16 0.020 2.38 0.022
Chaperonin-containing TCP1, subunit 2 (beta) CCT2 0.16 0.002 2.51 0.003
Chaperonin-containing TCP1, subunit 3 (gamma) CCT3 0.17 0.004 2.48 0.003
Chaperonin-containing TCP1, subunit 4 (delta) CCT4 0.16 0.013 2.56 0.016
Chaperonin-containing TCP1, subunit 5 (epsilon) CCT5 0.19 0.006 2.87 0.006
Chaperonin-containing TCP1, subunit 6 (zeta 1) CCT6A 0.17 0.037 2.68 0.039
Chaperonin-containing TCP1, subunit 7 (eta) CCT7 0.12 0.000 1.84 0.001
Chaperonin-containing TCP1, subunit 8 (theta) CCT8 0.21 0.006 3.22 0.005
TCP/CCT complex* (CCT1-8)16 1.34 0.002 1.28 0.000
Actin, alpha, cardiac muscle 1 ACTC 0.11 0.144 2.38 0.149
Tubulin, beta 4B class IVb TUBB2C 0.63 0.035 11.38 0.031
mtHsp60 (GROEL) HSPD1 0.53 0.015 7.91 0.016
mtHsp10 (GROES) HSPE1 0.07 0.001 5.51 0.001
mtHsp60 complex (HSPD1)14 0.53 0.015 0.57 0.016
mtHsp10 complex (HSPE1)7 0.07 0.001 0.78 0.001
Concentrations of cytosolic CCTs and their main actin and tubulin substrates and of mitochondrial Hsp60 and Hsp10 in HeLa cells
were obtained from ref. 1. Mean copy numbers per cell from all three independent measurement and P values are shown. Mean copy
numbers and P values for the entire 16-mer CCT complex (*) were estimated from the 24 measurements, assuming that the eight
different CCT1–8 subunits are equimolar in the complex (2). We deduced the cellular concentrations of individual proteins, assuming
a total protein mass of 150 pg per HeLa cell (3) with an estimated volume of 2,600 μm3 (4), containing a total of 2 × 109 polypeptides
(5). Each protein ﬁrst was expressed as a percentage of the total protein mass and then was converted into polypeptide copy number
per cell. mtHsp60, mitochondrial GroEL; mtHsp10, mitochondrial GroES.
1. Geiger T, Wehner A, Schaab C, Cox J, Mann M (2012) Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol Cell
Proteomics 11(3):M111.014050.
2. Dekker C, Willison KR, Taylor WR (2011) On the evolutionary origin of the chaperonins. Proteins 79(4):1172–1192.
3. Volpe P, Eremenko-Volpe T (1970) Quantitative studies on cell proteins in suspension cultures. Eur J Biochem 12(1):195–200.
4. Zhao L, et al. (2008) Intracellular water-speciﬁc MR of microbead-adherent cells: The HeLa cell intracellular water exchange lifetime. NMR Biomed 21(2):159–164.
5. Nagaraj N, et al. (2011) Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol 7:548.
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-Synuclein aggregation and accumulation in Lewy bodies
are implicated in progressive loss of dopaminergic neurons in
Parkinson disease and related disorders. In neurons, theHsp70s
and their Hsp40-like J-domain co-chaperones are the only
known components of chaperone network that can use ATP to
convert cytotoxic protein aggregates into harmless natively
refolded polypeptides.Herewe developed a protocol for prepar-
ing a homogeneous population of highly stable-sheet enriched
toroid-shaped -Syn oligomers with a diameter typical of toxic
pore-forming oligomers. These oligomers were partially resis-
tant to in vitro unfolding by the bacterial Hsp70 chaperone sys-
tem (DnaK, DnaJ, GrpE). Moreover, both bacterial and human
Hsp70/Hsp40 unfolding/refolding activities of model chaper-
one substrates were strongly inhibited by the oligomers but,
remarkably, not by unstructured-Synmonomers even in large
excess.Theoligomers acted as a specific competitive inhibitor of
the J-domain co-chaperones, indicating that J-domain co-chap-
erones may preferably bind to exposed bulky misfolded struc-
tures in misfolded proteins and, thus, complement Hsp70s that
bind to extended segments. Together, our findings suggest that
inhibition of theHsp70/Hsp40 chaperone system by-Syn olig-
omers may contribute to the disruption of protein homeostasis
in dopaminergic neurons, leading to apoptosis and tissue loss in
Parkinson disease and related neurodegenerative diseases.
A number of neurodegenerative disorders, such as Alzhei-
mer, amyotrophic lateral sclerosis, Huntington, prion enceph-
alopathy, and Parkinson diseases (PDs)2 are characterized by a
loss of neurons associated with protein misfolding and the
accumulation in and outside cells of stable protein aggregates
composed of specific proteins, such as tau tangles, amyloid-
plaques, -Syn fibrils, and Lewy bodies (1). Under ideal in vitro
conditions, such as low protein concentrations and low tem-
peratures, the primary amino acid sequence may suffice to dic-
tate the spontaneous folding of polypeptides into discrete
three-dimensional, active structures called the native state (2).
Yet in the crowded environment of the cell (for review, see Ref.
3) and especially under stress conditions, such as heat shock, de
novo synthesized or imported polypeptides andmutant or dam-
aged proteins may undergo transient unfolding, thereby expos-
ing hydrophobic segments that readily self-associate to form
stable non-functional high molecular weight, -sheet-en-
riched, oligomers and fibrillar assemblies, generally named
“aggregates” and amyloids (4, 5).
PD is characterized by the selective degeneration of dopam-
inergic neurons in the substantia nigra of human brain along-
side with the presence of cytoplasmic neuronal inclusions
called Lewy bodies (LBs). LBs are proteinaceous inclusions
mainly composed of aggregates and insoluble fibrillar -Syn
(6) associated with different members of the protein homeo-
stasis machinery. LBs and other types of -Syn inclusions are
also found in cases of dementia in some types of Alzheimer
disease, Down syndrome, and several other neurological dis-
eases, collectively denominated synucleinopathies (for review,
see Ref. 7).
-Syn is a 14.5-kDa protein mainly expressed in the central
and peripheral nervous systemof vertebrates, from torpedo fish
to humans (8). In humans, it is expressed mostly in presynaptic
terminals (9), astrocytic and oligodendroglial cells (10). Under
physiological conditions, native soluble-Syn is involved in the
differentiation of dopaminergic cells, where it functions as an
activity-dependent negative regulator of dopamine neurotrans-
mission (for review, see Ref. 11). Because in the purified state,
human-Syn is amonomer apparently devoid of stable second-
ary structures, it has been described as “natively” unfolded or
intrinsically unstructured (12, 13). Yet, in the membrane-rich
crowded environment of the cell, -Syn may become struc-
tured and upon binding to membranes is thought to adopt par-
tially an -helical conformation (14). During PD pathogenesis
or aging, loose -helical or natively unfolded -Syn monomers
may spontaneously convert, by a mechanism still unclear, into
highly stable -sheet-enriched oligomers, some of which pro-
tofibrils (15) that can ultimately formmore compact, protease-
resistant and apparently less toxic fibrils in LBs (for review, see
Ref. 16). Three specific point mutations in -Syn have been
* This work was supported by Swiss National Science Foundation Grant
3100A0-109290 and by a Zwahlen grant from the Faculty of Biology and
Medicine of Lausanne University.
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THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 285, NO. 49, pp. 38173–38182, December 3, 2010
© 2010 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
DECEMBER 3, 2010•VOLUME 285•NUMBER 49 JOURNAL OF BIOLOGICAL CHEMISTRY 38173
 at SM
A
C Consortium
 - Lausanne on A
pril 10, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
linked to autosomal dominant inherited forms of PD and cor-
relate with early onset of the disease (17–19). Interestingly, all
three also accelerate the in vitro oligomerization and fibril for-
mation of -Syn and promote the spontaneous formation of
toxic oligomers, including amyloid pores (20).
There is strong evidence that the soluble, low molecular
weight forms of -sheet-enriched oligomers are the primary
toxic species in the disease (21), whereas fibril formation is
already part of a detoxification mechanism whereby toxic olig-
omers become sequestered and, thus, incapacitated at partici-
pating in aberrant interactions withmembranes and other pro-
teins of the cell (for review, see Ref. 1). In solution and at high
concentrations (200 M), -Syn spontaneously forms annu-
lar pore-like structures (20, 21) that, when added externally to
the culture medium, can cause toxic ion leakage in neuroblas-
toma cells (22).
Here, we developed a reproducible protocol for preparing
and purifying a homogeneous population of highly stable
-sheet enriched, toroid-shaped -Syn oligomers with a diam-
eter typical of toxic protofibrils.We then compared the effect of
purified native monomeric -Syn to that of the purified olig-
omers on the in vitro ATP-dependent chaperone unfolding/
refolding activity of bacterial (DnaK, DnaJ or CbpA, GrpE) or
human (HSPA1A, DNAJA1) Hsp70/Hsp40 chaperones. We
found that-Syn oligomers can specifically inhibit the function
of the Hsp70/Hsp40 chaperone systems, suggesting that -Syn
oligomer-induced toxicity may also result from the specific
stalling of the cellular chaperonemachinery, leading to the col-
lapse of protein homeostasis and pathogenesis.
EXPERIMENTAL PROCEDURES
Purification and Characterization of Recombinant -Syn—
pT7 plasmid carrying the human wild-type (WT) -Syn gene
was expressed in BL21 (DE3) Escherichia coli cells. Cells were
grown in 1.2 liters of Lysogeny (Luria) Broth medium contain-
ing 100 mg/liter ampicillin at 37 °C with shaking. At A0.6, 0.2
mM isopropyl--D-thiogalactopyranoside was added, and cells
were further grown for 3 h. Centrifuged cells were sonicated in
buffer A (50 mM Tris, pH 8.0, 50 mM KCl, 5 mM Mg(Ac)2, 0.1%
Na azide), 0.2 mg/ml lysozyme, and the protease inhibitor mix-
ture from Sigma (catalog no. P8465). After 15 min of centrifu-
gation at 6000 rpm, the supernatant was heated at 73 °C for 4.5
min. After a second 15-min centrifugation at 10,000 rpm, the
supernatant was precipitated in 40% (NH4)2SO4 and incubated
overnight at 4 °C. After a 15-min centrifugation at 6000 rpm,
the pellet was then resuspended in Buffer A, filtered through a
0.2-m membrane, and loaded on a Superose 6 gel filtration
column (Amersham Biosciences). Proteins were eluted in
buffer A at a flow rate of 0.5 ml/min. For each eluted peak,
fractions were pooled and concentrated by ultrafiltration in a
100-kDa cut-offmembrane (Sartorius 13269E) and analyzed on
a 15% SDS-PAGE or on a 5.5% native PAGE and stained with
Coomassie Blue. The total protein concentration was deter-
mined at 560 nm with the bicinchoninic acid assay (BCA)
(Sigma) using bovine serum albumin as a standard and then
stored in buffer A supplemented with 20% glycerol at80 °C.
Immunoblotting—Samples were separated on a 7.5% native
PAGE or on a 12% SDS-PAGE (Fig. 1) and transferred by elec-
troblotting to a nitrocellulose membrane (Bio-Rad) using
standard protocols. Membranes were blocked in 1% skimmed
milk and incubated overnight at 4 °C with a rabbit anti--Syn
polyclonal antibody (Stressgen, Ann Arbor, MI, catalog no.
905-565) (1/1000, v/v) and then incubated with a HRP-labeled
goat anti-rabbit antibody (Bio-Rad, catalog no. 170-5046)
(1/15000, v/v). Immune complexes were visualized using the
chemiluminescent ImmunstarTMKit (Bio-Rad) according to
the manufacturer’s instructions.
Proteins—DnaK, DnaJ, and CbpA were purified according to
Gur et al. (24); ClpB was purified according to Woo et al. (25).
His-tagged Luciferase was expressed from the pT7lucC-His
plasmid fromA. S. Spirin (TheProteinResearch Institute,Mos-
cowRegion, Russia) andpurified according to Svetlov et al. (26).
GrpE was a gift from H.-J. Scho¨nfeld, F. Hoffmann-La Roche,
Basel, Switzerland. Glucose-6-phosphate Dehydrogenase
(G6PDH) from Leuconostoc mesenteroides and BSA were from
Sigma. Heat denaturation of the G6PDH was as described in
Ben-Zvi et al. (27). Cold inactivation of His-tagged Luciferase
was achieved by four consecutive cycles of freezing in liquid
nitrogen and slow thawing at 4 °C (62).
Atomic Force Microscopy—10 l of -Syn monomers or oli-
gomers (1 M each, expressed in protomers) in buffer (50 mM
Tris, 50 mM KCl, 10 mM MgCl2, pH 7.5) were deposited onto
freshly cleaved mica at room temperature. After 1 min, the
sample was gently rinsed with 1ml of nanopure H2O and dried.
Samples were imaged using a Nanoscope III (Digital Instru-
ment, Santa Barbara, CA) in the tapping mode. The probes
were NSC35 (NT-MDT, Troisk, Russia).
Reactivation of Heat-preaggregated G6PDH by Chaperones—
Heat-preaggregated G6PDHwas refolded by the DnaK chaper-
one system as described in Ben-Zvi et al. (27) with the following
modifications; 0.75 M heat-aggregated G6PDH (final concen-
tration) was reactivated in the presence of 5 M DnaK, 5 M
DnaJ, 0.5 M GrpE (the full DnaK chaperone system) or 5 M
HSPA1A and 5 M DNAJA1 (the minimal human Hsp70/40
system), and 4 mM ATP. G6PDH activity was measured at dif-
ferent times of chaperone-mediated refolding reaction at 30 °C.
Luciferase Assays—Luciferase activity was measured as de-
scribed previously (26) using aVictor Light 1420 Luminescence
Counter from PerkinElmer Life Sciences.
Inhibition of G6PDH Reactivation by -Syn Species—Ali-
quots from each eluted fraction resulting from the gel filtration
chromatographywere diluted to a final concentration of 2.2M
-Syn and added to 0.75Mheat-inactivatedG6PDHand incu-
bated in the presence of the full DnaK/DnaJ/GrpE bacterial
systemor theminimalHsp70/Hsp40 human system at 30 °C for
1 h. G6PDH activity was measured at different times of chap-
erone-mediated refolding reaction.
Thioflavin T Fluorescence Assays—The -sheet content of
G6PDH and -Syn were evaluated by measuring the fluores-
cence in a luminescence spectrometer, PerkinElmer Life Sci-
ences LS 55 (excitation, 446 nm; emission, 480 nm), in a 500-l
cuvette containing 10 M thioflavin T (Th-T) (final concentra-
tion) in the refolding buffer: 100 mM Tris-HCl, pH 7.5, 100 mM
KCl, 10mMMgAc, 10mMDTT, 4mMATP, 4mMPEP, and 0.02
mg/ml PK.
-Synuclein Oligomers Inhibit Chaperone Activity of Hsp70/40
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RESULTS
To address the possible effects of unstructured -Synmono-
mers and structured oligomers on the in vitro activity of a typ-
ical Hsp70/Hsp40/NEF chaperone system (here, the E. coli
DnaK/DnaJ/GrpE chaperone machinery), we first designed a
protocol to purify a distinct population of stable -Syn olig-
omers with reproducible characteristics. Immunoblots from
SDS gels of soluble extracts from E. coli cells overexpressing
plasmid-encoded human -Syn revealed a predominant frac-
tion of SDS-soluble 14.5-kDa -Synmonomers (Fig. 1A, lane 1,
I) and aminor fraction of SDS-resistant oligomers: somedimers
(Fig. 1A, lane 1, II), highmolecular weight species thatmigrated
as 10–14-mers (Fig. 1A, lane 1, III), and very large insoluble
oligomers that did not enter the resolution gel (Fig. 1A, lane 1,
IV). To deplete this last insoluble fraction of very large SDS-
resistant oligomers (fraction IV), the extractwas heat-treated at
73 °C for 4.5min and centrifuged (14,000 rpm, 15min) (Fig. 1A,
lane 2). After ammonium sulfate precipitation, we obtained a
much reduced fraction, albeit of 95% pure -Syn, that was
devoid of large insoluble species, composed of fully soluble,
discrete oligomers that resolved on native gel mainly as 10–14
mers (140–200 kDa) as well as some dimers and monomers
(Fig. 1B, lane 3).
To better understand the relative size distribution of mono-
meric and oligomeric -Syn complexes, this soluble fraction
was further separated by gel filtration (Fig. 2A, blue line). As
expected from the native gel (Fig. 1B), we observed two broad
peaks; one corresponding to soluble high molecular weight
(Mr) -Syn oligomers ranging from 102 to 103 kDa (7.5–11 ml)
with a very high specific affinity for the amyloid specific dye,
Th-T, and a second that was resolved at the expected position
of the 14.5-kDa -Syn monomer (15–18 ml) with a very low
specific affinity for Th-T (Fig. 2A, dark line). SDS and native gel
electrophoresis confirmed that this lowMr fraction contained a
uniform population of SDS-soluble 14.5-kDamonomers whose
low affinity for Th-T is indicative of a lack of-sheet structures,
in agreement with the intrinsically unfolded state that is pre-
dominantly observed in the case of -Syn monomers in vitro
(13). In contrast, SDS and native gel electrophoresis confirmed
that the highMr, -sheet-enriched fraction from the 7.5–11ml
peak was partially SDS-resistant (Fig. 2B) and formed on the
native gel a remarkably discrete soluble -Syn oligomer whose
high stability was reflected by its ability to withstand extensive
dilutions during gel filtration and native gel electrophoresis
(Fig. 2C).
The discrete nature of this stable highMr, yet soluble -Syn
oligomer was confirmed by atomic force microscopy (Fig. 2,
D–G); whereas the low Mr fraction contained mostly -Syn
monomers, undetectable at this low resolution (Fig. 2D), the
high Mr fraction showed a dense, remarkably homogeneous
population of globular, mildly flattened oligomers (Fig. 2E),
with a narrow size distribution (average diameter of 21 nm 3
nm) (Fig. 2G). The tapping procedure revealed a weaker region
at the center of the particles, suggesting a less dense interior or
a pore-like toroid (Fig. 2F) indistinguishable in size and shape
from previously described toxic pore-forming -Syn oligomers
(20).
This protocol of production of stable -Syn oligomers was
highly reproducible. Yet, depending on the batches, -Syn oli-
gomers bound about 20 times more Th-T than monomeric
-Syn and about 8 times more than heat-aggregated G6PDH
(Fig. 3A). G6PDH is a heat-generated misfolded protein sub-
strate that is commonly used to test the unfolding/refolding
activity of molecular chaperones (5, 27). The high stability of
the-sheet structures in the-Syn oligomerswas confirmed by
their relative high resistance to prolonged (48 h) incubations
after extensive dilutions; whereas prolonged incubations of
heat-aggregated G6PDH caused a 33% loss of Th-T binding
(Fig. 3B), only 8% loss of Th-T binding was observed in the
case of -Syn oligomers under identical conditions (Fig. 3C).
We next addressed the biochemical properties of -Syn olig-
omers as a possible substrate of the full E. coli Hsp70 chaper-
one machinery. Confirming earlier observations (27), in the
presence of DnaK, DnaJ, GrpE, and ATP, heat-preaggregated
G6PDH lost 25% of its Th-T binding structures within 50 min
(Fig. 4A, open squares) and correspondingly formed 25% of
natively refoldedG6PDHenzyme (Fig. 4A, filled circles). In con-
trast, the-Syn oligomers lost less than 10%of their Th-T bind-
ing structures (Fig. 4A, filled squares), indicating that although
interacting with the aggregates, the chaperones are less effec-
tive at unfolding the misfolded -sheets structures in -Syn
oligomers than in heat-aggregated G6PDH substrate. Remark-
ably, immunoblots of native gels confirmed that the Hsp70
chaperone machinery can convert a significant fraction of the
stable -Syn oligomers into monomers in an ATP-depen-
dent manner (Fig. 4B). This indicates that the chaperone
machinery, although capable of interacting and causing the
partial disassociation of the oligomers, are poorly effective at
fully unfolding stably misfolded -sheets structures into
unstructured polypeptide segments.
Thus, we next addressed the possibility that the oligomers
may stall the Hsp70/40 chaperone machinery. The in vitro
chaperone-mediated ATP-dependent reactivation of G6PDH
was tested in the presence of increasing amounts ofmonomeric
FIGURE 1. The initial stages in the purification of recombinant
-synuclein protofibrils. Shown is an immunoblot with an anti--synuclein
antibody from a SDS gel (A) or a native gel (B) of cell extracts from BL21 E. coli
cells expressing WT human -synuclein. Lane 1, soluble initial crude extract.
Lane 2, soluble extract after heat treatment. Lane 3, resolubilized ammonium
sulfate pellet from the heat-treated soluble extract in lane 2. Numbers, esti-
mated molecular masses from the SDS gel in kDa. Roman numbers with
arrows: I, monomers; II, dimers; III, soluble oligomers; IV, large oligomers that
do not enter the resolution gel.
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FIGURE 2. Characterization of recombinant human -synuclein (AS). A, shown is size exclusion chromatography of recombinant -synuclein from the
resolubilized amonium sulfate pellet of the heat-treated crude extract shown in lane 3 of Fig. 1, A and B. Elution profile from the Superose 6 column shows the
protein concentration profile according to the absorbance at 280 nm (blue circles) and the Th-T fluorescence profile (black circles). Above the inset, Coomassie
stain of the correspondingeluted fractions after separationon12%SDS-PAGE is shown.B andC, two fractionswerepooled from15–18ml asmonomeric AS and
from 7.5–11ml as oligomeric AS, concentrated, and further separated by SDS-PAGE (B) or native-PAGE (C) and Coomassie-stained. Standardmolecular masses
(M) in kDa are indicated for the SDS-gel. D–F, shown are atomic force microscopy morphological studies of AS monomers and AS oligomers, as in B and C.
Atomic force microscopy images (1 m 1 m) of AS monomers (D) and AS oligomers (E) are shown. At higher magnitude, AS oligomers present a globular
flattened-shape structure (F). G, shown is cumulative function of the diameter distribution of the AS oligomers with a mean size of 21.1 nm and a S.D. s 2.4
nm. Inset, shown is s histogram of the distribution superimposed with a Gaussian (mean 21.1 nm, s 2.4 nm).
-Synuclein Oligomers Inhibit Chaperone Activity of Hsp70/40
38176 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 49•DECEMBER 3, 2010
 at SM
A
C Consortium
 - Lausanne on A
pril 10, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
or oligomeric -Syn (Fig. 5A). We found that the refolding rate
of heat-pre-aggregated G6PDH by an excess of chaperones (5.0
M DnaK, 1 M DnaJ, and 0.5 M GrpE) was strongly inhibited
by -Syn oligomers but not by the monomers. Half-inhibition
of the chaperone reaction was observed in the presence of 2M
-Syn oligomers (expressed in protomers) (Fig. 5B). Remark-
ably, up to a 10-fold molar excess of monomeric -Syn did not
inhibit and was even slightly beneficial to the chaperone reac-
tion (Fig. 5A, open circles). Chaperone inhibitionwas specific to
-Syn oligomers and not to other types of protein aggregates, as
equimolar amounts of heat-aggregatedMDH or of cold-inacti-
vated luciferase did not compete with the chaperone-mediated
reactivation of heat-denatured G6PDH (supplemental Fig. S1).
Moreover, the oligomers inhibited the chaperone-mediated
refolding of cold-inactivated Luciferase to the same extent as
they did in the case of heat-denatured G6PDH (supplemental
Fig. S2), indicating that inhibition is not caused by the compe-
tition between the different substrates for a limited amount of
chaperones but rather by a non-competitive actionmediated by
a specific interaction of the oligomers with a component of the
chaperone system. This specific chaperone inhibitory effect
was further tested on different-Syn oligomers with increasing
apparent molecular masses (and/or shapes, as elongated pro-
teins may elute with larger than real
apparent molecular masses) ob-
tained by gel filtration fractionation.
Remarkably, the size/shape-depen-
dent profile of the specific chaper-
one inhibitory activity (Fig. 5C)
matched that of the specific Th-T
binding (Figs. 2A and 5C), suggest-
ing a strong correlation between the
-sheet or amyloid-like content of
the -Syn oligomers and their abil-
ity to inhibit the chaperone activity.
The specific in vitro inhibitory
effect of the -Syn oligomers was
confirmed with HSPA1A and
DNAJA1, which represent a central
hub of the stress-induced chaper-
one network and are among the
most strongly expressed Hsp70
chaperone and Hsp40 co-chaper-
ones of the cytoplasm of human
cells, includingPDneurons prone to
-Syn aggregation (61). We found
that, similar to E. coli Dnak/DnaJ/
GrpE chaperones, -Syn oligomers,
but not monomers, strongly inhib-
ited the human HSPA1A/DNAJA1
chaperone machinery (supplemen-
tal Fig. S3A). Moreover, in the pres-
ence of 1.5 M DNAJA1, inhibition
was half, and in the presence of 3M
DNAJA1, inhibition was fully allevi-
ated. This confirms that, as with
bacterial chaperones, the inhibition
of the human chaperone system by
the -Syn oligomers, but not by themonomers, is also predom-
inantly caused by the incapacitation of theHsp40 co-chaperone
(supplemental Fig. S3B).
Both chaperone and co-chaperone can bind to unfolded or
misfolded proteins, albeit in differentmanners (28).Whereas in
its ADP-liganded and substrate-bound state, DnaKmay tightly
bind only to protruding unfolded hydrophobic polypeptide seg-
ments by tightly enclosing them, DnaJ may directly bind with
much less steric limitations to bulky hydrophobic surfaces on
misfolded structures on the substrate (28–30). Therefore, we
next considered the possibility that -sheet-enriched olig-
omers expose binding sites with a particular affinity for DnaJ,
thereby potentially stalling the chaperone reaction. This was
addressed by measuring the rates of ATP- and chaperone-me-
diated refolding without or with a fixed amount of oligomeric
-Syn in the presence of increasing concentrations of DnaK
(Fig. 6A) or of DnaJ (or the DnaJ-like co-chaperone CbpA) (Fig.
6, B and C) or of chaperone substrate (Fig. 6D). The half inhib-
itory effect (IC50), which was observed at 5 M DnaK, was not
alleviated by higher DnaK concentrations of up to 13 M (Fig.
6A), suggesting that inhibition is not because DnaK becomes
sequestered by the oligomers. As expected, excess GrpE did not
alleviate inhibition (data not shown), consistent with the fact
FIGURE 3. AS oligomers are stable and -sheet-enriched. A, the specific -sheet content of various protein
forms is shown. The relative Th-T fluorescence by a constant amount (1 M, expressed in protomers) of AS
oligomers was compared with AS monomers (black bars) to heat pre-aggregated and to native G6PDH (white
bars). B and C, shown is an estimation of the relative stability of various oligomers. The relative Th-T fluores-
cence (normalized to 1 M, expressed in protomers) of heat-pre-aggregated G6PDH (B) and AS oligomers (C)
was measured either immediately after dilutions from 1 to 0.1 M (open circles) or 48 h after dilutions (filled
symbols). AU, absorbance units.
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that GrpE is a mere nucleotide exchange factor that exclusively
interacts with DnaK. In contrast, increasing concentrations of
the J-domain co-chaperones were found to gradually alleviate
chaperone inhibition by oligomers (Fig. 6, B and C); inhibition
was strongly diminished above 2.5 M DnaJ and was negligible
at 5 M DnaJ (Fig. 6B). This was confirmed using CbpA, which
can substitute for DnaJ in our type of in vitro DnaK-mediated
protein disaggregation assays (24); the inhibition, which was
initially set to 50%, remained so below 1 M CbpA. The inhibi-
tion gradually decreased above 1 M CbpA and in the presence
of 5 M CbpA was reduced to 10% (Fig. 6C). This suggests that
-Syn oligomers may inhibit the chaperone reaction by way of
specifically sequestering the J-domain co-chaperones.
Because the same quality of G6PDH aggregates cannot be
obtained when they have been heat-denatured at different con-
centrations (31), we chose to use freeze-inactivated luciferase,
which shows no differences of chaperone reactivity once inac-
tivated at different concentrations (62) to test the effect of
increasing concentrations of a chaperone substrate. Here again,
the same amount of oligomers, which inhibited by half the
chaperone-mediated refolding of 125 nM luciferase, kept inhib-
iting by more than half the refolding of five times more lucifer-
FIGURE 4. AS oligomers are partially resistant to the Hsp70 chaperone
machinery. A, AS oligomers are more resistant to the unfolding chaperones
than G6PDH aggregates. Time-dependent loss of Th-T fluorescence (squares)
of 1 M heat pre-aggregated G6PDH (open squares) or 1 M (protomers) AS
oligomers (filled squares) in the presence of 5 M DnaK, 0.75 M DnaJ, and 1
M GrpE (KJE) and ATP and the corresponding time-dependent reactivation
of native G6PDH (filled circles) is shown. B, AS oligomers are partially dissoci-
ated by the ATP-fueled DnaK/DnaJ/GrpE chaperone system. AS oligomers
were incubated as in A but for 3 h at 30 °C with or without ATP and chaper-
ones, as specified. Samples were separated on native gel, and -synuclein
was detected by Western blot analysis as in Fig. 1.
FIGURE 5. AS oligomers inhibit the unfolding/refolding activity of the
Hsp70 chaperone system. A, time-dependent reactivation of heat-pre-ag-
gregated G6PDH by the full DnaK chaperone system is shown. The heat pre-
aggregated G6PDH (0,75 M) was first incubated with increasing concentra-
tions of AS oligomers (0- 20 M protomers) (filled symbols) or 20 M AS
monomers (open symbols, asterisk) and then incubatedwith 5MDnaK, 1M
DnaJ, 0.5 M GrpE, and ATP. B, optimal G6PDH refolding rates from A as a
function of increasing concentrations of AS monomers (open triangles) or
oligomers (filled triangles) are shown. C, the specific chaperone inhibitory
activity profile (open circles) compared with the Th-T binding profile (filled
circles) of AS species in the different fractions from the size exclusion chroma-
tography in Fig. 2B is shown.
-Synuclein Oligomers Inhibit Chaperone Activity of Hsp70/40
38178 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 49•DECEMBER 3, 2010
 at SM
A
C Consortium
 - Lausanne on A
pril 10, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ase (650 nM) substrate (Fig. 6D). Thus, inhibition cannot be
attributed to the sequestering of the chaperone substrate by
-Syn oligomers.
DnaJ and -Syn being devoid of Trp residues, we could fol-
low the changes in the steady-state intrinsic fluorescence of the
unique Trp residue, which is in the nucleotide binding domain
of DnaK, in the presence of ATP and increasing amounts of
monomeric or oligomeric-Synwith orwithoutDnaJ. Fluores-
cence changes (supplemental Fig. S4) showed that in the
absence of DnaJ, DnaK had the same low apparent affinity for
monomeric -Syn as for oligomeric -Syn. In contrast, in the
presence of DnaJ, increasing amounts of oligomeric -Syn
caused a dramatic change in the DnaK fluorescence, whereas
increasing amounts of monomeric -Syn caused similar minor
fluorescence changes, as without DnaJ. This confirms that it is
the DnaJ co-chaperone rather than the DnaK chaperone that is
able to specifically distinguish between oligomeric and mono-
meric -Syn. Moreover, DnaJ acts as if it instructed DnaK to
interact with the oligomers and specifically act upon them as a
disaggregating/unfolding chaperone.
DISCUSSION
Recombinant -Syn Oligomers Recapitulate Biochemical
Properties of Oligomers from PD Tissues—The physiological
non-toxic species of -Syn is presumably a soluble monomer
that in healthy neurons may loosely bind to membranes as
amphiphilic -helices (14). In the
purified state the full-length -Syn
polypeptide is found in a so-called
natively unfolded or unstructured
state, apparently devoid of second-
ary structures. At high concentra-
tions, -sheet-enriched oligomers
may spontaneously form by a yet
unclear mechanism and undergo
subsequent growth and/or self-as-
sembly to form the mature fibrils
found in the Lewy bodies of PD
brains (32). Soluble oligomers, typi-
cally composed of about 12–24 sub-
units, were isolated from the cere-
bral cortex of PD and dementia with
LBs patients and from -Syn-
transgenic mesencephalic neuronal
(MES) cells and mouse brains (33).
Because oligomers have a higher
surface/volume ratio as compared
with large fibrils and amyloids, they
can be very toxic, and their appari-
tion in cells correlates with a general
failure of the protein homeostasis
(proteostasis) machinery, the onset
of apoptosis, tissue loss, and neuro-
degeneration (34, 35).
Both artificially formed and in
vivo formed -Syn oligomers are
partially resistant to detergents such
as Triton and SDS (36) and have a
typical high affinity for the amyloid-specific dyes likeCongo red
or Th-T (37). Upon reconstitution in synthetic membranes,
they can spontaneously form discrete spheroid pore-like struc-
tures that cause ion leakage (38). -Syn oligomers have been
previously isolated from cold-induced dissociation of amyloid
fibrils (39). Here, we described a protocol to isolate recombi-
nant human -Syn oligomers that recapitulate a number of
important properties of the toxic -Syn oligomers found in PD
neuronal tissues; they were very stable soluble oligomeric spe-
cies that were partially resistant to SDS. They could withstand
extensive dilutions and native gel electrophoresis and bound
much more Th-T (here about 20 times) than the monomeric
form. Moreover, the -Syn oligomers were a remarkably uni-
form population of discrete spheroid-like flattened structures
of the same diameter as previously described for the toxic spe-
cies shown to spontaneously form pores in artificial mem-
branes and cause ion leakage in cell cultures.
Yet, in contrast to classic protofibrils, we found that these
oligomers remained ineffective as seeds of spontaneous -Syn
fibril formation in vitro (supplemental Fig. S5). This suggests
that our specific -Syn oligomers are off-fibrillation pathway
species whose negative effects on the chaperone network and
possibly on the cell cannot be neutralized by the spontaneous or
aggresome-mediated formation of less toxic larger fibrils and
amyloids.
FIGURE 6. AS protofibrils interact with J-domain chaperones. The reactivation of heat-pre-aggregated
G6PDH was performed under the same conditions as in Fig. 4A with constant GrpE (0.5 M) and increasing
DnaK, DnaJ, or CbpA or luciferase substrate concentrations without (open circles) or with AS oligomers (4 M
protomers) (filled circles). A, shown are optimal rates of G6PDH reactivation by constant (1 M) DnaJ and
increasingDnaKconcentrations.B, shownareoptimal ratesofG6PDHreactivationbyconstant (5M)DnaKand
increasing DnaJ concentrations. C, procedures are as in B but with increasing CbpA concentrations instead of
DnaJ.D, shown is optimal rates of luciferase reactivation by constant (0.8M) DnaK, (0.4M) DnaJ, and (0.8M)
GrpE and increasing concentrations of inactive luciferase substrate without (open circles) or with AS oligomers
(2 M protomers) (filled circles).
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The -Syn Oligomers Feebly but Effectively Interact with the
Hsp70 Chaperone Machinery—Although Th-T fluorescence
showed that, as compared with denatured G6PDH or lucifer-
ase, the -Syn oligomers were relatively resistant,Western blot
analysis of native gels revealed that oligomers were relatively
efficiently disaggregated by the bacterial ATP-dependent
Hsp70 chaperone machinery. This is consistent with earlier
finding (40) showing that human Hsp70 can efficiently inhibit
-Syn fibril formation in vitro and further suggests that partial
ATP-fuelled, chaperone-mediated unfolding can lead to the
partial disaggregation of -Syn oligomers. It should be noted,
however, that incomplete chaperone-mediated unfolding of
more compact and, therefore, less toxic aggregates could lead to
a transient increase of protein toxicitywhenmore active species
are formed but are not further converted into nontoxic mono-
mers. The concomitant binding of more than one Hsp70 mol-
ecule to the same misfolded polypeptide has been shown to be
essential for the effective cooperative unfolding action of the
chaperone on relatively resistant protein aggregates such as
heat-denaturedG6PDH species (27, 41). According to the algo-
rithm of Ru¨diger et al. (29), the -Syn sequence has only one
good potential Hsp70 binding site (instead of the three-four
sites expected on an average polypeptide of the same size). The
lack of another chaperone binding site would strongly limit the
ability of the single chaperone molecule to efficiently pull and
unfold the stable -sheets and could explain the apparent
resistance ofmisfolded-Syn conformers to the protein quality
control machineries in neurons affected by PD (for review, see
Ref. 4).
-Syn Oligomers Inhibit the Unfolding Activity of the Hsp70/
40 System—Consistent with the observed co-localization of
humanHsp40 proteins (andHsp70) with -Syn in Lewy Bodies
(34), our -Syn oligomers behaved in vitro as a competitive
inhibitor of the human and bacterial (E. coli) Hsp70/40 chaper-
one machineries by interacting with J-domain co-chaperones.
Noticeably, we found that DnaJ preincubated either with-Syn
monomers or with oligomers did not show differences of elu-
tion profiles on gel filtration and, moreover, that DnaJ did not
co-immunoprecipitate with -Syn oligomers better than with
monomers (data not shown). We conclude that the specific
strong inhibitory effect that is exerted by the -Syn oligomers
on the J-domain co-chaperones must be mediated by rather
weak interactions. This is not entirely surprising given that a
very ubiquitous “generalist” chaperone, such as Hsp70/Hsp40
could hardly afford having very strong affinities for hundreds of
different substrate proteins in various misfolded and aggre-
gated states in the same cell.
We found that tryptophan fluorescence independently sup-
ported the evidence from the chaperone assays and confirmed
that the J-domain co-chaperone is the primary component of
the Hsp70 chaperone system that can specifically distinguish
between the oligomeric and themonomeric form of -Syn and,
moreover, direct Hsp70 to interact with -Syn oligomers in a
limited attempt to disaggregate them.
The binding of de novo-forming oligomers to Hsp40
co-chaperones would partially sequester and, therefore, neu-
tralize the whole Hsp70/Hsp40 chaperone system, adding to
the direct deleterious effects of oligomers on membrane integ-
rity (38) and the indirect effects on the stability of other labile
andmutant proteins in the cell, as observed in the case of polyQ
aggregates in thermo-sensitive mutants of Caenorhabditis
elegans (42). In addition, because Hsp70/Hsp40 activity can
repress IkB and, therefore, repress NF-B-mediated apoptosis
(43), the blockage of Hsp70/Hsp40 by -Syn oligomers could
promote neuroinflammation, cell death, and tissue loss in PD.
Moreover, the toxicity of -Syn oligomers may not only
result from the inhibition of the Hsp70/40 chaperone machin-
ery.-Syn oligomers have also been shown to strongly inhibit in
vitro protein degradation mediated by the 26 S proteasome
(44). Likewise, PC12 cells expressing the pathogenic A53T
and/or A30P -Syn diseases-associated mutants showed an
altered lysosomal activity as compared with WT -Syn (45).
This fits in vivo observations of altered proteasomal and/or
lysosomal pathways in dopamine neurons of the substantia
nigra from PD patients (35). Together, this suggests that -Syn
oligomers may impair their own degradation along with that of
other damaged proteins in the cell, leading to a vicious cycle of
proteostasis imbalance, causing cell death (for review, see
Ref. 46).
The Hsp70/Hsp40 Is the Main Chaperone That Can Unfold
Toxic Protein Conformers in Neurons—Previous studies have
demonstrated the positive effect of molecular chaperones,
more particularly of the Hsp70/40 chaperone system, on the
cytotoxicity of -Syn oligomers. Hsp70 overexpression in flies
expressing -Syn prevents dopaminergic neuronal loss caused
by -Syn oligomers. It also reduces -Syn oligomerization both
in mice and in H4 cells expressing -Syn. In the mouse model
Hsp70 overexpression leads to a significant reduction both in
high molecular weight and detergent-insoluble -Syn species
(47). Moreover, purified Hsp70 effectively inhibits -Syn fibril
formation in vitro and suppresses the permeabilization of syn-
thetic vesicles induced by prefibrillar -Syn (40). Chaperones
other than Hsp70/Hsp40 may also contribute to the reduction
of toxic oligomers in the cytoplasm of mammalian cells; the
expression of Hsp27 or of the yeast Hsp104 can reduce toxicity
associated with -Syn oligomers in human H4 neuroglioma
cells or rat models of PD, respectively (48, 49). However, the
contribution of sHSPs is expected to be limited to the passive
prevention of protein aggregation as, unlikeHsp70/Hsp40, they
cannot use the energy of ATP hydrolysis to unfold misfolded
proteins. It can, however, stabilize and deliver misfolded pro-
teins to the Hsp70/Hsp40 chaperone system (50).
True functional homologues of ClpB acting together with
Hsp70/Hsp40/NEF in the disaggregation of large compact
aggregates (51) have been identified only in bacteria in the
organelles and the cytoplasm of plants, yeast, and fungi (for
review, see Ref. 5). In animal cells, among themany cytoplasmic
AAA proteinswith conservedWalkermotives, none has been
convincingly shown thus far to function as true ClpB/Hsp104
homologues. Our immunoblot analysis showed that, unlike
with a classic heat-aggregated chaperone substrate, -Syn olig-
omers remained resistant to the unfolding action of ClpB,
which remained unable to improve the limited disaggregating
activity ofDnaK/DnaJ/GrpE alone (data not shown).Hence, the
Hsp70/40/NEF remains thus the only known chaperone
machinery in the cytoplasmofmammalian cells that canuse the
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energy of ATP hydrolysis to unfold toxic misfolded protein
conformers, such as -Syn oligomers, into non-toxic natively
refoldable or protease-degradable species (5, 27).
Recruiting Hsp70/Hsp40/NEF to Reduce PD Is a Promising
Therapeutic Approach—An age-dependent progressive failure
of the protein clearance machinery, including the Hsp70/
Hsp40 chaperone system, has been shown in aging organisms
(for review, see Ref. 52). Interestingly, in agreement with our
finding that J-domain co-chaperones play a central role in
aggregate recognition and processing, a systematic screen in
human cell cultures expressing disease-associated polyglu-
tamine proteins (polyQ) revealed that two human DnaJ homo-
logues, DNAJB6b and DNAJB8, are effective suppressors of
polyQ aggregation and toxicity (53). This suggests new avenues
of therapeutic approaches using chaperone-inducing drugs,
such as Hsp90 inhibitors (54) or non-steroidal anti-inflamma-
tory drugs (55). Alternatively, vectors could mediate the spe-
cific expression of particular effective J-domain co-chaperones
in aging or diseased neurons, thus, targeting more effectively
the unfoldase activity of the cytoplasmic Hsp70/Hsp40s to the
cytotoxic -Syn oligomers in PD.
Mechanistic Implications; J-domain Co-chaperones May
Preferably Bind Misfolded Structures—Although the native
unstructured monomeric form of human -Syn apparently
optimally exposes a typical high affinity binding motive,
32KTKEGVLYVGSKTR45, for the potential binding and lock-
ing ofHsp70 (29) (see supplemental Fig. S6), we found that even
in large molar excess, it did not inhibit the ATP- and DnaK/
DnaJ/GrpE-mediated unfolding/refolding reaction of classic
amenable chaperone substrates. This is consistent with NMR
and gel filtration studies that showno interaction ofHsp70with
monomeric -Syn (56, 57). Our work further shows that DnaJ
too has no apparent affinity for the unstructured monomeric
form of -Syn. In contrast, we found that the three J-domain
co-chaperones, DnaJ, CbpA, and DNAJA1, have an apparent
specific affinity for the structured oligomeric form of the same
protein. This is consistentwith earlier findings showing that the
yeast Sis1 and Ydj1 Hsp40s co-chaperones have a stronger
affinity for Sup35 prionogenic oligomers than for the soluble
monomers (58). Thus, unlike Hsp70, which in the ADP-ligan-
ded state may only “lock” around extended loops extruding
from the aggregate, J-domain co-chaperones may directly bind
surfaces of bulky misfolded structures made of hydrophobic
residues joined in trans, which are otherwise individually scat-
tered in the primary sequence. This could explain why in the
unfolded-Synmonomer, for lack of a DnaJ binding site, DnaK
lacks the ability to lock onto the DnaK binding site and more-
over could justify why J-domain co-chaperones do not neces-
sarily compete withHsp70 for substrate binding andwhy chap-
erone and co-chaperone best collaborate when they are bound
alongside rather than instead of each other on the same native
(59) or unfolded polypeptide substrate (23, 28). Moreover, this
would explain for the first time how, subsequent to their initial
binding to the substrate, J-domain co-chaperones tend to dis-
sociate from the product of the Hsp70-mediated ATP-fueled
unfolding reaction (60); with the co-chaperones preferentially
binding the composite trans-assembled structures, the unfold-
ing action of substrate-bound Hsp70 (41) would result in the
progressive destruction of the co-chaperone-binding sites on
substrate.
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SUPPLEMENTARY FIGURES 
 
 
SUPPLEMENTAL FIG. S1. The inhibition of the G6PDH refolding is specific to oligomeric species. 
Time-dependent reactivation of heat pre-aggregated G6PDH by the DnaK chaperone machinery was 
performed as in Figure 4. Heat pre-aggregated G6PDH (0,75 µM, ie 38 µg/mL) was incubated in 
absence (opened circles) or in presence of 58 µg/mL Malate dehydrogenase (MDH) (native or heat-
denatured, (squares)), or with 58 µg/mL Luciferase (native or cold-denatured, (triangles)), or with 
58µg/mL α-synuclein (monomeric or oligomeric, (diamonds)).  
 
 
 
 
 
 
 
 
SUPPLEMENTAL FIG. S2. The oligomeric species of α-synuclein inhibit the refolding of freeze-
inactivated luciferase mediated by the DnaK chaperone system. Time-dependent reactivation of 
freeze-inactivated luciferase (0,5µM) by the DnaK chaperone system (2.5µM DnaK, 0.5 µM DnaJ, 0.5 
µM GrpE), in absence (circles) or in presence of either 2.5µM oligomeric α-synuclein (triangles) or 
2.5µM monomeric α-synuclein (squares). 5 mM ATP were supplemented at time 0min, and aliquots 
were assayed for Luciferase activity at the indicated time points, as described in Sharma et al, 2008.
 2 
A       B 
 
SUPPLEMENTAL FIG. S3. α-Syn oligomers inhibit human Hsp70/40 chaperone mediated refolding 
of heat denatured G6PDH. G6PDH (750 nM) was heat-denatured 7 minutes at 52oC without 
chaperones, as in Diamant et al., 2000, then supplemented with purified recombinant human HSP70 
(HSPA1A, 5 µM) and Hsp40 (DNAJA1, 1 µM), without (green line), or with 4µM monomeric α-syn 
(blue line) or 4 µM oligomeric α-syn (red line). The reaction was initiated by addition of 5 mM ATP. 
A, time-dependent refolding of G6PDH at 30oC. B, refolding rates in the presence of 5 µM HSPA1A 
and 1.5 or 3.0 µM DNAJA1. 
 
 
 
 
 
 
SUPPLEMENTAL FIG. S4: Steady-state tryptophan fluorescence using a LS50 spectrofluorimeter 
from Perkin Elmer. 1 µM DnaK in refolding buffer was incubated at 25oC in the presence of 1 mM 
ATP, 5 µg/ml pyruvate kinase and 4 mM PEP, without or with of 0.5 µM DnaJ and increasing 
concentrations of monomeric or oligomeric α-syn, as indicated (concentrations expressed in 
protomers). Excitation was at 300 nm and emission at 348 nm. 
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SUPPLEMENTAL FIG. S5. α-Syn oligomers do not seed the fibrilization of α-Syn monomers. α-Syn 
monomers (50 µM; black line) were incubated at 37°C for the indicated time without or with freshly 
sonicated α-syn fibrils (10 µM protomers; red line) or α-Syn oligomers (1 µM protomers; blue line). 
At indicated times, fibril formation was measured by fluorescence in the presence of 60 µM ThT 
(excitation: 450 nm; emission: 485 nm) and expressed in arbitrary units (a.u.). 
 
 
 
 
 
 
 
 
 
SUPPLEMENTAL FIG. S6. α-synuclein possess a single Hsp70 binding site. Free energies of binding 
shown as a function of the residue number within the α-synuclein primary sequence, as deduced from 
the algorithm of Rudiger and co-workers (Rudiger et al, 1997), using a sliding window approach. The 
red dotted line indicates a -5 kJ/mol threshold of confidence, and the red segment of the solid line 
indicates the region within the α-syn primary sequence predicted to be the Hsp70 binding site 
(residues 36-41, highlighted in red). 
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Abstract Molecular chaperones are central to cellular protein
homeostasis. In mammals, protein misfolding diseases and
aging cause inflammation and progressive tissue loss, in
correlation with the accumulation of toxic protein aggregates
and the defective expression of chaperone genes. Bacteria and
non-diseased, non-aged eukaryotic cells effectively respond
to heat shock by inducing the accumulation of heat-shock
proteins (HSPs), many of which molecular chaperones
involved in protein homeostasis, in reducing stress damages
and promoting cellular recovery and thermotolerance. We
performed a meta-analysis of published microarray data and
compared expression profiles of HSP genes from mammalian
and plant cells in response to heat or isothermal treatments
with drugs. The differences and overlaps between HSP and
chaperone genes were analyzed, and expression patterns were
clustered and organized in a network. HSPs and chaperones
only partly overlapped. Heat-shock induced a subset of
chaperones primarily targeted to the cytoplasm and organelles
but not to the endoplasmic reticulum, which organized into a
network with a central core of Hsp90s, Hsp70s, and sHSPs.
Heat was best mimicked by isothermal treatments with Hsp90
inhibitors, whereas less toxic drugs, some of which non-
steroidal anti-inflammatory drugs, weakly expressed different
subsets of Hsp chaperones. This type of analysis may uncover
new HSP-inducing drugs to improve protein homeostasis in
misfolding and aging diseases.
Keywords Chaperone network . Heat shock proteins .
Foldase . NSAID . Cellular stress response .
Unfolded protein response
Introduction
The term “heat-shock proteins” (HSPs) was first used to
describe Drosophila melanogaster proteins that
massively accumulate during heat stress (Tissieres et al.
1974). When subject to a sharp increase in temperature,
prokaryotes and eukaryotes alike transiently reallocate
their general house-keeping protein synthesis machinery
to the specific accumulation of a small subset of highly
conserved Hsps, initially named according to their
molecular weight on sodium dodecyl sulfate polyacryl-
amide gels: Hsp100 (ClpB/A/C), Hsp90 (HtpG), Hsp70
(DnaK), Hsp60 (GroEL), Hsp40 (DnaJ), the small Hsps
(IbpA/B), and Hsp10 (GroES) (E. coli proteins in brackets;
Daniels et al. 1984; Tissieres et al. 1974; Kimpel and Key
1985). A general mechanism was then proposed for Hsp70
by Pelham (1986) and for GroEL by Ellis, whereby these
two major classes of Hsps may prevent the aggregation of
stress-denatured or nascent proteins in the cell and thus
“chaperone” the correct native folding and/or assembly
of other proteins, without being part of the final native
protein structures (Ellis et al. 1989).
Under physiological and stress conditions, the various
chaperone families act in a tightly interconnected network
(Csermely et al. 2008). Genetic and biochemical studies
show that in bacteria, the chaperone network has a key role
in housekeeping (Deuerling et al. 1999) and in the cellular
response to various stresses (Liberek and Georgopoulos
1993). Eukaryotes may use different subsets of redundant,
partially overlapping chaperones to fold and translocate
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proteins under physiological conditions, to prevent protein
misfolding and aggregation during stress (Albanese et al.
2006), and to recover misfolded proteins after stress (Mogk
et al. 1999; Tomoyasu et al. 2001). During a noxious heat
shock, an overload of the cellular chaperones may occur
(Csermely 2001; Nardai et al. 2002), overwhelming
chaperone- and protease-based cellular proteostasis
(Morimoto 2008). When the stress is over, the cellular
protein network is restructured, and the so-called hubs,
which, under stress were transiently replaced by molecular
chaperones, regain control of cellular functions (Soti et al.
2005; Szabadkai et al. 2006; Szalay et al. 2007). The
general purpose of this study was to gain knowledge on
HSP- and chaperone-inducing treatments and drugs that
best recapitulate natural patterns of HSP chaperone gene
expression in tissues challenged by heat or cellular stresses,
to improve proteostasis, particularly in deficient tissues, in
aging or degenerative diseases associated to protein
misfolding (for a review, see Hinault et al. 2006).
Hsp70s and co-chaperones With the exception of some
archaea (Large et al. 2009), members of the evolutionary
conserved Hsp70 chaperone family are present in all the
ATP-containing compartments of living organisms
(Macario and de Macario 1999). Thus, in human, the major
isoform Hsp72 (HSPA1A) and the heat shock cognate 70
(Hsc70/HSPA8) are located in the cytosol and nucleus,
whereas BiP (Grp78/HSPA5) is in the endoplasmic reticulum,
mtHsp70 (Grp75/mortalin/HSPA9) is in mitochondria
(Hageman and Kampinga 2009), and there are possibly also
Hsp70s in peroxisomes (Hageman et al. 2007). In addition,
plant chloroplasts and protozoan apicoplasts contain Hsp70s
most similar to cyanobacteria (Soll 2002; Tarun et al. 2008).
The functional Hsp70 chaperone network entails ATP-driven
interactions between many diverse substrate-specific and less
specific J-domain co-chaperones (49 in human) that target
the fewer Hsp70 isoforms (Kampinga et al. 2009) onto
hundreds of protein substrates in the cell and are regulated
by various nucleotide exchange factors (NEF) such as GrpE
(Harrison 2003), BAG (Kabbage and Dickman 2008),
HspBP1 (Kabani et al. 2002), and Hsp110 proteins
(Shaner and Morano 2007). These networks are crucial to
the co-translational folding of nascent polypeptides, the
remodeling of native protein complexes, the transduction
of cellular signals, the regulation of the cell cycle,
proliferation and apoptosis (Jolly and Morimoto 2000),
the regulation of the heat shock response, the unfolding
and refolding of stress-denatured proteins, and the import
of proteins into the mitochondria (De los Rios et al. 2006),
chloroplasts (Shi and Theg 2010), and the endoplasmic
reticulum (reviewed in Zimmermann et al. 2010).
Moreover, the Hsp70/Hsp40 networks control the stability
and activity of native proteins such as σ32 and the
oligomeric state of native protein complexes, such as repE
(Rodriguez et al. 2008), clathrin cages (Schuermann et al.
2008), and IkB (Weiss et al. 2007) and yeast prions
(Wickner 1994; Shorter and Lindquist 2008).
The Hsp100 The Hsp100 chaperones are ATPase members
of the AAA+ superfamily, including bacterial ClpB,
mitochondrial Hsp78, chloroplast ClpC/D, and eukaryotic
orthologues in the cytoplasm of fungi, yeast (Hsp104), and
plants (Hsp101), (Mogk et al. 2008). The Hsp100
chaperones share sequence, structural, and functional
similarities with the AAA+-gated proteases, such as the
lid of the eukaryotic proteasome, the ATPase moiety of the
bacterial proteases HslU/V, ClpA/P, ClpX/P, and Lon (for a
review, see Sharma et al. 2009). Whereas the sole bacterial
Hsp70/Hsp40/NEF chaperone network can effectively
disaggregate and unfold small soluble protein aggregates
(Diamant et al 2000; Ben-Zvi et al. 2004), it best acts in
concert with Hsp100 (ClpB) in bacteria and in the
cytoplasm of plants and fungi (but not in animals), to
disaggregate large insoluble aggregates into natively
refoldable polypeptides (Glover and Lindquist 1998;
Goloubinoff et al. 1999; Motohashi et al. 1999). As with
the other major classes of molecular chaperone, Hsp100
plays a vital role in the survival of bacteria, yeast, and plant
cells during and following exposures to high temperatures
or chemical stresses (Sanchez and Lindquist 1990).
Hsp60/10 Whereas the proper folding of nascent proteins
in bacteria mostly depends on the activity of the Hsp70/40/
NEF network, 10–15% of newly synthesized polypeptides
are better substrates for bacterial Hsp60/Hsp10 network (for
a review, see Liberek et al. 2008). Class I chaperonins
represented by Hsp60 homologues are found in bacteria
(GroEL), mitochondria, and chloroplasts. A functional
Hsp60/Hsp10 complex comprises 14 identical subunits
arranged in two stacked heptameric rings, requiring two
heptameric co-chaperones, Hsp10/GroES (Azem et al.
1995). Seminal observations showed that artificially
denatured proteins become prevented from aggregating
upon binding to purified GroEL and, moreover, become
subsequently refolded to the native state in a strict
GroES- and ATP-dependent manner (Goloubinoff et al.
1989).The class II of chaperonins, which are present in
archaea and in the cytoplasm of eukaryotes (Large et al.
2009), forms TCP-1 ring complex (TRiC, also named
CCT for chaperonin-containing TCP1) consisting of two
stacked rings with eight different paralogous subunits per
ring (Booth et al. 2008). The TRiCs act as ATP-dependent
central mediators of cytosolic protein folding and
assembly (Hartl and Hayer-Hartl 2009), which are also
important to prevent protein aggregation and toxicity
(Kitamura et al. 2006).
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Hsp90 family and co-chaperones Whereas the
physiological and stress-related functions of HtpG, the
bacterial Hsp90, and of the mitochondrial and chloroplast
Hsp90s remain unclear (Sato et al. 2010; Hasan and
Shimizu 2008), in vitro, Hsp90 can prevent protein
aggregation in an ATP-independent manner (Wiech et al.
1992). Owing to the early discovery of specific Hsp90
inhibitors (Whitesell et al. 1994), the cellular functions of
endoplasmic reticulum (ER) (Grp94), cytosol, and nuclear
located Hsp90s in eukaryotes are better known than a role
of prokaryotic HtpG. The EEVD motif at the carboxy-
terminus of cytoplasmic Hsp90 and some cytoplasmic
Hsp70s is a docking site for connecting proteins with
tetratricopeptide repeats (TPR) (Blatch and Lassle 1999;
van der Spuy et al. 2000). Bridged by TPR-containing co-
chaperones, both chaperones can form functional super-
complexes that modify in a yet ill-defined ATP-dependent
mechanism, the structure, and consequently the function,
of hundreds of the so-called native “client” proteins in the
cell (Whitesell and Lindquist 2005; Zhao et al. 2005).
Thus, the Hop co-chaperone containing three TPR repeats
bridges Hsp70 and Hsp90, which, together with Hsp40
and p23 co-chaperone, drive structural and functional
changes in native protein complexes in the cell, such as
the progesterone receptor (Cintron and Toft 2006; Onuoha
et al. 2008). CHIP is another TPR co-chaperone of Hsp90
with a U-box domain, whose activity promotes “protein
triage” of Hsp70- or Hsp90-bound proteins fated to
proteasomal degradation (Connell et al. 2001). Taken
together, in eukaryotic cells, heterocomplexes of Hsp90
with about a dozen co-chaperones (Picard 2006; for an
updated list of Hsp90 co-chaperones, see http://www.
picard.ch/downloads/Hsp90interactors.pdf) with Hsp70
and protein clients are key to various physiological
processes, in particular signal transduction.
Small Hsps Unlike the ATPase chaperones Hsp100, Hsp90,
Hsp70, and Hsp60, the small Hsps (sHSPs) have a
conserved α-crystalline domain that passively binds
misfolded intermediates, independently from ATP
hydrolysis (Jakob et al. 1993). Without stress, sHsps are
mostly assembled into large oligomeric complexes (Garrido
et al. 2006), which, under stress conditions, may dissociate
into amphiphilic dimers that prevent misfolding
polypeptides from aggregating (Jakob et al. 1993) and
protect membranes from heat disruption (Horvath et al.
2008; Haslbeck et al. 2005). sHsps cooperate with Hsp70/
Hsp40 and Hsp100 or the GroEL/GroES chaperone
networks in refolding of misfolded proteins (for a review,
see Nakamoto and Vigh 2007). Human Hsp27 and Hsp70
are often, although not obligatorily, co-expressed in
response to a variety of physiological and environmental
stimuli (Garrido et al. 2006) (Vigh et al. 2007). As sHsps
have strong cytoprotective properties (Garrido et al. 2006),
their inhibition is an important target in pharmacological
therapies to cancer (Didelot et al. 2007), whereas the
upregulation sHsp may prevents liver damage (Kanemura et
al. 2009) or pathologies caused by protein misfolding, such
as Alzheimer’s (Fonte et al. 2008; Wu et al. 2010),
Parkinson’s (Zourlidou et al. 2004), and Huntington’s
disease (Perrin et al. 2007).
Here, we used published microarray data from Homo
sapiens and the land plant Arabidopsis thaliana to perform
a meta-analysis of the expression profiles of bioinformati-
cally predicted chaperones, co-chaperones, and foldase
genes (together called the chaperome), following various
abiotic and chemical stresses. Clustering of induction
profiles revealed that heat shock primarily induces cyto-
plasmic and mitochondrial but not ER chaperone networks,
a profile that was best mimicked by isothermal treatments
with Hsp90 inhibitors or less faithfully by other com-
pounds, many of which are known as anti-inflammatory
drugs. Sequence analysis of HSP promoters showed that
canonical heat hock elements (HSEs) were unexpectedly
rare in HSP genes. This type of analysis may uncover new
HSP-inducing drugs that best recapitulate natural patterns
of HSP chaperone gene expression in undamaged tissues, to
improve protein homeostasis in defective aging tissues and
in protein misfolding pathologies.
Methods
List of human and plant chaperones, co-chaperones,
and foldases
Two lists of bio-informatically identified “chaperomes”
were compiled for the human and the A. thaliana
genomes (Supplemental Tables 1a and 2, respectively),
which included all the predicted protein sequences sharing
at least 40% homology with one of the conserved
canonical chaperone families in eukaryotes and their
corresponding, identifiable prokaryotic homologues
(prokaryote genes named in brackets): Hsp70 (DnaK),
Hsp90 (HtpG), Hsp100/Hsp78 (ClpB/C), Hsp40 (DnaJ),
Hsp60 (GroEL), and the α-crystalline domain containing
small HSPs (IbpA/B), trigger factors, co-chaperones and
nucleotides exchange factors (such as Hsp110, Grp170,
Bag2, GrpE, GroES, Cpn10, and Cpn20), all J-domain
containing proteins with a conserved HPD motive, over a
dozen of Hsp90 co-chaperones (interactors) as listed by
Picard (http://www.picard.ch/downloads/Hsp90interactors.
pdf). Because peptidyl prolyl isomerases (PPIs) and
protein disulfide isomerases (PDIs) are clearly involved
in cellular protein homeostasis in general and although
they do not belong to the canonical chaperone families, we
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chose to add them to this analysis (for a review, see
Sharma et al. 2009).
Bioinformatic analysis
All data are MIAME compliant. The raw data were extracted
from the National Center for Biotechnology Information
(NCBI) Gene Expression Omnibus (GEO). For the A.
thaliana chaperome metadata analysis, the microarray data
for dithiothreitol (DTT), tunicamycin, and the five heat
treatments were extracted from the GEO (ATH1-121501
Affymetrix Arabidopsis ATH1 Genome Array), under the
following series accession numbers: GSE4021 (leaf disks),
GSE11758 (mature leaves), GSE4760 (seedlings),
GSE16222 (seedlings), GSE12619 (seedlings), GSE4062
(shoots), and GSE11758 (mature leaves), respectively.
Microarray datasets for salicylic acid (seedlings), ibuprofen
(seedlings), 2,3,5-triiodobenzoicacid (TIBA, seedlings), and
2,4,6-trihydroxybenzamide (2,4,6-T, seedlings) were
obtained from Genevestigator (Zimmermann et al. 2004).
Array metadata for DTT, tunicamycin, and one heat
treatment denoted in GEO as GSE16222 were joined to the
rest of metadata obtained from Genevestigator as a tab
delimited file.
For the human and Arabidopsis chaperome metadata
analysis, respectively, 167 and 281 probes (Supplemental
Tables 1a and b and 2) corresponding to unique genes were
chosen as described (Hageman and Kampinga 2009). The
microarray data for the predicted human chaperome was
searched in NCBI GEO (HG_U133 Plus 2.0 Affymetrix
Human Genome Array): sapphyrin PCI-5002 GSE6962
(A549 tumor), echinomycin GSE7835 (U251 cells),
etoposide GSE11954 (hepatic stellate cells), simvastatin
GSE4883 (human peripheral blood monocytes macrophages),
2-deoxyglucose GSE13548 (HeLa cells), tunicamycin
GSE13548 (HeLa cells), phorbol 12-myristate 13-acetate
GSE12736 (K562 cells), cadmium (early) GSE9951 (immor-
talized human normal prostate epithelial cell line), paclitaxel
GSE11552 (294T cells), heat shock study GSE9916 (THP-1
cells), elesclomol study GSE11552 (294T cells), smoking
study six brands of cigarettes (early) GSE10718 (normal
human bronchial epithelial cells), propiconazole GSE10410
(human primary hepatocytes), N-acetylcystein GSE11552
(294T cells), rifampicin GSE10410 (human primary
hepatocytes), myclobutanil GSE10410 (human primary
hepatocytes), estrogen (late) GSE11324 (MCF7 cells),
dihydrotestosterone GSE7708 (LNCaP cells), doxycycline
GSE7678 (SW480 cells), VAF347 GSE10463 (immature
monocyte-derived dendritic cells), and apple procyanidin
GSE9647 (human vascular endothelial cells). The array
metadata for 2-deoxyglucose and tunicamycin were from
GEO and joined to the rest of the metadata obtained from
Genevestigator as a tab delimited file. Solar ultraviolet,
Hsp90 inhibitors and non-steroidal anti-inflammatory drug
(NSAID) microarray data for available human Hsp70 and
Hsp40 genes were searched directly in Genevestigator
(HG_U133A Affymetrix Human Genome Array) and joined
with data from the heat shock study (GSE9916) as a tab
delimited file.
Transcripts were considered responsive only when
showing at least a 2-fold change in response to an
investigated treatment. The distance matrix was evaluated
using the Pearson correlation coefficient, and clusters were
created using the complete linkage method by Cluster 3.0
(http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/soft ware/clus-
ter/manual/index.html) and visualized by the JavaTreeView
(Saldanha 2004) algorithm, exported as a postscript file,
processed by Adobe Illustrator (Adobe Systems, Mountain
View, CA, USA). Annotation and presumed subcellular
localization of chaperones were performed according to the
Uniprot database.
In an attempt to generate a significant network best
describing the degree of connectivity between the various
chaperones, co-chaperones, and foldases in the human
chaperome, we used the STRING database and web
resource. STRING weights both physical and functional
protein–protein interactions and integrates various informa-
tions from different metadatabase sources, to produce a
network map showing all possible protein–protein
interactions in the chaperome (http://string-db.org) (Jensen
et al. 2009). Because under non-stressed conditions, the
members of the chaperone network are expected to have
more but weaker interactions among themselves than under
stressful conditions (Csermely et al. 2008), we chose the
low confidence factor of 0.15 for this analysis. The
interactions between chaperones was visualized using
Medusa (Hooper and Bork 2005)
Using the search PromForm program from the
Promoter Database (http://rulai.cshl.edu/cgi-bin/TRED/
tred.cgi?process=searchPromForm), a search for HSEs
containing direct or inverted repeats of 5′-nGAAn-3′ was
performed from 3 kbp upstream to 300 bp downstream
from the predicted transcription start site of each bio-
informatically identified chaperone gene from mammals
(as listed in Supplemental Table 1b).
Results
Most HSPs are not chaperones, and most chaperones
are not HSPs
As exemplified by the two seminal reviews, “Molecular
chaperone functions of heat-shock proteins” (Hendrick and
Hartl 1993) and “Heat-shock proteins as molecular
chaperones” (Becker and Craig 1994), the terms “chaper-
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ones” and “HSPs” are often indiscriminately used in the
literature. In 2009, a survey of 300 articles in PubMed
citing both “chaperones” and “Hsp70” in their title,
abstract, or introduction, a third stated that molecular
chaperones are Hsps and Hsps are molecular chaperones
without distinction (data not shown). To estimate the
validity of the generally assumed strong linkage between
HSPs and molecular chaperones, we examined the
microarray responses to mild heat treatments in two very
different eukaryotes, a higher plant and a mammal, and
compared the messenger RNA (mRNA) expression
patterns of bio-informatically identified chaperome genes
(listed in Supplemental Tables 1a and 2), to the rest of the
corresponding genomes. Because of the high degree of
evolutionary conservation, members of the α-crystalline-
containing small HSPs and of the four canonical families
of ATP-hydrolyzing chaperones Hsp100, Hsp90, Hsp70 and
Hsp60 and their respective co-chaperones, as well as the PPIs
and the PDIs, were identified by simple bioinformatic analysis
(see “Methods”). Hence, of the 23,438 predicted protein-
encoding genes in H. sapiens (The Genome Reference
Consortium, version GRCh37), 168 genes were identified
as belonging to “the human chaperome” (Supplemental
Table 1b). Similarly, of the 27,379 predicted protein-
encoding genes in the terrestrial plant A. thaliana (The
Arabidopsis Information Resource, version TAIR9), 305
genes were identified as “the Arabidopsis chaperome”
(Supplemental Table 2).
A meta-analysis of microarray data from different
organisms and laboratories is always limited by the smallest
number of available probes for HSP and chaperome genes,
printed on the chips. Thus, we could effectively follow the
changes in the expression profiles of up to 167 human
chaperome genes and up to 281 Arabidopsis chaperome
genes. Microarray data showed that a short sub-lethal heat
treatment (37°C–>43°C, 60 min for human, 23°C–>38°C,
90 min for the plant) upregulated more than 3.16-fold
(log10 value=0.5) about 2% of the human genes and 4% of
the plant genes, respectively (Fig. 1). Noticeably, in human
and plant, chaperome genes were, respectively, 17 and
seven times, more likely to be induced by heat than non-
chaperone genes. Moreover, while being only 0.7% of the
human genome, 20% of the chaperome was massively
(>20-fold) induced by heat (Fig. 1a), a remarkable 28-fold
enrichment of expressed mRNA levels. Similarly, while
being only 1.1% of the plant genome, 16% of the
chaperome was most massively (>20-fold) induced by heat,
a 14-fold enrichment of mRNA levels (Fig. 1b). Despite
this general high propensity of the chaperomes to be
induced by heat, a majority of chaperome genes (66% for
human and 72% for plant) yet remained uninduced by heat,
confirming the importance not to confuse HSPs for
chaperones and vice versa. Hence, molecular chaperones
and foldases should be specifically referred as such and not
as HSPs, especially in a context of their physiological
functions in protein homeostasis, cellular trafficking,
signaling, or of their induction by other means than heat.
The heat-inducible chaperones can be upregulated
by isothermal chemical treatments
Although heat has a demonstrated strong effect on the
induction of a specific subset of chaperome genes, other
isothermal chemical or physical stresses may also induce
similar or different subsets of chaperome genes (Saidi et al.
2005, 2007).
In Arabidopsis, five independent heat treatments (HS)
by different laboratories and different temperature
conditions showed comparable induction patterns of
chaperome genes associated to the cellular stress
response (CSR), demonstrating the robustness of our
approach (see Supplemental Fig. 1). Isothermal treat-
ments with inhibitors of polar auxin transport, such as
TIBA and 2,4,6-T and also with the plant hormone
salicylic acid and with ibuprofen, which are both NSAIDs
in mammals, showed mildly increased levels of particular
chaperones, which, however, only loosely clustered with
the heat treatments (Fig. 2, Supplemental Fig. 2). Two
main treatment clusters were, however, clearly observed,
one following heat or specific chemical treatments,
corresponding to a general response associated to the
CSR (for a review, see Calabrese et al. 2008; Fig. 2a), in
which chaperones mostly targeted to the cytosol, the
plasma membrane and the mitochondria were upregulated
(Aparicio et al. 2005), and the other following chemical
treatments with stressors specific to the ER, corresponding
to a response known as the “unfolded protein response”
(UPR), in which chaperones mostly targeted to the ER
lumen and membranes were upregulated (Schroder and
Kaufman 2005, Fig. 2b). Unexpectedly, several plant heat
shock cognates, in particular Hsc70s, were also
upregulated by heat in plants (Supplemental Fig. 1,
arrows) as well as in animal cells. Thus, Hsc70 (HspA8)
was induced by heat (Fig. 3, treatment I) or isothermal
treatments with N-acetylcycteine or estrogen (Fig. 3,
treatment E, T). Hsc70s are thus either wrongly named,
or their definition as being non-heat inducible chaperone
cognates must be corrected.
In cultured animal cells, several seminal studies
using isothermal treatments with amino acid analogs
(Hightower 1980) or low concentrations of zinc (Whelan
and Hightower 1985) caused expression of molecular
chaperones. In a similar manner, isothermal treatments of
human cells with Hsp90 inhibitors, UV light, elesclomol,
or cigarette smoke best recapitulated the expression
pattern of heat shock by inducing a similar subset of
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about 45 out of 167 chaperome genes (Supplemental
Fig. 3), most of which targeted to the cytoplasm,
membranes, and mitochondria, but not to the ER
(Fig. 3a). In contrast, treatments with tunicamycin,
2-deoxyglucose, or dithiothreitol induced a very different
set of human chaperome genes, whose products were
targeted to the ER lumen and membranes (Fig. 3b).
Interestingly, the antibiotic rifampicin and two antifungal
agents, myclobutanil and propiconazole, induced an
additional chaperone cluster (Fig. 3c), which was not
apparently related to a given subcellular localization. In
conclusion, members of UPR gene cluster should be
specifically called “UPR chaperones” and of the CSR
gene cluster “CSR chaperones”, not HSPs, even when
addressed in a context of heat shock.
As with plants, treatments of human cells with several
NSAIDs induced various chaperones, in particular
members of the Hsp70/40 family. However, expression
patterns were generally heterogeneous and at lower
intensities than with CSR-inducing treatments (Fig. 4).
Together with the fact that NSAIDs also induce CSR
chaperones in plants (Saidi et al. 2005), this suggests that
different drugs commonly classified as NSAIDs may have
unconventional activation mechanisms that may not
necessarily involve the inhibition of cyclooxygenases of
which plants are devoid.
CSR but not UPR activates the core elements
of the chaperone network
Our clustering analysis of the mammalian chaperome was
thus far based only on mRNA expression metadata under
various physical and chemical treatments (Figs. 3 and 4).
We next estimated the robustness of this result using the
STRING database that includes additional criteria, such as
physical and known functional interactions (co-expression
and experimental view) or computational predictions of
homology and text mining co-occurrence (Jensen et al.
2009). The STRING analysis revealed a network with a
strong core that cumulated most connections with other
members of the chaperome that was mainly composed of
Hsp90s (HSP90AA1, HSP90AB1, and HSP90B1) and
Hsp70s (HSPA1A HSPA1L, HSPA2, and HSPA8), tightly
interconnected to each other through common co-
chaperones, such as Hip (ST13) and Hop (STIP1)
(Fig. 5a). This chaperone network could be simply
subdivided into five chaperone subnetworks comprising
most of: (1) the Hsp70s and their co-chaperones (green,
Fig. 5a, upper right), (2) the Hsp90s and their co-
chaperones (magenta, Fig. 5a, upper left), (3) the PPIase
and PDIs (yellow, Fig. 5a, lower left), the chaperonins
(grey, Fig. 5a, lower right), and the small HSPs (black,
Fig. 5a, lower right). Justifying our choice to include
PPIases and PDIs in the chaperome, these foldases were
nearly all found to be well-connected to the Hsp90s and the
chaperonins subnetworks but, unexpectedly, much less
connected to the Hsp70s and the small Hsps subnetworks
(Fig. 5a).
We next examined the positioning of proteins that
were at least 2-fold upregulated by heat, as a paradigm
of CSR (Fig. 5b, red), or by tunicamycin, as a paradigm
of UPR (Fig. 5b, yellow). Most sHSPs, together with the
Hsp70s and Hsp90s core of the whole chaperone
network, were strongly enriched with CSR-induced but
not with UPR-induced proteins. This confirms that CSR
chaperones are not evenly scattered over the whole
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Fig. 1 Distribution and expression levels of heat-induced chaperome
genes in human and plant. Distribution and fold-expression levels of
heat-induced genes in (a) human monocyte leukemia THP-1 cells (37°
C–>43°C 1 h and (b) plant Arabidopsis thaliana (23°C–>38°C,
90 min). Microarray probes corresponding to bio-informatically
predicted chaperome genes are in black and non-chaperome genes
are grey. The microarray data for human and plant sets were extracted
from the National Center for Biotechnology Information (NCBI) Gene
Expression Omnibus under the series accession nos. GSE9916 and
GSE16222, respectively
20 A. Finka et al.
a  
D
TT
Tu
ni
ca
m
yc
in
Sa
lic
yli
c 
ac
id
 
Ib
up
ro
fe
n 
2,
4,
6 
T 
TI
BA
 
5d
 a
t 2
3˚
C 
to
 1
h 
at
 3
7˚
C 
 AT5G23240, J-protein (Type III) 
 AT3G54960, PDI (Like 1-3) 
 AT5G18750, J-protein (Type III) 
 AT5G12430, J-protein (Type III) 
 AT4G19580, J-protein (Type III) 
 AT3G08910, J-protein (Type II) 
 AT3G04980, J-protein (Type III) 
 AT1G21750, PDI (Like 1-1) 
 AT4G21810, Hsp90 co-chaperone (DERLIN-2.1) 
 AT2G32920, PDI (Like 2-3) 
 AT2G47470, PDI (UNFERTILIZED EMBRYO SAC 5) 
 AT1G04980, PDI (Like 2-2) 
 AT3G62600, J-protein (Type I) 
 AT4G24190, Heat shock protein 90, ER (erHSP90, GRP94) HtpG like 
 AT1G77510, PDI (Like 1-2) 
 AT1G24120, J-protein (Type II) 
 AT5G03160, J-protein (Type III) 
 AT1G09080, Heat shock protein 70, ER (erHSC70, BIP3); DnaK like 
 AT5G42020, Heat shock protein 70, ER (erHSC70, BIP2); DnaK like 
 AT4G29330, Hsp90 co-chaperone (DERLIN-1) 
 AT4G16660, Heat shock protein 110 (erHSP110) 
 AT3G08970, J-protein (Type II) 
 AT4G22670, Hsp90 co-chaperone (Hip1) 
 AT4G09350, J-protein (Type III) 
 AT1G77930, J-protein (Type III) 
 AT1G56410, Heat shock protein 70 (HSP70); DnaK like 
 AT3G12170, J-protein (Type III) 
 AT1G76770, Small heat shock protein 
 AT2G15790, PPIase  (cyclophilin, SQN) 
 AT1G59980, J-protein (Type II) 
 AT5G54660, Small heat shock protein 
 AT4G04610, PDI (thioredoxin) 
 AT2G42750, J-protein (Type III) 
 AT1G62180, PDI (thioredoxin) 
 AT5G20720, Chaperonin 20; GroES like 
 AT5G51440, Small heat shock protein HSP23.5-M 
 AT3G13310, J-protein (Type III) 
 AT5G52640, Heat shock protein 90 (HSP90.1); HtpG like 
 AT3G12580, Heat shock protein 70 (HSP70); DnaK like 
 AT4G12400, Hsp90 co-chaperone (Hop2) 
 AT2G20560, J-protein (Type II) 
 AT5G12020, Small heat shock protein HSP17.6II 
 AT4G10250, Small heat shock protein ATHSP22.0 
 AT1G54050, Small heat shock protein HSP17.4-CIII 
 AT5G59720, Small heat shock protein HSP18.2 
 AT2G29500, Small heat shock protein HSP17.6B-CI 
 AT3G46230, Small heat shock protein ATHSP17.4 
 AT4G25200, Small heat shock protein HSP23.6-M 
 AT2G25140, Heat shock protein 100 (HSP100); ClpB like 
 AT1G07400, Small heat shock protein HSP17.8-CI 
 AT5G12030, Small heat shock protein HSP17.6A 
 AT1G74310, Heat shock protein 100 (HSP100, HS101); ClpB like 
 AT4G27670, Small heat shock protein HSP21 
 AT1G16030, Heat shock protein 70B (HSP70B); DnaK like 
 AT2G46240, Bcl-2-associated atahnogene 6 
 AT1G53540, Small heat shock protein HSP17.6C-CI 
 AT1G52560, Small heat shock protein HSP26.5-P 
 AT5G56010, Heat shock protein 90 (HSP81.3); HtpG like  
 AT5G49910, Heat shock protein 70-2, chloroplast (cpHsc70-2); DnaK like 
 AT3G13860, Heat shock protein 60-3a; GroEL like 
 AT3G07770, Heat shock protein 90, mitochondrial (mtHSP90); HtpG like 
 AT1G71000, J-protein (Type III) 
 AT2G19310, Small heat shock protein 
 AT3G14200, J-protein (Type III) 
 AT3G09440, Heat shock cognate protein 70-3 (HSC70-3); DnaK like 
 AT1G62740, Hsp90 co-chaperone (Hop1) 
 AT5G37670, Small heat shock protein HSP15.7-CI 
 AT3G44110 , J-protein (Type I) 
 AT2G41520, J-protein (Type III) 
 AT3G02530, Chaperonin class II (TCP) 
 AT2G33735, J-protein (Type III) 
 AT5G02490, Heat shock cognate protein 70-2 (HSC70-2); DnaK like 
 AT5G22060 , J-protein (Type I) 
 AT4G28480, J-protein (Type II) 
 AT5G48570, PPIase (ROF2, FKBP65) 
 AT2G32120, Heat shock cognate protein 70 (HSC70); DnaK like 
 AT5G15450, Heat shock protein 100 (HSP100); ClpB like 
 AT4G24280, Heat shock protein 70-1, chloroplast (cpHsc70-1); DnaK like 
 AT5G56030, Heat shock protein 90 (HSP81.2); HtpG like  
 AT3G13470, Chaperonin-60beta2: GroEL like 
 AT5G09590, Heat shock protein 70-2, mitochondrial (mtHsc70-2); DnaK like 
 AT3G12050, Hsp90 co-chaperone (Aha1) 
 AT1G11660, Heat shock protein 110-1 (HSP110-1) 
 AT3G25230, PPIase (ROF1) 
 AT3G23990, Heat shock protein 60; GroEL like 
 AT2G04030, Heat shock protein 90, chloroplast (cpHSP90); HtpG like 
 AT1G79930, Heat shock protein 110-3 (HSP110-3) 
 AT4G25340, PPIase (Rotamase) 
 AT1G04130, Hsp90 co-chaperone (TPR containing, homolog of human TTC4) 
 AT1G01940, PPIase (cyclophilin) 
 AT5G02500, Heat shock cognate protein 70-1 (HSC70-1); DnaK like 
 AT5G53400, Hsp90 co-chaperone (nuclear movement protein) 
 AT1G75100, J-protein (Type III) 
 AT2G28000, Chaperonin-60alpha; GroEL like 
 AT1G14980, Chaperonin 10; GroES like (1) 
 AT4G21990, PDI (thioredoxin) 
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Fig. 2 Clustering of upregulated RNA expression levels in Arabi-
dopsis chaperome under seven abiotic and chemical treatments:
dithiothreitol (DTT), tunicamycin, salicylic acid, ibuprofen, 2,3,5-
triiodobenzoicacid (TIBA), 2,4,6-trihydroxybenzamide (2,4,6-T), and
heat treatment as indicated. Gene clusters typical of (a) the cellular
stress response (CSR) or of the (b) unfolded protein response (UPR).
The presumed subcellular localizations are indicated with different
background colors
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network but rather form a compact, specific core
subnetwork (Fig. 5b, red circles). Confirming our
transcriptomic analysis (Fig. 3), UPR-induced chaperones
were fewer (Fig. 5b, yellow circles) with only three proteins
(HSPA5, DNAJC3, and DNAJB9) induced by both treat-
ments. Remarkably, many J-domain, co-chaperones, and
Hsp90 co-chaperones and most of the PPIases and PDIs
remained uninduced by either heat or ER stressors.
HSEs are frequent but not obligatorily present in promoters
of heat-induced chaperone genes
The presence of HSEs is essential to the specific binding
of activated heat-shock factors, in particular HSF-1, and
to the recruitment of RNA polymerase II at the
transcription start sites of HSP genes (Xing et al. 2005;
Yao et al. 2006). In animals, yeast, and plants, HSEs are
thought to be optimal when composed of three direct
repeats of 5′-nGAAn-3′ (Amin et al. 1988; Kroeger and
Morimoto 1994; Yamamoto et al. 2009), or less optimal,
with inverted repeats of 5′-nTTCn-3′. We next searched
for complete or partial, direct or inverted HSE patterns,
between positions −3000 and 300 bp from the translation
start site of each predicted human chaperome gene
(Supplemental Table 1b). Expectedly, HSEs were found
to be more frequent in the regulatory sequences of 45
chaperone genes that are induced at least 2-fold by heat
(Fig. 6), compared to less- or non-heat induced chaperone
genes. Whereas in the CSR chaperone cluster (Fig. 3,
cluster a), 17 out of 24 genes (71%) contained an average
of two HSEs, in the UPR chaperone cluster (Fig. 3a,
cluster b), only two out of 12 genes (17%) contained a
single HSE motive. However, a majority of mammalian
heat-induced chaperone genes remained devoid of
identifiable HSEs, suggesting that HSEs are contributing
only partially to the specificity of the heat-shock response
and that other specific HSF-binding sites remain to be
experimentally identified.
Our combined microarray, networking and sequence
promoter analysis, may contribute to the identification of
potential chaperone and co-chaperone matches. Thus, the
HSPD1 and HSPE1 genes, respectively encoding for
mitochondrial Hsp60 and Hsp10, have similar patterns of
mRNA expression (Figs. 3, 5) and were also similar in
terms of HSEs patterns in their promoters (Fig. 6).
Likewise, the Hsp70 chaperone genes, HSPA1A and
HSPA6, had expression profiles similar to the Hsp40
co-chaperones DNAJA4, DNAJB6, DNAJB1, DNAJB4,
and DNAJA1 and to the nucleotide exchange factors BAG3
or HSPH1. All but two (DNAJA4 and DNAJB1) had one
or two HSEs in their promoters, suggesting that they may
preferably collaborate with each other under particular
stressful or physiological conditions.
Discussion
The term molecular chaperone is adequate but incomplete
The term “molecular chaperone” was first used by Laskey to
describe the properties of nucleoplasmin (Laskey et al. 1978).
In 1989, Ellis adorned protein biochemistry with this social
term to describe the new molecular function of a class of
proteins that mediate the native folding and/or assembly of
other polypeptides (Ellis et al. 1989). Whereas a social
chaperone has a rather passive function—it merely prevents
improper associations between youngsters—molecular
chaperones, in particular the ATP-fuelled GroEL (Shtilerman
et al. 1999), ClpB (Goloubinoff et al. 1999), and Hsp70
(Ben-Zvi et al. 2004), have since been found to carry an
active function of repairing structural damages by unfolding
and promoting native protein refolding or degradation
(reviewed in Sharma et al. 2009). Hence, the social term
“molecular police” might have better reflected the energy-
consuming mechanism by which ATPase chaperones first
apprehend, then “rehabilitate” strayed-off misfolded proteins,
converting them into non-toxic functional proteins of the cell
(Hinault and Goloubinoff 2007). Noticeably, alongside
maintaining a “state of law” among cellular proteins, called
protein homeostasis (or proteostasis, Morimoto 2008) in the
crowded protein population of the cell, the network of
chaperones, like a highly coordinated police force, is also
involved in non-stress housekeeping functions, such as
regulating protein trafficking, signaling, and import into
organelles. Thus, although incomplete, the term “molecular
chaperone” is not entirely wrong and should be maintained,
primarily because it is now well-anchored into the scientific
community.
The cellular stress response is likely under the control
of the plasma membrane
Sensing temperature changes in eukaryotes has been
initially attributed to unspecified thermolabile proteins in
the cytoplasm, whose unfolding supposedly recruits
inhibitory Hsp90 and Hsc70 chaperones, thereby
activating formerly chaperone-repressed Hsfs (Voellmy
and Boellmann 2007). However, it has been recently
Fig. 3 Clustering of upregulated RNA expression levels in the human
chaperome under 21 treatments: A 2-deoxyglucose, B tunicamycin, C
phorbol 12-myristate 13-acetate, D cadmium, E N-acetylcysteine, F
paclitaxel, G doxycycline, H echinomycin, I heat shock study, J
elesclomol, K smoking, L simvastatin, M etoposide, N VAF347, O
sapphyrin PCI-5002, P propiconazole, Q myclobutanil, R rifampicin,
S dihydrotestosterone, T estrogen, and U apple procyanidin. Gene
clusters typical of the (a) cellular stress response (CSR), of the (b)
unfolded protein response (UPR), and of the (c) less specific cell
responses are shown. The presumed subcellular localizations are
indicated with different background colors of the gene names

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 HSPA6, Hsp70, member 6 (Hsp70B’) 
 DNAJA4, Hsp40, subfamily A, member 4 
 HSPA1L, Hsp70, member 1-Like 
 HSPA1A, Hsp70, member 1A 
 DNAJB6, Hsp40, subfamily B, member 6 
 DNAJA1, Hsp40, subfamily A, member 1 
 STIP1, Stress-Induced-Phosphoprotein 1 
 PTGES3, Prostaglandin E Synthase 3 (Cytosolic) 
 HSPA4L, HSP110 protein 4-Like 
 DNAJB4, Hsp40, subfamily B, member 4 
 DNAJB1, Hsp40, subfamily B, member 1 
 BAG3, Bcl2-Associated Athanogene 3 
 PPIL3 (CLK1), Cdc-Like Kinase 1 
 HSPB2, Small HSP27, protein 2 
 DNAJC2 (ZRF1), Hsp40, subfamily C, member 2 (Zuotin-Related Factor 1) 
 HSPB8, Small HSP22, protein 8 
 HSP90AB1, Hsp90 Alpha (Cytosolic), Class B member 1 
 CCT4, Tcp1, Subunit 4 (Delta) 
 HSPA9, Hsp70, member 9 (Mortalin) 
 ST13, Suppression Of Tumorigenicity 13 (Hsp70 interacting protein) 
 HSPE1, HSP10 (Co-chaperonin 10, GroES) 
 TCP1, T-Complex 1 
 CRYAB, Crystallin, Alpha B 
 HSPD1, HSP60 (Chaperonin, GroEL) 
 PPIL6, PPIase (Cyclophilin)-Like 6 
 CCT6A, Tcp1, Subunit 6A (Zeta 1) 
 AHSA1, Aha1, Activator of Hsp90, member 1 
 FKBP4, Fk506 binding protein 4 
 HSPB1, Small Hsp, member 1 
 HSPH1, HSP110 protein 1 
 HSP90AA1, Hsp90 Alpha (Cytosolic), Class A member 1 
 HSPA4, Hsp110 protein 4 
 PTPLAD1, Protein tyrosine phosphatase-like A domain containing protein 1 
 CCT8, Tcp1, Subunit 8 (Theta) 
 NUDC, Nuclear Migration protein Nudc 
 HSPB9, Small HSP, B9 
 PDILT, PDI-like of the testis 
(HSPB10, Small HSP, member 10 
 DNAJB3, Hsp40, subfamily B, member 3 
 DNAJC5G, Hsp40, subfamily C, member 5 gamma 
 FKBP15, Fk506 binding protein 15 
 DNAJC5B, Hsp40, subfamily C, member 5 beta 
 PPIA, PPIase A (Cyclophilin A) 
 DNAJB13, Hsp40, subfamily B, member 13 
 FRAP1, Serine/Threonine-protein Kinase, MTOR 
 PPP5C, Protein phosphatase 5 
 DNAJB8, Hsp40, subfamily B, member 8 
 SEC63, Hsp40, subfamily C, member 23 
 HSP90B1, Hsp90 Beta (Grp94), member 1 
 HYOU1, Hsp110, Hypoxia Up-Regulated 1 
 PDIA3, PDI Family A, member 3 
 DNAJB11, Hsp40, subfamily B, member 11 
 PDIA6, PDI Family A, member 6 
 DNAJC3, Hsp40, subfamily C, member 3 
 DNAJC10, Hsp40, subfamily C, member 10 
 P4HB, Protein disulfide-isomerase (PDI) 
 PDIA4, PDI Family A, member 4 
 FKBP2, Fk506 binding protein 2 
 ERp44, Endoplasmic reticulum resident protein ERp44 
 SELS, Selenoprotein S 
 SGTB, Small Glutamine-Rich TPR-containing protein beta
 DNAJB2, Hsp40, subfamily B, member 2 
 DNAJB5, Hsp40, subfamily B, member 5 
 PPIB, PPIase B (Cyclophilin B) 
 HSPA5, Hsp70, member 5 (Glucose-regulated protein 78) 
 CHORDC1, Cysteine And Histidine-Rich Domain-containing protein 1 
 DNAJB9, Hsp40, subfamily B, member 9 
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shown in plants that ambient temperature upshifts, for
example, from 12 to 27°C, can trigger the upregulation of
2,764 HSP genes, many of which are chaperone genes
(Kumar and Wigge 2010). Likewise, isothermal treat-
ments with non-toxic chemicals, such as hormones and
NSAIDs unlikely to denature proteins in bacteria, yeast,
plants, and animals can upregulate specific HSP and
chaperone genes (Saidi et al. 2005, 2007; Vigh et al.
2007). Similarly, the generally observed induction of the
CSR in various organisms by treatments with membrane
fluidizers strongly suggests that subtle changes in the
plasma membrane state (fluidity, the raft/non-raft
organization) are the most upstream events of the
temperature-sensing and signaling pathway, both in
prokaryotes and eukaryotes (de Marco et al. 2005; Vigh
et al. 1998, 2007). Because abnormally exposed hydro-
phobic parts of misfolded proteins often wrongly interact
with membranes and because, without a Ca2+ entry-
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 Hsp40, subfamily C, member 15 
 Hsp40 , subfamily C, member 22 
{
NSAIDs{iHsp90Fig. 4 Expression profile ofhuman Hsp70 and Hsp40 ortho-
logs under different treatments.
Heat and UV induced up- and
downregulated human Hsp70
and Hsp40 genes, as compared
to isothermal treatments with
two Hsp90 inhibitors and four
different NSAIDs, as indicated
Fig. 5 Chaperone network rearrangements in CSR and UPR. a
Interaction network of proteins in different cellular functions from
STRING analysis of the chaperome (Supplemental Table 1) showing
Hsp70 (green), Hsp90 (magenta), foldases (orange), small Hsp
(black) and chaperonin subnetwork (gray). b Stress-induced central-
ization of chaperone hubs in CSR (red), UPR (orange), or both (pink)
b
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dependent clearance signal from the plasma membrane,
Hsp90 inhibitors cannot directly induce an isothermal
HSR in plants, the plasma membrane also stands as a
sensor of intra- and extracellular protein aggregates,
activating the CSR chaperones to reduce aggregate
toxicity (Saidi et al. 2009).
Analysis of the chaperone network under stress
Molecular chaperones with their co-chaperones form a
dynamic network with hundreds of so-called client proteins
(Picard 2006). During and after stress, a massive realloca-
tion of the cellular resources occurs, which in turn causes
dramatic rearrangements in the chaperone network (Szalay
et al. 2007). Pallotai et al. (2008) showed that in the
stressed interactome in yeast, novel centralities or impor-
tant interactions in the network appeared, which in parallel
increased the number of unlinked or isolated network
elements or modules. As resources diminish during stress,
the function of most protein networks becomes transiently
arrested, whereas the few that remains active, such as the
CSR chaperone network, become more active and abundant
and take control on many of the cellular functions in a
centralized and highly hierarchical manner (Szalay et al.
2007). Thus, in Escherichia coli, heat shock places the
transcription factor σ32 as a central hub regulating other
protein networks (El-Samad et al. 2005), while in yeast,
refolding of damaged proteins by stress-induced chaperones
is prioritized, compared to the folding of newly synthesized
proteins indicating a massive rearrangement in the cellular
protein networks (Albanese et al. 2006). Our comparative
analysis of mRNA co-expression under various physical
and chemical treatments revealed a modular organization of
the chaperone networks, whereby the UPR, involving only
a small set of ER chaperones, can be clearly distinguished
from CSR chaperones, mainly located to the cytoplasm and
organelles. This was confirmed using additional comparative
criteria in the STRING-generated network map that showed
that CSR chaperones contribute mostly to a core of Hsp70s,
Hsp90s, and sHSPs, and to a much lesser extent to chaperone
regulators such as the co-chaperones and to the foldases.
Mechanistically, a massive increase in the cellular concen-
trations of Hsp90s and Hsp70s without an equivalent
accumulation of co-chaperones is expected to create an
imbalance resulting, at least in the case of Hsp70, in a higher
binding/holdase capacity than processive unfolding/folding
activity (Sharma et al. 2009). Such a pro-holdase tendency
under heat shock is corroborated by our data (Fig. 5b),
showing strong over-representation of heat-induced sHSPs,
which are holdases par excellence of the whole chaperone
network (Veinger et al. 1998). This suggests that the primary
concern of heat-stressed cells is to prevent protein misfolding
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Fig. 6 Heat shock elements found in heat-induced human chaperome
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genes in human monocyte leukemia THP-1cells (graph) and the
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start site of each genes (lower panel). The microarray data for the human
chaperome subset (Supplemental Table 1a) is as in Fig. 1a
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and aggregation during stress, while ATP-consuming unfol-
dase/refoldase activities depending on co-chaperones are
postponed to the recovery phase after the stress, a condition
under which the proteins refolded by the chaperones can
become and stably remain native.
Treatments that increase the cellular chaperone load
Aging and protein misfolding diseases apparently result
from a general failure of the cellular protein homeostasis
machinery, which is most relevantly composed of
molecular chaperones, foldases, and proteases. Whereas
environmental stresses, pollutants, and mutations may
increase the rate at which toxic misfolded protein
conformers accumulate in cells, aging cells show de-
creasing abilities to respond to proteotoxic species by
upregulating their cellular chaperone load (Ben-Zvi et al.
2009; Hinault et al. 2006). To combat aging and protein
misfolding diseases, it is therefore central to identify the
reasons for the failure of the CSR in aging and diseased
cells. One possible reason could be an increased rigidity of
membranes commonly observed in aging cells, as lipid
saturation and loss of fluidity may strongly decrease the
cell’s ability to sense a heat stress and induce an
appropriate HSR (Horváth et al. 1998), implying that in
old cells, the CSR too could become deficient when
challenged by intra- or extracellular proteotoxic species
(Vigh et al. 2007). An additional possibility is that
particular toxic protein conformers, such as oligomers or
protofibrils of α-synuclein, tau or polyglutamine proteins,
respectively found in diseased neurons in Parkinson,
Alzheimer, and Huntington diseases, act as non-
competitive inhibitors of the various layers of cellular
defenses, such as the chaperones themselves, the protea-
some, the aggresome, and lysosomal autophagy (reviewed
in Kopito 2000; Ross and Poirier 2004). Moreover, toxic
protein conformers can directly damage membranes by
spontaneously forming pores that cause ion leakage and
cell death (Lashuel et al. 2002).
One therapeutic approach would be to identify treat-
ments that can restore the expression levels and the activity
of the CSR chaperones in particular. Mild repetitive heat-
shocks, as with daily saunas, would probably be the most
natural way to induce the accumulation of protective and
repairing CSR chaperones in tissues suffering from stress
damages or chronic protein misfolding diseases. However,
arguing against long-term beneficial effects of thermotherapy
(Pouppirt 1929), increased temperatures also increase the
propensity of proteins to unfold and form toxic misfolded
species. Rather, isothermal exposures to non-toxic
HSP-inducing drugs might better treat protein misfolding
diseases and aging, especially drugs that cross the
blood–brain barrier (Hinault et al. 2006).
Alongside Hsp90 inhibitors that are very toxic and
cause apoptosis through oxidative stress (Kirshner et al.
2008) and are therefore used in cancer therapy (Solit and
Chiosis 2008), we found that the thiobenzoylhydrazide,
elesclomol, best recapitulated in human cells the heat-
induced chaperome pattern (Fig. 3). Thus, despite their
ability to best mimic the induction of anti-inflammatory,
anti-aggregation CSR chaperones load, Hsp90 inhibitors
and elesclomol may counter-productively accelerate, rath-
er than delay, neuronal death in protein misfold
ing diseases.
In contrast, other hydroxylamines, such as arimoclomol
and bimoclomol, are apparently much less toxic than
elesclomol and are also inducers of CSR chaperones,
although not nearly as effective (Vigh et al. 1997; Kieran
et al. 2004; Lanka et al. 2009). Likewise, but less
pronounced, several NSAIDs, such as aspirin, diclofenac,
ibuprofen, and indomethacin, also upregulated the
expression of some chaperone genes, albeit not in clearly
recognizable clusters, as with elesclomol or tunicamycin.
NSAIDs are known to decrease inflammation and fever
via inhibitory mechanisms of prostaglandin synthesis,
and, in parallel, they induce the accumulation of some
CSR chaperones (Hinault et al. 2006; Smalley et al.
1995). It is thus possible that in mammals, specific
NSAIDs may decrease the pro-apoptotic consequences of
inflammation and oxidative stress while at the same time
maintain an artificially elevated load of protective
anti-apoptotic chaperones.
Possibly, the use of various NSAID combinations,
together with other of CSR-chaperone-inducing drugs,
such as hydroxylamine derivatives (Vigh et al. 1997),
vanilloids, such as curcumin (Kanitkar and Bhonde 2008),
flavonoids, such as quercetin (Aalinkeel et al. 2008), or
omega-3-fatty acids (Narayanan et al. 2006), with
anti-aging and anti-apoptotic effects on developing brain
(Sinha et al. 2009), may improve protein misfolding
diseases and aging in general (Gidalevitz et al. 2010).
Combinations of non-toxic HSP drugs could directly
decrease the cellular concentration of cytotoxic protein
conformers and indirectly block neuroinflammation and
apoptosis signals, leading to an arrest of tissue loss. This
type of mRNA expression meta-analysis, combined with
network analysis, thus provides important tools to test
known and new drugs for their potential specific
chaperone-inducing ability, to combat protein-misfolding
diseases and aging.
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Introduction
Anfinsen demonstrated that under optimal non-physio-
logical conditions of low protein concentrations and low 
temperatures, the primary amino acid sequence of a poly-
peptide contains the necessary instructions for its spontane-
ous acquisition of a narrow range of relatively stable but 
dynamic functional structures, generally referred to as the 
“native state” [1]. Yet, the refolding process is often inef-
ficient because hydrophobic residues that in stress-unfolded 
or de novo-synthesized polypeptides become abnormally 
exposed to the aqueous phase, may spontaneously seek 
intra-molecular stability by forming wrong beta sheets 
and improper inter-molecular ensembles generally called 
aggregates. Because of cooperativity, a simple increase in 
the number of surface-exposed hydrophobic residues may 
result in a synergic increase of the affinity between sev-
eral misfolded polypeptides. Thus, aggregate-entrapped 
polypeptides may become precluded from dissociating 
and reaching their native state within a biologically rel-
evant time-scale [2, 3]. Moreover, aggregates may be cyto-
toxic, especially to animal cells, and cause aging-induced 
degenerative disorders, such as Parkinson’s, Huntington’s 
and Alzheimer’s diseases [4]. In youth, however, a cellular 
network composed of molecular chaperones and of chap-
erone-controlled proteases can efficiently counteract toxic 
protein aggregation by a mechanism generally termed as 
“holdase”, corresponding to the non-catalytic tight binding 
of aggregation-prone misfolding intermediates to the chap-
erone surface. For a general review on the main chaperone 
families, their structures, and their anti-aggregation activi-
ties, see [5]. Here, we focus on chaperones that seem to 
function as catalytic unfolding enzymes and are of impor-
tance in combating early proteotoxic intermediates in pro-
tein conformational diseases.
Abstract  By virtue of their general ability to bind (hold) 
translocating or unfolding polypeptides otherwise doomed 
to aggregate, molecular chaperones are commonly dubbed 
“holdases”. Yet, chaperones also carry physiological func-
tions that do not necessitate prevention of aggregation, 
such as altering the native states of proteins, as in the disas-
sembly of SNARe complexes and clathrin coats. To carry 
such physiological functions, major members of the Hsp70, 
Hsp110, Hsp100, and Hsp60/CCT chaperone families act 
as catalytic unfolding enzymes or unfoldases that drive 
iterative cycles of protein binding, unfolding/pulling, and 
release. One unfoldase chaperone may thus successively 
convert many misfolded or alternatively folded polypeptide 
substrates into transiently unfolded intermediates, which, 
once released, can spontaneously refold into low-affinity 
native products. whereas during stress, a large excess of 
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of degenerative protein conformational diseases.
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Several independent studies have reported unfolding of 
misfolded polypeptides by chaperonins and Hsp70 chap-
erones [6–11]. Recently, members of conserved chaperone 
families Hsp70, Hsp110, and Hsp60/CCT have been shown 
to drive catalytic polypeptide unfolding activity, where 
sub-stoichiometric quantities of chaperones could process 
a molar excess of high-affinity misfolded substrates into 
low-affinity native products [12, 13]. A clear understanding 
of the passive “holding” and the catalytic unfolding mecha-
nisms by which some chaperones can oppose the forma-
tion of toxic protein conformers, and others actively revert 
already-formed toxic aggregated conformers into harmless 
native or degraded polypeptides, is central to the design of 
new therapeutic solutions to protein conformational dis-
eases. Here, we review the different molecular functions of 
chaperones and critically discuss the adequacy of the terms 
that are used in the literature to describe them.
The role of chaperones in protein misfolding diseases
Under physiological conditions, molecular chaperones and 
proteases control house-keeping processes of cellular pro-
teostasis, such as assisting the proper de novo folding of 
polypeptides exiting the ribosome, or of cytoplasmic pro-
teins exiting the import pores in the endoplasmic reticulum 
lumen or the mitochondrial matrix. Molecular chaperones 
also activate or inhibit various signaling pathways [14–16]. 
For example, Hsc70 regulates SNARe complexes [17, 18]. 
After exocytosis, when the cis-SNARe complex is stuck 
on the target membrane, the AAA+ ATPase N-ethylma-
leimide sensitive factor disassembles it and after disas-
sembly, Hsc70 together with cysteine-string protein-alpha 
and small guanine-rich tetratricopeptide protein, are then 
required for the refolding of the SNARe SNAP-25, con-
verting it into an active form [19]. Chaperones can also dis-
assemble native complexes such as clathrin cages [20] and 
they may target short-lived or stress-damaged proteins to 
proteasomal or lysosomal degradation and reorient mutant 
proteins prone to aggregation back on track of the native 
pathway, to undergo functional folding and assembly [4].
The expression of molecular chaperones is markedly 
increased under different environmental stress condi-
tions, for example following hyperthermia or heat shock, 
hypoxia, oxidative stress, or exposure to toxins [5, 21–23]. 
The stress response is thought to be activated by the accu-
mulation of unfolded or misfolded proteins, eliciting chap-
erone expression by turning on a signaling pathway that 
engages the transcription factor heat shock factor 1 (HSF-
1) [22–25]. Under stress, such as heat shock, all organ-
isms massively synthesize heat-shock proteins (HSPs), 
many, but not all, belonging to the molecular chaperone 
category. Compared to average human genes, members of 
the human “chaperome” network [26] are 20 times more 
likely to be stress-inducible [21]. Yet, noticeably, two-
thirds of the human chaperome is constitutively expressed 
without stress and constitutes up to 10 % of the total pro-
tein mass of HeLa cells [27]. In young animals, molecular 
chaperones can effectively retard the formation of cytotoxic 
protein aggregates such as fibrils, tangles, and amyloids, 
which are hallmarks of degenerative diseases, such as Alz-
heimer’s, Parkinson’s, Huntington’s, diabetes type 2, and 
Prion diseases.
The involvement of molecular chaperones in neurode-
generative diseases can be exemplified with the particular 
case of Parkinson’s disease (PD). Indeed, Hsp90, Hsp70, 
Hsp60, Hsp40, and Hsp27 were found in Lewy bodies and 
Hsp70 in particular was inferred to be an important chap-
erone to mitigate α-synuclein toxicity [28–31]. Further, 
exposure of cells and whole mice to toxins like rotenone 
or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, or to the 
proteasome inhibitor lactacystin, showed a marked increase 
in chaperone levels, particularly of Hsp70 [32, 33]. Like-
wise, targeted overexpression of α-synuclein using viral-
vector in the substantia nigra of mice resulted in increased 
mRNA levels of Hsp70, Hsp40 and Hsp27 [34]. Moreo-
ver, the sequestration of molecular chaperones into pro-
tein aggregates results in their cellular depletion and thus 
a subsequent loss of chaperone function that may promote 
neurodegeneration [35]. Consistently, in vitro, α-synuclein 
oligomers caused the depletion of Hsp40 (DnaJ) render-
ing the Hsp70 machinery (DnaK–DnaJ–Grpe) inefficient 
at unfolding/refolding misfolded proteins [36]. A system-
atic study of the interaction of several small Hsps (αB-
crystallin, Hsp27, Hsp20, HspB8, and HspB2B3) showed 
that transient binding to the various forms of α-synuclein 
resulted in the inhibition of mature α-synuclein fibril for-
mation [37]. Further, in vitro experiments showed that the 
small HSP, αB-crystallin (HspB5) can mediate the depo-
lymerization of α-synuclein fibers with the help of other 
chaperones, including Hsp70 and its co-chaperones [38]. 
Moreover, in an in vitro system, mammalian Hsp110 can 
synergize Hsp70 to drive the catalytic disaggregation of 
α-synuclein amyloid fibrils [39]. All these studies show a 
close linkage between cellular stress, toxic protein misfold-
ing, and chaperone induction, suggesting that protein mis-
folding diseases could result from chaperone failure and 
that the artificial increase of the cellular chaperone load 
by ectopic expression or drugs mimicking various stresses 
could combat protein misfolding diseases [4].
Noticeably, under mildly stressful conditions, protein 
aggregates in the cell and in vitro can serve as nucleat-
ing seeds to the aggregation of other metastable proteins 
that would otherwise spontaneously revert to the native 
state [40, 41]. Chaperones are thus key factors to neutral-
ize the aggregation seeds, thereby disallowing a prion-like 
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propagation-of-aggregation effect even among regular 
labile proteins [4, 40]. Hence, small amounts of arsenite-, 
lead-, or cadmium-induced protein aggregates can serve as 
seeds that commit other labile proteins in excess to misfold 
and aggregate even after all traces of heavy metals have 
been removed from the seeds. Fortunately, this seeding 
process can be effectively counteracted by “holding” and 
unfolding chaperones such as Hsp70 and CCTs [42, 43].
The various chaperone activities
whereas many but not all chaperones can passively bind 
misfolding proteins and thus arrest further aggregation into 
insoluble, potentially cytotoxic species, chaperone activ-
ity goes much beyond mere passive stoichiometric bind-
ing of metastable polypeptide species. Because binding or 
tight holding are not catalytic processes, the term “hold-
ase” that is often used in the chaperone literature should be 
avoided. Moreover, many molecular chaperones function 
under physiological conditions as regulators of native pro-
tein folding, translocation, and assembly that do not call for 
their ability to prevent aggregation. Significantly, at least 
three out of five main chaperone families can act as bona 
fide polypeptide unfoldase enzymes.
In unstressed cells, molecular chaperones play a central 
role in protein homeostasis and regulate structural transi-
tions between native and “alternative” states of proteins, 
such as between the oligomeric active versus the mono-
meric inactive states of native IκB, caspases or HSF-1 
[44–47], or between inactive and active steroid hormone 
receptors [48–50]. In stressed cells, molecular chaperones 
become a primary line of cellular defenses against stress-
induced protein misfolding and aggregation events [51] 
that otherwise become increasingly toxic by compromis-
ing the stability of other proteins and the integrity of mem-
branes [52]. In aging mammalian neurons, toxic protein 
aggregates generally cause neuro-inflammation, oxidative 
stress, apoptosis, and tissue loss, leading to neurodegenera-
tion and diseases.
Most molecular chaperones fall into five main families 
of highly conserved proteins: the Hsp100s (ClpB), the 
Hsp90s (HtpG), the Hsp70/Hsp110 (DnaK), Hsp60/CCTs 
(GroeL), and the α-crystalline-containing domain gen-
erally called the “small Hsps” (IbpA/B) (Escherichia 
coli orthologues shown in parentheses). Apparently, 
all families share the ability to screen for proteins with 
hydrophobic residues that are abnormally exposed to the 
solvent, and are thus prone to associate and form sta-
ble inactive aggregates [3, 4, 53]. with the exception of 
the small Hsps, the major classes of molecular chaper-
ones are also ATPases, suggesting that their function can 
implicate an ATP-driven increase of the free energy in 
their bound misfolded or alternatively folded polypeptide 
substrates [54].
Chaperones with holdase activity
The first in vitro chaperone assay showed that the E. coli 
Hsp60, GroeL, could passively prevent the aggregation 
of a urea-, acid- or Guanidium HCl-denatured RuBisCO 
substrate. Importantly, in addition to the GroeL ability to 
“hold” the inactive RuBisCO in a soluble inactive state, 
the addition of GroeS and ATP subsequently released the 
substrate from the holding GroeL, which then refolded 
into native active RuBisCO [55]. Yet, rather than referring 
to this remarkable ability of chaperones to drive the strin-
gent native refolding of unfolded proteins, which would 
have otherwise remained inactive and aggregated, most 
subsequent papers chose to adopt the definition of chaper-
one activity as being the ability to prevent aggregation of 
heat- or Guanidium HCl-denatured proteins. In addition to 
chaperonin, many but not all chaperone families, including 
Hsp40, Hsp90, CCTs, and sHsps but not Hsp104 (ClpB), 
were shown to effectively prevent the aggregation of pro-
teins in the absence of ATP [5, 56]. The term “holdase” thus 
was dubbed to describe the physical tight interaction of a 
chaperone with a non-native unfolded or misfolded poly-
peptide, which thus became prevented from forming larger 
aggregates that scatter light [4]. The “holdase” activity 
could be qualitatively observed with a previously unfolded 
polypeptide set to aggregate in a fluorometer cuvette: the 
presence of a given amount of chaperone caused the lower-
ing and slowing down of the time-dependent increase in the 
light scattering signal [57]. However, the “holdase” activity 
of chaperones remained mostly a mere qualitative observa-
tion, since light-scattering assays suffer from low sensitiv-
ity and signals lack a direct connection with the size distri-
bution of the aggregates.
A further depreciation of the concept that chaperones 
are “holdases”, is the fact that the Hsp100/ClpB chaperones 
are unable to passively prevent the aggregation of unfold-
ing or unfolded polypeptides, but rather act as very effec-
tive disaggregase chaperones, which together with HSP70, 
use ATP to forcefully solubilize already preformed, sta-
ble protein aggregates [58]. Although not all chaperones 
have a “holdase” activity, there is a general agreement to 
describe the activity, at least of the small-HSPs, as such, 
possibly because the α-crystallin domain-containing small 
heat shock protein (sHSPs) are devoid of ATPase activity 
of their own. Thus, under stress conditions, small-Hsps like 
Hsp25 or IbpB can bind very tightly to non-native unfold-
ing or unfolded proteins and maintain them in an inactive 
non-aggregated state, which may be subsequently fed to 
an ATP-dependent unfoldase chaperone machinery such as 
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Hsp70–Hsp40, to become reactivated after the stress (Fig. 1) 
[59–61]. Several in vitro studies using purified sHsps from 
various organisms have demonstrated that sHsps can effec-
tively prevent the thermal aggregation of other proteins in 
an ATP-independent manner. They describe “holding” by 
sHsps as a single step, which is nearly irreversible in biolog-
ical timescales, rather than a dynamic binding/release pro-
cess [62–65]. whereas small Hsps (sHsps) do not generally 
drive dissociation at a useful rate and are energy independ-
ent, other chaperones can bind (and unfold) already-formed 
stable misfolded proteins, as in the case GroeL and CCT, 
which need energy to drive dissociation at a useful rate. Yet, 
other chaperones bind and disaggregate already-formed 
large insoluble stable protein aggregates, as in the case of 
Hsp110–Hsp70 and Hsp100–Hsp70 bichaperone machiner-
ies [58, 66]. It should be noticed that because all enzymes 
need to bind their substrate, it is futile to mention protein 
binding as a particular property of the chaperones. even 
when non-enzymatic polypeptides bind other macromol-
ecules, as with histones binding DNA, this does not qualify 
them to be named DNA bindases or holdases. In another 
example, glucose-6-phosphate dehydrogenase (G6PDH) 
binds glucose-6-phosphate (G6P) and NADP with high 
affinity and converts them into 6-phosphoglucono-lactone 
and NADPH + H [67]. It would be misleading and poorly 
informative to name G6PDH “G6P holdase”. Thus, it would 
Fig. 1  Folding of nascent and misfolded polypeptides by the cyto-
solic chaperone network. A newly synthesized polypeptide emerg-
ing from the eukaryotic ribosome (PDB:3O2Z) tunnel (red circle) 
encounters in a typical eukaryotic cell such as yeast, ribosome-asso-
ciated chaperones that can apply an entropic pulling force to unfold 
misfolded secondary structures in the growing nascent polypeptide 
chain. Upon exposure of the nascent polypeptide to the crowded 
environment of cytosol it may expose hydrophobic residues leading 
to misfolding. The misfolded conformers may then become a sub-
strate of Hsp70 (PDB:1KHO) system (Hsp70–Hsp40 and nucleotide 
exchange factor, PDB:1DKG), which by reiterative cycles of binding, 
ATP-fueled unfolding and spontaneous refolding, converts the mis-
folded polypeptide into a native protein (cycle I). In case of failure, 
the misfolded substrate can bind instead to holding chaperones such 
as Hsp90 or sHsps that may keep the substrate in a non-aggregated, 
folding competent state, which may be subsequently passed on to 
the unfolding machinery of Hsp70 system for refolding to the native 
state. Possible unfolding of misfolded substrate by sHsps, structure 
adapted from [157], is unclear and is shown as a question mark. The 
aggregated protein in the cytosol of metazoans can be reverted to the 
native state by the Hsp110–Hsp70 system (PDB:3C7N) and also by 
the Hsp100s (structure adapted from [158]) and Hsp70 system in 
yeasts and plants (cycle II). In case of failure, the misfolded polypep-
tide can bind instead the CCT chaperonin (PDB:4A13), where it will 
undergo cycles of binding, unfolding, and ATP-fueled release, leading 
to the native state (cycle III). The structures are from highly homolo-
gous chaperone orthologs from various organisms, because they are 
not all available from yeast
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seem inappropriate to assign a holdase activity to chaper-
ones that drive the forceful unfolding and translocation of 
polypeptides across membranes [20]. Polypeptide translo-
cases, unfoldases, and/or even pullases would better fit the 
definition of their function.
In order to label a given protein as an enzyme, it should 
carry basic properties common to all enzymes. Like all cat-
alysts, it should act by way of lowering the energy of acti-
vation of a spontaneous reaction and thus increase the rate 
at which equilibrium is reached and it should not remain 
stably associated to its products. It should not be consumed 
by the reactions, nor should it alter the equilibrium of the 
catalyzed reaction. The International Union of Biochem-
istry and Molecular Biology (IUBMB) has formulated 
several principles to name new enzymes. First, the name 
should end with suffix “-ase”, implying that it has a cata-
lytic mode of action, driving iterative cycles of substrate 
binding, substrate conversion into product, and product 
release. The use of the suffix “-ase” is strongly discouraged 
for non-enzyme molecules. Second, efforts should be made 
to classify new enzymes among the six existing classes of 
the Oxidoreductases, Transferases, Hydrolases, Lyases, 
Isomerases, and Ligases. Third, enzymes should be named 
according to the main reaction they catalyze (enzyme 
Nomenclature 1992, Academic Press, San Diego, Califor-
nia, ISBN 0-12-227164-5).
The term “holdase” is thus an oxymoron: either a chap-
erone is an enzyme deserving the suffix “-ase”, in which 
case it should act as a catalyst, i.e., it should also be able to 
carry many cycles and in particular to release its products 
within a biologically relevant time-scale at the end of every 
cycle, or it should not harbor the suffix “-ase” and rather 
be called “holding” chaperones. Noticeably, even the small 
HSPs for the activity of which, the term “holdases” is most 
often used, can also accelerate the native refolding of arti-
ficially unfolded proteins, raising the possibility that small 
HSPs might also act as polypeptide foldases [68].
Chaperones with catalytic polypeptide unfoldase 
activity
Molecular chaperones such as Hsp70, Hsp110, Hsp100, or 
Hsp60s can use ATP to unfold stable misfolded or aggre-
gated proteins and convert them into natively refoldable spe-
cies [6, 13, 66]. Hsp70, in collaboration with co-chaperones 
Hsp40 and nucleotide exchange factor (NeF), function as 
an efficient unfolding or disaggregation machinery [69–71]. 
The bacterial Hsp70 system that includes DnaK (Hsp70), 
DnaJ (Hsp40), and Grpe (NeF), can work at Vmax in mul-
tiple turnovers, converting a molar excess of stable inac-
tive misfolded protein species into the active native state, 
in a strict ATP-dependent manner [13]. This conversion by 
Hsp70s of stable misfolded polypeptides into the native spe-
cies is accomplished by working against a free energy bar-
rier, converting a stable misfolded protein with a low free 
energy into a transiently unfolded species with a higher 
free energy, which, after release may spontaneously fold to 
a native species with a lower free energy (Fig. 2). Demon-
strating that unfolding of stable misfolded species is highly 
conserved in evolution, a similar unfolding mechanism 
leading to spontaneous native refolding was shown in the 
case of human Hsp70 (and Hsp40) and its ortholog Hsp110 
(with Hsp40), which was indistinguishable from that of bac-
terial DnaK, except that is was energetically much more 
expensive [66] and also that NeF activity was not involved, 
as this was the case in the bacterial system [13]. Likewise, a 
similar unfolding mechanism leading to spontaneous native 
refolding was shown in the case of bovine CCT, which was 
indistinguishable from that of bacterial GroeL [12]. Indeed, 
the mere binding of a stable misfolded fluorescently labeled 
rhodanese was shown by fluorescent spectroscopy to cause 
significant unfolding in the substrate, which was exacer-
bated further upon ATP addition [6].
Fig. 2  Disaggregating and unfolding chaperones transiently increase 
the free energy of misfolded or alternatively folded substrates but 
not of natively folded products. The 3D mesh-plot shows a typical 
unfolded polypeptide with the highest free energy, which can spon-
taneously reach to lower free energy states, either by folding to the 
native conformation (right) or by misfolding to the aggregated state 
(left). when conditions are not favorable for native folding, the 
unfolded polypeptide may prefer undertaking the misfolding pathway 
to aggregation (green arrows). Native proteins under stress gaining 
free energy may partially unfold to a state from which it can readily 
seek a more stable misfolded state [3] and further aggregate (brown 
arrow) [2]. ATP-fueled unfoldase chaperones drive the substrate 
uphill the free energy barrier (red arrows) by converting stable aggre-
gates and misfolded species into unfolded products with a higher free 
energy. From there, if conditions are favorable to the end product, the 
unfolded species can collapse to the stable native state
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The catalytic unfolding of stable misfolded polypeptides 
by Hsp70s and Hsp60s, like other enzymatic reactions, 
starts with the misfolded polypeptide acting as a high-affin-
ity substrate, the unfolded species as an unstable intermedi-
ate of the reaction with a yet higher affinity for the cata-
lytic site of the enzyme, and the natively refolding/refolded 
protein as the low-affinity product of the reaction. Owing 
to their demonstrated abilities to convert a stoichiometric 
excess of misfolded polypeptide substrates through succes-
sive cycles of binding, unfolding, release, and native refold-
ing, Hsp70/Hsp110s and Hsp60/CCTs have thus earned the 
qualification of bona fide polypeptide unfoldases [13, 66].
The mechanism by which Hsp70 can use ATP hydroly-
sis to pull and unfold polypeptide segments in stably mis-
folded and aggregated proteins, or pull and unfold alter-
native proteins across the membranes, involves a possible 
direct unfolding effect on the bulky substrate, possibly 
by the clamping of the lid of the chaperone protein bind-
ing domain towards its base [72, 73], as well as by a sub-
sequent more global cooperative entropic pulling action 
[74] between the Hsp70 molecule and the import pore or 
between several Hsp70s concomitantly bound at different 
places on the same misfolded polypeptide [20]. In vitro, 
the ATPase chaperonins GroeL (organized in two homo-
heptameric rings) and CCT (organized in two hetero-octa-
meric rings) that consequently show multiple substrate 
binding sites, can mediate several consecutive cycles of 
binding-unfolding-release-refolding [12, 75, 76]. ATP is 
mostly used to fuel the forceful eviction of high-affinity 
over-sticky intermediates that following several cycles may 
start to accumulate on catalytic unfoldase sites and act as 
competitive inhibitors of the catalytic unfoldase reaction 
[12]. Other chaperones, such as the small HSPs, which are 
not ATPases, could also act as polypeptide unfoldases, pro-
vided an eviction mechanism of the over-sticky intermedi-
ates exists. In the case of the small HSPs, the Hsp70 chap-
erone system has been shown to carry such a regenerative 
function for over-sticky misfolded protein substrates asso-
ciated to sHSPs [61]. Recently, bacterial and mammalian 
Hsp90 has been shown to carry an ATP-dependent activity 
leading, in collaboration with the Hsp70 chaperone sys-
tem, to the refolding of some misfolded polypeptides such 
as luciferase and of native proteins, such as p53 (Fig. 1) 
[77–79].
Noticeably, depending on the conditions, catalytic 
unfoldases can reversibly switch into “holding” chaper-
ones. Under heat stress, heat-labile proteins such as firefly 
luciferase or malate dehydrogenase tend to spontaneously 
convert into stable inactive aggregates [80, 81]. Under 
such unfavorable unstable conditions for the native prod-
uct of the reaction, an active polypeptide unfoldase in the 
cell could result in the deleterious acceleration of protein 
misfolding and aggregation [80]. Thus, whereas at 25 °C, 
equimolar GroeL and GroeS can optimally catalyze the 
in vitro release and the native refolding of a pre-bound 
inactive malate dehydrogenase, at 43 °C, the affinity of 
GroeS for GroeL is reversely decreased with the conse-
quence that as long as the denaturing elevated temperature 
is maintained, GroeL binds (but does not release) the mis-
folded MDH substrate, despite the presence of equimolar 
GroeS and ATP in the solution. Thus, the GroeL-bound 
MDH is prevented from aggregating until the tempera-
ture is decreased and GroeS rebinding can resume, induc-
ing substrate release and native refolding [82]. Similarly, 
the chaperone activity of bacterial DnaK–DnaJ–Grpe can 
be reversibly arrested at elevated temperatures due to the 
reversible decrease of the substrate-release factor Grpe at 
high temperature [82, 83].
Given that various molecular chaperones are expected 
to arrest their catalytic polypeptide unfoldase activity 
under stress and thus become transiently passive “holding” 
chaperone that merely prevent aggregation, they may need 
to be present at much higher cellular concentrations than 
if they were only catalytic unfoldases. This could account 
for the observed very high cellular concentrations of core 
members of the chaperome network, which can reach up 
to 10 % of the total to protein mass [27]. Noticeably, an 
abundant chaperone is not evidence of its inefficiency as an 
unfolding catalyst. Suffice it to be slow, as in the case of 
RuBisCO, which owing to its relative slowness at catalyti-
cally incorporating inorganic carbon into the planet’s food 
chain [84], it also needs to be the most abundant protein in 
the biosphere [85].
Chaperones with disaggregase activity
Bacterial Hsp70 (DnaK), in the presence of its DnaJ and 
Grpe co-chaperones and ATP, has been shown in vitro to 
be able to convert stable preformed small soluble aggre-
gates [70]. Yet, for the disaggregation-unfolding-refolding 
reaction to be optimal, a large molar excess of the Hsp70 
chaperone over the substrate was necessary, a constraint 
that could be explained by a mechanism of entropic pulling 
[69, 70, 74]. To alleviate the necessity for a non-physiolog-
ical excess of Hsp70 over its aggregated substrates, nature 
may have designed specific Hsp70 co-chaperones in the 
form of the AAA+ rings of ClpB/Hsp104 or the Hsp70-
like Sse/Hsp110s.
Hsp100s (also named ClpB in bacteria, Hsp104 in 
yeast, and Hsp101 in plants) are AAA+ hexameric ring-
like chaperones termed “disaggregases” because they act 
as nanomachines harnessing the energy of ATP hydroly-
sis to the forceful unfolding and solubilization of large 
stable protein aggregates to be converted in collaboration 
with Hsp70s (DnaK) into natively refolded proteins (cycle 
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II, Fig. 1) [58, 86]. The disaggregase activity of the bac-
terial Hsp100–Hsp70 (ClpB-DnaK) system is attributed to 
both their individual and reciprocally regulated concerted 
unfolding actions on the stable misfolded and aggregated 
substrates (Fig. 1) [58, 70, 87, 88]. Demonstrating that dis-
aggregation of stable misfolded species is highly conserved 
in evolution, a similar disaggregation mechanism, leading 
to spontaneous native refolding, was initially shown in the 
case of yeast Hsp70 (and Hsp40) and the ClpB ortholog 
Hsp104 [89, 90]. Unlike yeast and plants, metazoans lack 
bona fide ClpB/Hsp104-like disaggregases. Yet, they pos-
sess another disaggregating chaperone couple composed of 
a bona fide Hsp70, loosely associated to an evolutionarily 
related chaperone called Hsp110. Noticeably, Hsp110 in 
animals, also called Sse in yeast, structurally and function-
ally belongs to the Hsp70 family [66, 91]. It is not to be 
confused with the Hsp100 chaperones, which are unrelated 
to Hsp70s and are rather AAA+ proteins. Hsp110 and Sse 
were initially described as mere NeF of the Hsp70 (Ssa in 
yeast) chaperones [92–94] and indeed, even without ATP, 
human Hsp110 was shown to induce the release of an 
unfolded substrate from human Hsp70, exactly as bacte-
rial Grpe induced the release of unfolded protein bound to 
bacterial DnaK [13, 66]. Moreover, suggesting a tight link 
between ATP-fueled unfolding and disaggregation, Hsp110 
with Hsp40 (but without Hsp70) was found to be able to 
unfold misfolded luciferase monomers, but not large aggre-
gates [66]. In contrast, human Hsp110 and Hsp70 chaper-
ones (with Hsp40) were shown to concertedly act as equal 
partners that use ATP hydrolysis to disaggregate and unfold 
large stable luciferase aggregates [39, 66, 91, 95, 96] 
(Fig. 1). The NeF, Bag1, could not substitute for Hsp110 
as a co-chaperone of the disaggregation mechanism [95]. 
Interestingly, the cytoplasm of plants, yeast, and fungi har-
bors both Hsp100–Hsp70 and Hsp110–Hsp70 disaggre-
gating machineries, suggesting that the two do not quite 
overlap in terms of their respective aggregate specificity. 
Thus, although the human cytoplasm propitiously carries at 
least one effective disaggregation system (Hsp110–Hsp70), 
compared to yeast it may still suffer from lacking the 
Hsp104–Hsp70-based disaggregating machinery, a loss of 
function that possibly contributes to the excessive sensitiv-
ity of aging metazoan neurons to toxic protein aggregates.
Chaperones with polypeptide translocase activity
Trigger factor (TF), initially described as a putative pep-
tidyl-prolyl cis–trans isomerase, is a bacterial chaperone 
that transiently associates to the ribosomal protein L23, 
where the growing polypeptide chain exits the ribosome 
and enters into the crowded cytosol. TF lacks ATPase 
activity. It passively interacts with most polypeptides early 
during synthesis where it possibly acts as a peptidyl pro-
lyl isomerase, i.e., as a foldase, accelerating native folding. 
It is the first chaperone to associate with nascent chains, 
thereby acting upstream to the cytosolic DnaK and GroeL 
unfoldase chaperone machineries [97–103]. Already dur-
ing passage through the ribosomal tunnel, nascent chains 
may acquire some wrong secondary structures [104]. TF is 
reported to “hold” the nascent chain and thus apply some 
pulling and unfolding on the exiting polypeptides [105, 
106]. Moreover, TF’s particular shape allows it to mould 
the de novo folding of small polypeptide domains [107] in 
a direct assisted-folding mechanism of the nascent chains 
that is clearly distinct from the pulling and unfolding mech-
anism by DnaK. In addition to its role at the ribosomal exit 
in de novo protein folding, in vitro assays with artificially 
unfolded polypeptides have shown that TF can also pro-
mote proper native refolding without ribosomes, by tran-
sient holding/pulling and/or by acting as a peptidyl prolyl 
cis-trans isomerase [108–110].
eukaryotes have evolved a different co-translational 
folding machinery that involves specific variants of Hsp70 
and Hsp40. In yeast, this system consists of an Hsp70-like 
chaperone, Ssz1 (Hsp70L1 in humans), a J-protein, Zuo1 
(MPP11 in humans), and a stable, ribosome-associated het-
erodimer named RAC, with two functionally interchange-
able Hsp70s, Ssb1 and Ssb2, thus forming a chaperone 
triad at the ribosome tunnel exit (Fig. 1). when expressed 
in S. cerevisiae, E. coli TF can bind to the yeast ribosomes 
and partially complement a knockout of the yeast riboso-
mal chaperone triad [111]. In mammals, Ssb is absent, but 
is functionally replaced by the abundant cytosolic Hsc70 
[112, 113]. RAC acts as a co-chaperone that stimulates 
the ATPase activity of Ssb (Hsp70) through the J-domain 
of Zuo1 [114]. Like other J-proteins, Zuo1 associates with 
ribosomes and target Hsp70 (Ssb) onto the growing poly-
peptide at the exit of the ribosomal tunnel [113] (Fig. 1).
Moreover, Hsp70 chaperones can assist in general in 
the post-translational translocation of polypeptides across 
the membranes of organelles, such as the endoplasmic 
reticulum (eR), mitochondria, and chloroplast [115–117]. 
The energy necessary to unfold a cytoplasmic precursor 
protein and translocate it unidirectionally into an orga-
nelle through a narrow pore allowing only unfolded poly-
peptides to cross, may come from the membrane potential 
driving the polypeptide initial insertion into the pore [118] 
and ATP hydrolysis by the Hsp70 (mtHsp70, also known 
as Mortalin, in mitochondria, and BiP in the eR) acting 
as an import motor on the acceptor side of the membrane 
[119–122]. The reversible docking of mtHsp70 to the pore 
and binding (locking) onto the entering polypeptide is 
simultaneously regulated by the pore-anchoring proteins 
Tim44 and the J-domain proteins Pam18/Pam16, and 
by the nucleotide exchange factor, Mge1. Similarly, the 
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post-translational translocation of specific proteins across 
the membrane of the eR to the lumen involves a pore-like 
protein, Sec63, which exposes a J-domain on the lumen 
side and by doing so, acts as a reversible anchor to BiP, 
the eR Hsp70 [116].
Two divergent models were initially proposed to explain 
the mechanism of chaperone-mediated unfolding and uni-
directional translocation of precursor protein to the mito-
chondria. The first was the Brownian ratchet model, where 
polypeptide-bound mtHsp70 was suggested to act as a 
ratchet that passively prevents backsliding to the cytoplasm 
and thus driving the polypeptide’s inward translocation 
[121, 123–126]. The second model, called power stroke, 
suggested that a polypeptide and pore-bound mtHsp70 
could use the energy of ATP hydrolysis to undergo a con-
formational transition that, exploiting the pore as a fulcrum, 
would act as a lever arm applying an inward force on the 
polypeptide and causing its unfolding on the cytoplasmic 
side and subsequent import [127–133]. Taking advantage 
of new mechanistic information in the absence of an import 
pore, on the involvement of Hsp70 (DnaK) and Hsp40 
(DnaJ), in the ATP-fueled solubilization and unfolding of 
stable protein aggregates, a unifying model called entropic 
pulling was proposed. It reproduced the combined effects 
of the two models above by drawing attention to the fact 
that upon release from the pore (or from the aggregates), 
an Hsp70 molecule locked onto a substrate polypeptide 
applies a pulling force of entropic origin on the polypeptide 
that needs neither coordinated structural transformations in 
Hsp70 nor a mechanical fulcrum. Instead, the pore and the 
surrounding membrane, or a large aggregate, constrain the 
freedom of movement (thus, the entropy) of the polypep-
tide–chaperone complex, with an effect that decreases as 
the distance of the complex from the constraint increases. 
As a consequence, because of thermodynamics, the com-
plex is entropically pulled away from the pore or from the 
aggregate. In entropic pulling, the energy of ATP is not 
directly converted into a mechanical force, as postulated 
by the power-stroke model, but rather into an indirect ther-
modynamic force. In the case of translocation, such force 
remains operative only until 30–40 amino acids have been 
imported, reducing thereafter to a pure ratchet, unless a 
new Hsp70 molecule binds [74, 134].
Chaperones with targetase activity
J-domain proteins are also described as holdases [135] 
but they are principally obligate co-chaperones of the 
Hsp70/Hsp110s ATPases. J-proteins bind first to misfolded 
[69, 70], alternatively folded chaperone substrates [136], or 
to unfolded polypeptides at the ribosomal exit pore [137], 
or at the import pores of mitochondria or eR [138–140], 
and may thus attract Hsp70 molecules onto their putative 
protein substrates. The docking of the highly conserved 
J-domain to the nucleotide binding domain of Hsp70 (or 
Hsp110) molecule poises the latter to hydrolyze ATP and, 
by allostery, causes the locking of the protein binding 
domain upon a misfolded, unfolded, or alternatively folded 
polypeptide substrate. The locking of a single Hsp70 mol-
ecule may cause the global unfolding of a single domain 
protein, as in the case of firefly luciferase that acts virtu-
ally as a single domain protein [13]. However, in the case 
of a multidomain polypeptide, such as G6PDH, the locking 
of a single Hsp70 is expected to cause only a local partial 
unfolding of the bound polypeptide segment [69, 141, 142]. 
In this case, the collaborative action of several concomi-
tantly bound Hsp70s at different places on the same poly-
peptide can cause an additional pulling effect of entropic 
origin, leading to the global unfolding of the protein (cycle 
I and II, Fig. 1) [69, 74]. Subsequent to Hsp70-mediated 
unfolding of the substrate, a nucleotide exchange factor, 
such as bacterial Grpe, or eukaryotic Bag3, may cause 
the dissociation of ADP and of the unfolded product from 
Hsp70 [143]. The product may then spontaneously refold 
to the native state [13]. If at this stage, misfolding happens 
rather than native refolding, further unfolding cycles may 
be needed until all molecules have reached the most stable 
native state (cycle I, Fig. 1).
Recently, it was reported that mere binding of Hsp40s 
(DnaJ) could cause some unfolding within a polypep-
tide [144]. This is, however, not a general effect as a large 
molar excess of bacterial DnaJ was shown not to disturb 
wrong beta sheets in a stable misfolded luciferase species, 
whereas substoichiometric amounts of DnaJ supplemented 
with DnaK and ATP readily unfolded it [13]. In the cyto-
plasm and the eR of human cells, the total copy number 
of J-proteins is respectively 6.4- and 9.6-fold less than the 
sum of the copy number of Hsp70 and Hsp110 present in 
the same compartments, confirming that J-proteins unlikely 
act as equal stoichiometric partners of the Hsp70/Hsp110 
unfoldase machinery, but rather as catalysts [27]. Indeed, 
in vitro refolding assays show that J-proteins (Hsp40s) are 
optimally acting when present in sub-stoichiometric ratios 
compared to their Hsp70 partners as in the cell [36, 91]. 
Thus, 20 times less DnaJ than DnaK can drive at half opti-
mal rates the active refolding of stably heat-preaggregated 
G6PDH enzyme [36]. This apparent catalytic mode of 
action by J-proteins implies that J-proteins should not act 
as holding chaperones but would rather need to be able to 
readily dissociate from their substrates as soon as Hsp70 
has hydrolyzed ATP and thus evicted the bound J-domain 
from the nucleotide binding domain, while concomitantly 
locking and unfolding the polypeptide substrate in the 
protein binding domain. Remarkably, once the DnaJ has 
bound to an aggregated substrate and recruited the DnaK 
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and once ATP-fueled DnaK locking onto the misfolded 
polypeptide has caused the substrate to unfold, this disen-
tanglement is observed to effectively drive DnaJ dissocia-
tion, likely because the ATP-fueled DnaK-mediated unfold-
ing destroyed the high affinity DnaJ-binding sites (cycle I, 
Fig. 1) [36, 145]. In the cell, this may be illustrated in the 
case of the J-protein auxilin, which in collaboration with 
Hsc70 mediates the de-oligomerization of clathrin baskets 
in an ATP-dependent manner. Auxilin, which is ~2,700 
times less abundant than Hsc70 in the cytoplasm, initially 
binds to the clathrin heavy chain, then it entraps Hsc70 by 
way of inserting its high affinity J-domain in the nucleo-
tide-binding domain. This triggers ATP hydrolysis and 
causes the locking of the protein binding domain of Hsc70 
onto the heavy chain [27, 146, 147]. In vitro, the binding 
of auxilin to clathrin saturates at three auxilin molecules 
per clathrin triskelion [148]. However, when auxilin acts as 
co-chaperone for the targeting Hsc70 onto clathrin baskets 
in the uncoating reaction, only catalytic amounts of auxi-
lin are required, compared to the Hsc70 and the triskeli-
ons [149]. Thus, rather than being referred to as holdases, 
J-proteins in general would better answer to the definition 
of the “Hsp70/110-targetases” (Table 1).
In conclusion, various well-known conserved families 
of molecular chaperones share the ability to bind more or 
less tightly and less or more reversibly, to misfolded, aggre-
gated, unfolded, or alternatively folded proteins, but not to 
native proteins. They may, however, strongly differ in the 
outcome of polypeptide binding. Upon binding, some chap-
erones may cause spontaneous unfolding of the polypeptide 
substrate, others merely prevent aggregation, and yet others 
may need to use the energy of ATP hydrolysis to forcefully 
unfold, pull apart, de-oligomerize, and/or disaggregate 
various polypeptide substrates. Because passive, tight poly-
peptide binding by a chaperone is not a catalytic process, 
the suffix “-ase” should be avoided, and the term “holding” 
chaperones used instead. Because there is a growing num-
ber of molecular chaperones that upon substrate binding 
and unfolding, end up releasing their bound polypeptides 
in a folding competent state within a biologically reason-
able time scale, these chaperones deserve the label of poly-
peptide unfoldases acting as bona fide enzymes. They are 
functionally related to the class 5 isomerases. Like pepti-
dyl prolyl cis–trans isomerases, Hsp70s, or GroeL/CCTs, 
they do not obligatorily require the breakage of a covalent 
bond in their polypeptide substrates to catalytically unfold 
them. Like topoisomerase, they may need to hydrolyze 
ATP to drive the conformational changes in the misfolded 
substrates, although catalysis does not change the overall 
chemical composition [54].
Type I and type II J-proteins can apparently bind to 
unfolded or misfolded polypeptides and thus inciden-
tally also prevent their aggregation to some degree. 
Other J-domain proteins can bind to alternatively folded 
substrates, such as sigma 32 [150], and SNAReS that 
are substrates that do not tend to aggregate under physi-
ological conditions. Likewise, auxilin is a J-protein that 
can bind only to the alternatively folded clathrin cages 
and Pam16/18 of the mitochondrial import pore do not 
directly bind to any substrate protein per se but only 
indirectly by way of the nearby pore [18, 20, 151, 152]. 
Rather, J-domain proteins principally act as chaperone tar-
geting devices. In sub-stoichiometric amounts, they drive 
the binding and “locking” of Hsp70s and/or Hsp110s 
onto their various alternative, misfolded, or translocating 
unfolded polypeptides substrates, leading to effective pull-
ing, unfolding, and, upon product release, to native refold-
ing. J-domain co-chaperones should thus best be termed 
Hsp70/110 targetases.
Table 1 summarizes the main classes of conserved 
molecular chaperones, the various well-established and yet 
ill-characterized molecular activities, from passive hold-
ing and targeting to spontaneous and ATP-fueled catalytic 
unfolding, disaggregating, pulling, and translocating.
Proteins that need to alternate between various states 
in order to carry their physiological functions may also 
bear an intrinsic sensitivity to environmental changes. 
Thus, labile proteins in cells under mild stresses may 
tend to unfold and transiently expose hydrophobic resi-
dues to the crowded hydrophilic environment, which, 
depending on the stress intensity and duration, may lead 
to intra-molecular misfolding and the gradual formation 
of increasingly stable inter-molecular ensembles called 
aggregates or amyloids. Likely owing to wrong hydro-
phobic interactions, the earliest forms of misfolded and 
aggregated species can compromise the integrity of cel-
lular membranes and the stability of other labile native 
proteins [153–155]. Moreover, in animal cells, misfolded 
Table 1  The major conserved families of molecular chaperones with their established functions, as well as their yet-to-be-demonstrated pos-
sible additional functions
Function(s) Hsp100 (ClpB) Hsp70/110 (DnaK) Hsp60 (GroeL) Hsp90 (HtpG) Small-Hsps J-Proteins
Generally accepted 
function
Disaggregase [58, 86] Unfoldase [13]
Translocase [159]
Holding [160]
Folding [161]
Holding [162] Holding [61] Holding [135]
Possible additional 
function
Unfoldase [163] Disaggregase [39, 66, 70]
Holding [164]
Unfoldase [6, 12] Unfolding [77] Folding [68] Hsp70/110
Targetase [74]
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conformers induce apoptotic signals, which can lead to a 
gradual loss of neural tissue, as in Alzheimer’s and Par-
kinson’s diseases [4]. These ensuing degenerative condi-
tions are late-onset diseases, likely because they corre-
late with an age-dependant decreased ability of neurons 
to sense various abiotic stresses and thus to appropriately 
produce protective HSPs [156]. In youth, however, when 
the cellular stress response is optimal, the HSP chaper-
one network can effectively prevent and avert the forma-
tion of early misfolded and aggregated proteotoxic con-
formers. It is therefore essential to understand which of 
the specific holding, unfolding, targeting, pulling, and/or 
disaggregating mechanisms the various members of the 
cellular chaperone network are using, individually and in 
collaboration, to reduce proteotoxic species and convert 
them into harmless, degraded or “rehabilitated” functional 
native proteins [100]. Detailed knowledge of the various 
chaperone mechanisms is central to the design of future 
chaperone-based therapies against protein conformational 
diseases and aging.
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 PERSPECTIVES 
 The study presented in this thesis 
showed that misfolded species which are likely 
to be the earliest species to form in the toxic 
aggregation pathway (chapter 2) can be 
efficiently reverted to the native state by 
chaperones acting as polypeptide unfoldases, 
such as Hsp70/Hsp110 and GroEL/CCT 
(Chapter 3 and 4). The early species in the 
aggregation pathway are said to be more toxic 
compared to the final aggregates, amyloids or 
fibrils. Once aggregation occurs, it can render 
chaperone systems less efficient e.g. α-
synuclein oligomers inhibit Hsp70 unfolding 
system (chapter 5). From this study, it appears 
that chaperones, particularly polypeptide 
unfoldases, must be available when the 
misfolded species are formed in the cell so that 
they can become unfolded and reactivated as 
native proteins before they become inhibitory 
and toxic after misfolding. Future studies 
should now address whether the misfolded 
species that have been isolated and 
characterized here, are indeed toxic to cells as 
expected. Moreover, other polypeptide-
unfolding chaperone systems need to be 
explored in addition to the Hsp70/Hsp110 and 
chaperonins (GroEL/CCT). Our meta-analysis 
of chaperone expressomic (Chapter 6) 
revealed that under different stress conditions, 
cytosolic chaperones are organized in three 
core chaperone network hubs contributed by 
Hsp70s, Hsp90s and small-Hsp. It is tempting 
to speculate that like Hsp70s, Hsp90s and 
sHsps can also act as polypeptide unfoldases 
of misfolded proteins. So, exploring the role of 
Hsp90s and sHsps in the active unfolding and 
refolding of misfolded proteins is the next 
important question that needs to be addressed. 
Finally, the mechanism by which Hsp110 
collaborates with Hsp70 (chapter 3) at 
disaggregating various large stable protein 
aggregates is completely unknown and it needs 
to be deciphered in order to control the protein 
disaggregation in animal cells. 
 Molecular chaperones are optimally 
expressed under stress, in youth and in 
cancerous cells resistant to chemotherapy. The 
expression of molecular chaperones become 
defective in aging cells that leads to many 
neurodegenerative diseases. The defective 
chaperone expression is thus an apparent 
central cause for aging and protein-
conformational diseases. There are several 
intuitive questions that need to be addressed, 
like why chaperone load decreases during 
aging and what measures may be undertaken 
to slowdown this process and restore the 
chaperone load in aging cells as in youth? On 
the other hand we need to understand and 
control how chaperone overload may lead to 
resistance of cancer cells to stress and 
chemotherapy in particular. The exploration of 
chaperone-inducing or chaperone-inhibiting 
drugs could be a therapeutic approach that 
holds great promise in combating aging and 
cancer. Yet, chaperone-inducing drugs against 
protein misfolding diseases could be 
oncogenic, emphasizing the importance of a 
detailed understanding and the specific 
differences of action between various 
chaperone and co-chaperone orthologs within 
given conserved chaperone families. 
 
 
